Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39428,-0.190436231328046,0.00804859915182702,-0.206211485665627,-0.174660976990465,1.53462284024056e-121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39455,-0.0782936850343842,0.0037142906039279,-0.0855736946180828,-0.0710136754506855,3.16532508798157e-97
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,39123,-0.220745996771032,0.0109665119305272,-0.242240360154865,-0.199251633387199,6.48863389221713e-89
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36847,-0.160169111759819,0.00835666316584036,-0.176548171564866,-0.143790051954772,1.02952258813063e-80
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39621,0.190778298390236,0.010402996196855,0.1703884258444,0.211168170936071,2.57530630451561e-74
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36916,-0.0820024211827007,0.00453692661217174,-0.0908947973425573,-0.0731100450228441,4.20771732889844e-72
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39531,0.0477319735151125,0.00281391763399364,0.0422166949524849,0.05324725207774,6.058432710822e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37255,-0.0611136424093733,0.00371281791820385,-0.0683907655290528,-0.0538365192896937,2.94447489740346e-60
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39601,-0.051845453820697,0.00326638556863236,-0.0582475695352165,-0.0454433381061776,2.79477767291937e-56
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),37006,0.23783256550174,0.0155734559082818,0.207308591921507,0.268356539081972,3.4753342560089e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,37243,0.0653591636632214,0.00431314254252881,0.0569054042798649,0.0738129230465779,2.00706350495329e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,37164,-0.0910178744329694,0.00605269315379748,-0.102881153014412,-0.0791545958515263,1.13512909389092e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,37243,0.0315724837544468,0.00211373519745013,0.0274295627674446,0.0357154047414491,5.00908780895161e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36955,-0.0676435968075216,0.0045388490870414,-0.0765397410181228,-0.0587474525969205,8.39527419366046e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39509,-0.0405107901254005,0.00287309243799999,-0.0461420513038805,-0.0348795289469205,7.31971568605149e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39258,0.0667703241751802,0.00475542080109686,0.0574496994050303,0.07609094894533,1.69015056160625e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36880,-0.147118958977077,0.0107183276444772,-0.168126881160252,-0.126111036793902,1.45082397423392e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39541,0.0322338830402182,0.0023958589514643,0.0275379994953481,0.0369297665850882,5.02754411678111e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,39106,-0.0699366226796291,0.00530070529438537,-0.0803260050566244,-0.0595472403026338,1.5996684633957e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,37247,-0.0917327368380933,0.00707760696708043,-0.105604846493571,-0.0778606271826157,3.54029026723681e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39455,0.0347612604023849,0.00280654020287458,0.0292604416047508,0.0402620792000191,4.62838585854971e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39526,0.0411687304028614,0.00333969951422871,0.0346229193549732,0.0477145414507497,9.52016892465869e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39462,-0.110207796511913,0.00895833599757142,-0.127766135067153,-0.0926494579566728,1.29298198786797e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,37243,0.0583721457350023,0.00477051589130123,0.0490219345880519,0.0677223568819527,3.10043481063821e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38988,-0.109013245101933,0.00899860811075985,-0.126650516999022,-0.0913759732048437,1.28576696133235e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39502,0.0214494570473014,0.00178560053108023,0.0179496800063842,0.0249492340882187,4.33010461291119e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39428,-0.0370061940933979,0.00308556968053901,-0.0430539106672544,-0.0309584775195414,5.45503473210867e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37203,0.0388003662275716,0.00323846355953977,0.0324529776508736,0.0451477548042695,6.70258522577666e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39428,-0.0382076933744769,0.0031917008728239,-0.0444634270852118,-0.0319519596637421,7.125880529326e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,37243,0.0502033234357619,0.00420742628751619,0.0419567679122302,0.0584498789592937,1.20007519668014e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39355,-0.0620398166452376,0.00531909675031773,-0.0724652462758603,-0.0516143870146148,2.67507144564631e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,39104,-0.051210524861764,0.00446011804099812,-0.0599523562221203,-0.0424686935014077,2.1946961014829e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39485,-0.0609695752699044,0.00533010556657056,-0.0714165821803827,-0.0505225683594261,3.5697871701881e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39534,-0.0343413759977999,0.00305440708380977,-0.040328013882067,-0.0283547381135327,3.2680634637163e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39414,-0.0400844353822646,0.00360290191095352,-0.0471461231277335,-0.0330227476367957,1.21977585764855e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39479,-0.0755755585431565,0.00682294588715485,-0.08894853248198,-0.0622025846043329,2.09703326132481e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39471,-0.0305159865795301,0.00277049278871633,-0.0359461524454141,-0.0250858207136461,4.16126779617094e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39485,-0.031892917965866,0.00302578562274312,-0.0378234577864425,-0.0259623781452895,6.92796217511842e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,37247,-0.0233257598854037,0.00221720149767148,-0.0276714748208398,-0.0189800449499676,8.86874368533309e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39636,-0.0254978493277465,0.00242601970428464,-0.0302528479481444,-0.0207428507073486,9.50731330959962e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39187,-0.0461497013842876,0.00439163893373961,-0.0547573136944172,-0.0375420890741579,9.73069085506608e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39319,-0.0679731771793785,0.00650605918368313,-0.0807250531793975,-0.0552213011793596,1.83966340895456e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39462,-0.0362136244489743,0.00354820837196231,-0.0431681128580204,-0.0292591360399281,2.23499477930907e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39617,0.0578672792967653,0.00568018410567642,0.0467341184496395,0.0690004401438911,2.69805206018066e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39458,0.156661162667667,0.0155863804531962,0.126111856979402,0.187210468355931,1.07901292013654e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36916,-0.0497328452977474,0.00501748578732698,-0.0595671174409083,-0.0398985731545865,4.49767200265764e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39274,-0.0260923950834394,0.00263580389314171,-0.0312585707139972,-0.0209262194528817,4.9458218666915e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39462,0.0340356758910348,0.0034571444879246,0.0272596726947026,0.040811679087367,8.44329292504431e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38417,-0.0348623178245416,0.00356671520510236,-0.0418530796265422,-0.027871556022541,1.71295142690072e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39545,0.0245817266521336,0.00251635873075903,0.0196496635398459,0.0295137897644213,1.78710403961423e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39518,-0.0553249637926179,0.00570969630619099,-0.0665159685527522,-0.0441339590324835,3.87186680844457e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39636,-0.0450593654423205,0.00468415678629059,-0.05424031274345,-0.0358784181411909,7.63358544313138e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39194,-0.0472536490512598,0.00493667769664069,-0.0569295373366755,-0.037577760765844,1.2125614800561e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36916,-0.0477873715956425,0.00505590982768681,-0.0576969548579086,-0.0378777883333763,3.92022776560736e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39531,-0.0282739154670844,0.00299233054273993,-0.0341388833308547,-0.0224089476033142,3.92128070984359e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39455,-0.0442106735400658,0.00472949675263684,-0.053480487175234,-0.0349408599048976,1.01818216178605e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39455,0.0241042939479061,0.00259357567004546,0.019020885634617,0.0291877022611952,1.68912094915556e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39355,-0.0578965336347303,0.00622999618300522,-0.0701073261534205,-0.0456857411160401,1.70096544901811e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39516,0.0373357091533451,0.0040475300454448,0.0294025502642733,0.0452688680424169,3.22558123908693e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39033,-0.045042696527576,0.00491381970225923,-0.0546737831440041,-0.0354116099111479,5.5265113935627e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37162,-0.0435881551598796,0.00481826194785835,-0.053031948577682,-0.0341443617420773,1.68934834820455e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39601,-0.0531716019575926,0.00588169879677916,-0.0646997315992798,-0.0416434723159055,1.75042596537833e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39568,-0.033753686677313,0.00374461260937926,-0.0410931273916963,-0.0264142459629296,2.22236298416671e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39428,0.032992606787479,0.0036733803829194,0.025792781236957,0.040192432338001,2.98325915540213e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37162,-0.0307997785240375,0.00342871728137184,-0.0375200643955263,-0.0240794926525487,3.00575257531619e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39462,-0.0307652991690463,0.0034727056751996,-0.0375718022924376,-0.0239587960456551,8.95198849407404e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,37255,0.0475452243638281,0.00537197747851013,0.0370161485059483,0.058074300221708,9.83807314218454e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39531,-0.0311992967155494,0.00356231291847445,-0.0381814300357593,-0.0242171633953394,2.1928432361539e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39531,-0.0189440493983045,0.00216364709922605,-0.0231847977127876,-0.0147033010838214,2.24269341109584e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,37203,-0.101468534596195,0.0116299461718708,-0.124263229093062,-0.0786738400993284,2.9957895818926e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39563,-0.0235984858991933,0.00270555343653797,-0.0289013706348078,-0.0182956011635789,3.00814206954887e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39589,-0.0183944574697679,0.00211174004378936,-0.022533467955595,-0.0142554469839407,3.33233463856817e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39191,-0.0576415122720839,0.00663805562354517,-0.0706521012942324,-0.0446309232499354,4.23585680446248e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39568,-0.0907647101427004,0.0104787549859671,-0.111303069915196,-0.0702263503702049,5.10851716232403e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,39125,-0.0383294830186437,0.00442843307238478,-0.0470092118405178,-0.0296497541967695,5.42070470366248e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39436,0.0238357337642821,0.0027709437963334,0.0184046839234686,0.0292667836050955,8.59964607844934e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,37269,-0.028034042801211,0.00326294879451348,-0.0344294224384574,-0.0216386631639645,9.55941695900615e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,39330,-0.040332799985323,0.00471112028383401,-0.0495665957416376,-0.0310990042290083,1.22523012116066e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39636,0.0197851731970876,0.0023228462254858,0.0152323945951354,0.0243379517990398,1.77947552361387e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39601,-0.034111028255405,0.00402341301493366,-0.041996917764675,-0.0262251387461351,2.49724280198495e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39428,-0.0342018568596148,0.00404184156387451,-0.0421238663248089,-0.0262798473944208,2.87044183283045e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36955,-0.0273997758208373,0.00323797498000589,-0.0337462067816488,-0.0210533448600257,2.91895584389461e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,37269,0.0498534315325798,0.00589171038547791,0.0383056791770431,0.0614011838881165,2.92110869069128e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37255,-0.0231655471705273,0.00274307898318417,-0.0285419819775682,-0.0177891123634863,3.36341418307014e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39462,-0.0246419040759682,0.00293620525565782,-0.0303968663770575,-0.0188869417748789,5.18272585259476e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39601,-0.0187312192917571,0.00224298874958368,-0.0231274772409412,-0.0143349613425731,7.34880274196671e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37057,-0.0191396273120075,0.0023009296402824,-0.023649449406961,-0.014629805217054,9.84261951730436e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36955,-0.0236988997307724,0.0028508956492117,-0.0292866552032273,-0.0181111442583175,1.03088079981403e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39187,-0.0497522012177693,0.00599006947976717,-0.0614927373981129,-0.0380116650374256,1.07727412559587e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39636,0.0189995196443518,0.00230169642218184,0.0144881946568754,0.0235108446318282,1.64886241382253e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39541,0.0151036442885891,0.00184091456868927,0.0114954517339581,0.01871183684322,2.50258819397801e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,39355,-0.0298386437789229,0.00363825367822413,-0.0369696209882422,-0.0227076665696037,2.56930089679898e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,39123,-0.0452946141776155,0.00553212302318783,-0.0561375753030637,-0.0344516530521674,2.88365361775852e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39589,0.027139825386105,0.00332766811564181,0.020617595879447,0.0336620548927629,3.73879172754513e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39485,-0.04904300089484,0.00603931617810074,-0.0608800606039174,-0.0372059411857625,4.99566232280737e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39455,0.0173835582581102,0.00214948497181112,0.0131705677133604,0.02159654880286,6.56299159075137e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,37164,-0.0584321908132078,0.00729835305788577,-0.0727369628066639,-0.0441274188197517,1.28533121433532e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,37203,-0.0513540761751281,0.0064221814267743,-0.0639415517716058,-0.0387666005786505,1.39154939467797e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39460,-0.0686803468398689,0.00867586809245689,-0.0856850483010844,-0.0516756453786534,2.61821756238453e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,39104,-0.0419311890031882,0.00530142637974832,-0.0523219847074949,-0.0315403932988814,2.76988843536563e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39450,-0.0137371386359441,0.00174175813436006,-0.0171509845792898,-0.0103232926925984,3.30943808728612e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36861,-0.0552786078250438,0.00700768136189516,-0.0690136632943583,-0.0415435523557293,3.31952808757362e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39428,-0.0573551839903347,0.00728174439008058,-0.0716274029948926,-0.0430829649857768,3.59488453602527e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36916,-0.0256742212195106,0.00326757661384095,-0.0320786713826389,-0.0192697710563823,4.24731127271233e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,39355,0.024770322984493,0.00315582855465842,0.0185848990173625,0.0309557469516235,4.47521215918437e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39420,-0.0209513770569072,0.00267506243281674,-0.026194499425228,-0.0157082546885863,5.11828353625474e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39428,-0.0411699987901201,0.00529651472801342,-0.0515511676570264,-0.0307888299232138,8.15915578359175e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,39280,-0.0248903031537749,0.0032129012412379,-0.0311875895866012,-0.0185930167209486,1.00174615660747e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36847,-0.0385884979087788,0.00498434431472323,-0.0483578127656364,-0.0288191830519213,1.05496339383085e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39654,0.0199498825624228,0.00258319483267065,0.0148868206903884,0.0250129444344573,1.20732683518891e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37269,0.0174607375030352,0.0022751517030363,0.013001440165084,0.0219200348409863,1.78006381310505e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39187,-0.0368817488610501,0.00484071029079447,-0.0463695410310073,-0.027393956691093,2.71015287313254e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37182,-0.0562976197382864,0.00740991243206047,-0.0708210481051249,-0.0417741913714478,3.22710645855683e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39485,-0.0283544078107913,0.00374510057485368,-0.0356948049375045,-0.0210140106840781,3.91644928747104e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,37247,-0.0613501338609602,0.00811068767365991,-0.0772470817013336,-0.0454531860205867,4.17168223049305e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39462,-0.018477874608189,0.00244601751644577,-0.0232720689404227,-0.0136836802759553,4.45473755625679e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39458,-0.0328118804122561,0.00435284447855845,-0.0413434555902306,-0.0242803052342815,5.04361212240681e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37247,-0.0188122920859421,0.00250579601958459,-0.0237236522843279,-0.0139009318875563,6.4249258541926e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39123,-0.0392847174148963,0.00523941440425986,-0.0495539696472456,-0.029015465182547,6.8546030726346e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39541,-0.0391165789587323,0.00523445919790848,-0.0493761189866329,-0.0288570389308317,8.27486552773879e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36955,-0.0322635616710819,0.00431978949160874,-0.040730349074635,-0.0237967742675287,8.63116922943789e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39187,-0.0560839532686206,0.00751802613620034,-0.0708192844955733,-0.041348622041668,9.13970975047848e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39541,-0.0509982881282411,0.00683963011181062,-0.0644039631473899,-0.0375926131090923,9.38258986633375e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39601,0.0301158319880825,0.00409289817428325,0.0220937515664874,0.0381379124096777,1.96160100301662e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39636,0.0190411457381653,0.00258935681771867,0.0139660063754367,0.0241162851008939,2.0275897828823e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39428,-0.0231939406044914,0.00317159056446435,-0.0294102581108416,-0.0169776230981413,2.74408881228219e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36947,-0.0296387257232615,0.00405910101389146,-0.0375945637104887,-0.0216828877360342,3.0115722872812e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39654,0.0157731818070539,0.00216581019571931,0.011528193823444,0.0200181697906638,3.42975881649755e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39524,0.0331407855900542,0.00456546315685645,0.0241924778026155,0.0420890933774928,4.089472462549e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39654,-0.0322642985799619,0.00445048453644174,-0.0409872482713877,-0.0235413488885361,4.38085753116021e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36847,-0.0409120020933079,0.00564278555622966,-0.0519718617835181,-0.0298521424030978,4.4047337873107e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39187,-0.0225832777576672,0.00311904227734238,-0.0286966006212582,-0.0164699548940761,4.69309581481825e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36955,-0.014422224512151,0.00199811114625734,-0.0183385223588154,-0.0105059266654866,5.58357919365213e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39455,-0.027136107353977,0.00377877643303487,-0.0345425091627253,-0.0197297055452286,7.23548227222648e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39485,0.0289802375744014,0.00404313750755765,0.0210556880595884,0.0369047870892144,7.97828962578523e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39455,-0.0229828773193727,0.00321876919164036,-0.0292916649349878,-0.0166740897037576,9.74259726716483e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36992,-0.0279453062395931,0.00391553768436592,-0.0356197601009503,-0.0202708523782359,1.00620620957933e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39601,-0.0181167071688859,0.00254324079692179,-0.0231014591308526,-0.0131319552069192,1.09981086676418e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39477,-0.0335909388954897,0.00472426668316464,-0.0428505015944924,-0.024331376196487,1.21014111790553e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39601,0.0216308248032684,0.00308313693111378,0.0155878764182854,0.0276737731882514,2.38241636103706e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39460,-0.0517554659392803,0.00741063043246559,-0.0662803015869129,-0.0372306302916478,2.99052911150011e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39455,0.0209132826802699,0.00300121895125847,0.0150308935358033,0.0267956718247365,3.34242351305838e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,37221,-0.0333421563482179,0.00479295712371702,-0.0427363523107032,-0.0239479603857325,3.65866596816731e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37203,-0.0180350708378813,0.00259286152996,-0.0231170794366029,-0.0129530622391597,3.68035093799622e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39428,-0.0257220953711769,0.00370067971058727,-0.0329754276039279,-0.0184687631384258,3.78650416607135e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,39104,-0.0219957292158745,0.00317366431660016,-0.0282161112764108,-0.0157753471553382,4.36234355297167e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39462,-0.0330910430696525,0.00478211300317115,-0.042463984555868,-0.0237181015834371,4.7074589140647e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36880,-0.0265074486316622,0.00383808540706843,-0.0340300960295163,-0.0189848012338081,5.21223148497475e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36955,-0.0176140157139465,0.00255170176968934,-0.0226153511825376,-0.0126126802453554,5.34310043290036e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,39194,-0.0315094175087882,0.0045673617935182,-0.0404614466240839,-0.0225573883934926,5.45714082716894e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39462,-0.0383184724419675,0.00555469365236037,-0.0492056720005939,-0.0274312728833412,5.46962285927926e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39104,-0.0340110941745878,0.00493342229063246,-0.0436806018642274,-0.0243415864849482,5.6455869595258e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,37164,-0.0676485813131944,0.00983064175795132,-0.086916639158779,-0.0483805234676098,6.20466111014808e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39455,0.0343636986592614,0.00502169809320879,0.0245211703965722,0.0442062269219506,8.05314248178217e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39526,0.0354834382144636,0.00518915573639029,0.0253126929711386,0.0456541834577886,8.33943505259825e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39636,-0.0227755679534382,0.0033427094007391,-0.0293272783788869,-0.0162238575279896,9.88316548417346e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39123,-0.0374748728000233,0.00551431424895436,-0.0482829287279739,-0.0266668168720728,1.11767881039097e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39427,-0.0295149805221434,0.00434719715236843,-0.0380354869407855,-0.0209944741035012,1.16813797047228e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37255,-0.0322896450962199,0.00476616680274112,-0.0416313320295925,-0.0229479581628473,1.30061642417839e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37164,-0.0346954756974951,0.00512997440805169,-0.0447502255372764,-0.0246407258577138,1.40801228438694e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,37269,-0.0111413892358595,0.00165874509315721,-0.0143925296184476,-0.00789024885327133,1.93656214564263e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,37228,-0.027368093450184,0.00407512633618224,-0.0353553410691012,-0.0193808458312668,1.94836453248089e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39428,-0.0405342820416744,0.00603679200741403,-0.0523663943762059,-0.0287021697071429,1.95449262515606e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39462,0.0183628991950098,0.00274243574102437,0.012987725142602,0.0237380732474175,2.22056492873101e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39344,-0.0224355265457267,0.0033546561036478,-0.0290106525088764,-0.015860400582577,2.34497789275002e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39530,-0.0346056313460594,0.00519722220043362,-0.0447921868589093,-0.0244190758332095,2.86225522790522e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36955,0.021115568089939,0.00317147067372665,0.0148994855694347,0.0273316506104432,2.89233789077945e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,39194,-0.0453219270337278,0.00683763937868801,-0.0587237002159563,-0.0319201538514993,3.51368137738138e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39187,-0.0223143945239765,0.00337709121820604,-0.0289334933116603,-0.0156952957362926,4.04064428275026e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39654,0.0148550669493856,0.00225653905297515,0.0104322504055543,0.0192778834932169,4.75770551589076e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39330,-0.026676593245237,0.00405682834464308,-0.0346279768007374,-0.0187252096897365,5.0030272289787e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36992,-0.0318407154123937,0.00484694599061047,-0.0413407295539902,-0.0223407012707972,5.25731802902766e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39428,-0.0797969546470508,0.0121654507418254,-0.103641238101029,-0.0559526711930729,5.58300350718117e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39601,-0.0265506757347538,0.00405594212940171,-0.0345003223083811,-0.0186010291611264,6.09505022417801e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,37221,-0.026651468120791,0.00407413038131661,-0.0346367636681715,-0.0186661725734104,6.31712209515245e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39289,-0.0267331362552285,0.00409782913848188,-0.034764881366653,-0.018701391143804,7.08010062895233e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39428,-0.0459877474620769,0.00706844289308866,-0.0598418955325307,-0.0321335993916232,7.95938897426064e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,37247,-0.0168800257032449,0.00259677434825808,-0.0219697034258308,-0.0117903479806591,8.30896431724786e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39307,0.0251954137759238,0.00387713083357486,0.017596237342117,0.0327945902097305,8.37266738203187e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,39187,0.0289704191990175,0.00446917984008044,0.0202108267124599,0.0377300116855752,9.32279794657696e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,39332,-0.0261164331021485,0.00405132837624529,-0.0340570367195893,-0.0181758294847078,1.18076120170361e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39589,0.017013114831372,0.00266275547551156,0.0117941140993693,0.0222321155633747,1.71529413395112e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39480,-0.0569040000811028,0.00890901197317353,-0.0743656635485229,-0.0394423366136827,1.73872595122747e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39462,-0.0291684178800208,0.00456873633167095,-0.0381231410900959,-0.0202136946699458,1.77183698070679e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39531,0.015600701431241,0.0024476738508184,0.0108032606836369,0.0203981421788451,1.89902001723633e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39123,-0.0428692085271882,0.00676931616302529,-0.0561370682067178,-0.0296013488476586,2.47648906256921e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,37164,-0.0583652011953205,0.00923381400066143,-0.0764634766366169,-0.0402669257540241,2.68889668613928e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,39403,-0.0432870069899629,0.00686527480855484,-0.0567429456147304,-0.0298310683651954,2.95883506268697e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39601,-0.0149922009682736,0.00239515200016599,-0.0196866988885989,-0.0102977030479482,3.96880525167812e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,37058,-0.0302644304297262,0.00483650426452818,-0.0397439787882015,-0.020784882071251,4.03866442751279e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39495,-0.0371698860827073,0.00595305202267698,-0.0488378680471542,-0.0255019041182604,4.38428998372936e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36916,-0.0355896485482859,0.00570086146925359,-0.046763337028023,-0.0244159600685489,4.4360446433001e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39498,0.0166281042916331,0.00266412034640254,0.0114064284126841,0.0218497801705821,4.45014424056915e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39355,-0.0286133495369392,0.00460843081510593,-0.0376458739345469,-0.0195808251393316,5.47664839573137e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39282,-0.020431960272011,0.00329204068645219,-0.0268843600174573,-0.0139795605265647,5.56285118735777e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39504,0.0176315905098561,0.00284411458312718,0.0120571259269268,0.0232060550927854,5.81850443579557e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39531,0.0227639265647243,0.00367393431735217,0.015563015302714,0.0299648378267345,5.9397459589184e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39428,-0.0308419706282694,0.00498040775078715,-0.0406035698198122,-0.0210803714367266,6.07018313201471e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39589,0.0255265055146411,0.00412643494366592,0.0174386930250559,0.0336143180042263,6.32603069657627e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39485,0.020024071921069,0.00326834230375208,0.0136181210057149,0.026430022836423,9.19715380194625e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39428,0.0157297794661616,0.00256804393175762,0.0106964133599166,0.0207631455724065,9.28350406615185e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39485,-0.0350489955419405,0.00572414643044847,-0.0462683225456195,-0.0238296685382615,9.41088668504923e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39553,-0.0241664086738136,0.00397259314739705,-0.0319526912427118,-0.0163801261049154,1.20587593100001e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36955,-0.0399010107510789,0.00657433797271594,-0.0527867131776021,-0.0270153083245557,1.32264651528613e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37221,-0.0309231563898553,0.00509585096532183,-0.0409110242818861,-0.0209352884978245,1.32931006846642e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37269,0.0144634153850629,0.00239083923021591,0.00977737049383977,0.0191494602762861,1.49331757655406e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39462,-0.0286484266616307,0.0047471421677994,-0.0379528253105175,-0.0193440280127438,1.62824940279684e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37203,-0.0161354212378271,0.00267417263395411,-0.0213767996003772,-0.0108940428752771,1.64588929632238e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39531,-0.0185491831555223,0.00308453243212291,-0.0245948667224832,-0.0125034995885614,1.85623937206737e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39654,-0.0284555760429993,0.00473487103349382,-0.0377359232686472,-0.0191752288173514,1.90009377100942e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39194,0.0218181878636453,0.00363346289252939,0.0146966005942877,0.0289397751330029,1.9607816924927e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37164,-0.044018160803087,0.00733502710461968,-0.0583948139281416,-0.0296415076780324,2.01331948934382e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39531,-0.0114806048662941,0.00191588264258585,-0.0152357348457624,-0.00772547488682587,2.11564062517102e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37255,-0.0246375555735357,0.00411664309005439,-0.0327061760300423,-0.0165689351170291,2.22359180385114e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39589,-0.0704940751036115,0.0117868802879855,-0.0935963604680631,-0.0473917897391598,2.27149737992139e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39445,-0.0440991429405473,0.00740868649572025,-0.0586201684721589,-0.0295781174089356,2.70205844475699e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,39355,0.0133185936990044,0.0022411406476551,0.00892595802960042,0.0177112293684084,2.86488344037317e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39419,0.0254426607384616,0.00428135169357279,0.0170512114190589,0.0338341100578642,2.86643642585581e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39428,-0.0292926117550144,0.00493497596423128,-0.0389651646449078,-0.0196200588651211,2.99030601956994e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39123,-0.0292263955434845,0.00492532737738747,-0.0388800372031639,-0.019572753883805,3.02488085423791e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36955,-0.0412546853625996,0.00695868688349389,-0.0548937116542476,-0.0276156590709516,3.13750106992806e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37247,-0.0152493355822313,0.00258454070245309,-0.0203150353590394,-0.0101836358054233,3.72219485235291e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37243,-0.0316330408867164,0.00536434664840004,-0.0421471603175805,-0.0211189214558523,3.79734356936001e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39582,-0.0323442313811119,0.0054922096551918,-0.0431089623052879,-0.021579500456936,3.96509456844883e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39462,-0.0321514233156375,0.00547205402309606,-0.0428766492009058,-0.0214261974303692,4.30320370036849e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39428,-0.0359879923675733,0.00613029515666767,-0.0480033708746419,-0.0239726138605047,4.43631923111342e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39476,0.0281153253913532,0.00480329431575002,0.0187008685324832,0.0375297822502233,4.91833364556454e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36928,-0.0187741835931728,0.00321332048819594,-0.0250722917500369,-0.0124760754363088,5.26716186766461e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39104,0.0174006079132437,0.00298298214049298,0.0115539629178775,0.0232472529086099,5.54902778601104e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39355,-0.011812601079604,0.00202738946758319,-0.0157862844360671,-0.00783891772314095,5.77672218282319e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39455,0.0203909865172245,0.00350823061532458,0.0135148545111883,0.0272671185232606,6.28609535944692e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37173,-0.0211176514549363,0.00364033399002054,-0.0282527060753765,-0.013982596834496,6.74813425128258e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39455,-0.0344304520319333,0.00593653134813686,-0.0460660534742816,-0.0227948505895851,6.77472083493507e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39428,-0.0400386866678596,0.0069095386468535,-0.0535813824156924,-0.0264959909200267,6.98201256515824e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,39145,-0.0324277515241752,0.00560872756520059,-0.0434208575519684,-0.021434645496382,7.54696813639422e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39636,-0.0206682016908971,0.00359955848247539,-0.0277233363165489,-0.0136130670652454,9.542650028103e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39355,-0.016378664486631,0.00286057855255091,-0.0219853984496308,-0.0107719305236313,1.05025633476089e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36934,-0.0290535864863617,0.00508378711365738,-0.0390178092291302,-0.0190893637435932,1.12246983342924e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39428,0.010163135521245,0.00178076332514002,0.00667283940397052,0.0136534316385194,1.1703871178611e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37230,0.0372120659683605,0.00652317851543931,0.0244266360780995,0.0499974958586215,1.19209733341153e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36955,-0.0201854256319785,0.00354152681050695,-0.0271268181805721,-0.0132440330833849,1.22774290882218e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37243,0.0130716377497162,0.00229564480759417,0.00857217392683168,0.0175711015726008,1.26750824174624e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39355,-0.0375600627870994,0.00660599127765678,-0.0505078056913067,-0.0246123198828921,1.32676151000701e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39455,0.0137282382283405,0.00241522730902461,0.00899439270265225,0.0184620837540287,1.33999921724427e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39462,-0.0395044739110742,0.00695217948287263,-0.0531307456975045,-0.0258782021246438,1.35351386085542e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,37269,-0.037798088284295,0.00665306456234919,-0.0508380948264994,-0.0247580817420906,1.36579936703378e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39507,0.0155121128574128,0.0027404588034516,0.0101408136026477,0.020883412112178,1.53768234538156e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39526,0.0223141918576078,0.00396366032777009,0.0145454176151784,0.0300829661000371,1.83749199102975e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,37030,-0.0314256023365565,0.00558530360500443,-0.0423727974023652,-0.0204784072707478,1.87850565749758e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39268,-0.0741663867940675,0.0131836226249773,-0.100006287139023,-0.048326486449112,1.88159196250097e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39589,0.0147688946623042,0.00263082715747809,0.0096124734336471,0.0199253158909612,2.0142548558817e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39462,-0.0265616547055952,0.00473780066714048,-0.0358477440131905,-0.0172755653979998,2.10307504145991e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,37162,-0.0177806374322858,0.003174262207733,-0.0240021913594425,-0.0115590835051292,2.16913946192803e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,39355,0.0168048991008716,0.00300446257956505,0.0109161524449241,0.022693645756819,2.26694660885751e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39102,0.0234838698275495,0.00420102067462328,0.0152498693052879,0.0317178703498112,2.31070520115249e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39428,-0.025506747367235,0.00456455086378966,-0.0344532670602628,-0.0165602276742073,2.33692987942377e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39485,0.0168873216270399,0.0030223531528959,0.0109635094473639,0.0228111338067158,2.34394961252524e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37247,-0.0294688475008147,0.0052941563955968,-0.0398453940361845,-0.019092300965445,2.65444934569192e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,39166,-0.0215254079096365,0.00386926218821668,-0.0291091617985412,-0.0139416540207318,2.69519661254843e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39589,0.0393446642418184,0.0070889174887608,0.0254503859638472,0.0532389425197896,2.90192415500219e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37247,-0.0313059300441894,0.00564583682025172,-0.0423717702118828,-0.020240089876496,2.99851709046487e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37255,-0.0136967278952337,0.00247166079452545,-0.0185411830525035,-0.00885227273796379,3.05803377045248e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39541,0.0334800841779481,0.00604574036514131,0.0216304330622712,0.0453297352936251,3.11415142535081e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39621,-0.0301495827046645,0.00545830245574391,-0.0408478555179226,-0.0194513098914065,3.37549095988085e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36955,-0.012906225674561,0.00234315676788099,-0.0174988129396077,-0.00831363840951424,3.70000141855669e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39601,-0.0188759835132276,0.00343348283018484,-0.0256056098603899,-0.0121463571660654,3.9117537859989e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39429,0.0176094762124056,0.00320991318906537,0.0113180463618374,0.0239009060629737,4.17884594565856e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36955,0.0196658098741958,0.0035854214205452,0.0126383838899272,0.0266932358584644,4.21658288563458e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36916,-0.0262796501766586,0.00479892374005702,-0.0356855407071704,-0.0168737596461469,4.43090930237616e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,39358,-0.0258189435200886,0.00471945144122559,-0.0350690683448908,-0.0165688186952865,4.55357230728319e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39477,-0.0186218621555285,0.00341099267517994,-0.0253074077988812,-0.0119363165121758,4.85414195400193e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,39104,-0.0172925480405417,0.00317527163646986,-0.0235160804480226,-0.0110690156330608,5.23435730166459e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39079,-0.0337696506056276,0.00620772412286241,-0.0459367898864379,-0.0216025113248173,5.41549815215653e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39601,-0.0218731871951707,0.00402562013838817,-0.0297634026664115,-0.0139829717239299,5.61142400358401e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,37162,-0.00994143349186304,0.00183068075789917,-0.0135295677773454,-0.00635329920638066,5.72435398337513e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39589,0.021935511186025,0.00404615163555013,0.0140050539803468,0.0298659683917033,6.00646088606247e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39499,0.0116257135791073,0.0021481734479538,0.0074152936211179,0.0158361335370968,6.3311939603529e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36906,-0.0135463288609223,0.00250311025709864,-0.0184524249648357,-0.00864023275700899,6.35503418937019e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37162,-0.0275352613199695,0.00512462976064642,-0.0375795356508365,-0.0174909869891025,7.87501800214287e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,37237,0.0160461529837522,0.00298899797782107,0.0101877169472229,0.0219045890202815,8.08242411271632e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,37247,-0.0206190661986822,0.00384505520796896,-0.0281553744063014,-0.0130827579910631,8.35103740252696e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37203,-0.0188074360692918,0.00351093756268923,-0.0256888736921627,-0.0119259984464209,8.61746695341733e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36916,-0.0250011271806114,0.00466821880606379,-0.0341508360404965,-0.0158514183207264,8.67863958509432e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39123,-0.0276334345349815,0.00516337659503174,-0.0377536526612437,-0.0175132164087193,8.83857516781512e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39636,-0.0232641785020978,0.00434969624311967,-0.0317895831386124,-0.0147387738655833,8.99907419096739e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,37247,-0.0122814319571261,0.00229856559278832,-0.0167866205189912,-0.00777624339526097,9.29444612928745e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36955,0.0144543001315911,0.0027056198596669,0.00915128520664394,0.0197573150565382,9.33714469700195e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39392,0.0294434196976968,0.00551247903671908,0.0186389607857274,0.0402478786096662,9.36702904621452e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37057,0.0198725849614901,0.00372341992439228,0.0125746819096813,0.027170488013299,9.60361832960167e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36880,-0.0165465072629355,0.00310151978845109,-0.0226254860482997,-0.0104675284775714,9.72388706704366e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37255,-0.0109446021751088,0.00205160607475006,-0.0149657500816189,-0.00692345426859871,9.73587479675252e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,39104,-0.0245264252871157,0.00460208260883795,-0.0335465072004381,-0.0155063433737933,9.99868296626238e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39601,-0.0312779640530515,0.00587043784268377,-0.0427840222247117,-0.0197719058813913,1.00695231046864e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39601,0.0135835773662766,0.00255005425899125,0.00858547101865379,0.0185816837138995,1.01398234692364e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,39194,-0.0208570299034811,0.00391835474739515,-0.0285370052083756,-0.0131770545985866,1.03619160891336e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36916,-0.0172581228965201,0.00324471001463746,-0.0236177545252095,-0.0108984912678306,1.06231694262829e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,37221,-0.0206236344665636,0.00387910685959522,-0.0282266839113702,-0.0130205850217569,1.07509463755737e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37164,0.0481554988975841,0.00905772013657049,0.030402367429906,0.0659086303652623,1.07564196490471e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39531,-0.0248606376824521,0.00468213633162381,-0.0340376248924348,-0.0156836504724694,1.11376356442656e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39485,-0.0122282585922984,0.00230657924782446,-0.0167491539180343,-0.00770736326656245,1.16498845907791e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39455,0.0127481099924978,0.00240474617099954,0.00803480749733873,0.0174614124876569,1.16655205123237e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36880,-0.0331769905640735,0.0062585295746402,-0.0454437085303683,-0.0209102725977787,1.17087958206372e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39433,-0.0259424581731824,0.00489953593744956,-0.0355455486105836,-0.0163393677357813,1.20775876827637e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39462,0.0227046952062793,0.00429106818733976,0.0142942015590933,0.0311151888534652,1.23256461387061e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36955,-0.0255961852208437,0.00484403957009887,-0.0350905027782375,-0.01610186766345,1.28476641548578e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39549,-0.0225382914581608,0.00427089964514081,-0.0309092547626368,-0.0141673281536848,1.33003874124762e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39482,-0.0212917204893898,0.00403960323234355,-0.0292093428247832,-0.0133740981539965,1.37749392100489e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37221,0.0424027073240006,0.00805350516047163,0.0266178372094762,0.058187577438525,1.4236720942468e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37085,-0.0125755344888781,0.00238976906352013,-0.0172594818533776,-0.00789158712437867,1.4464092623877e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39428,-0.0261506141618373,0.00497088462428747,-0.0358935480254408,-0.0164076802982339,1.45439984222552e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39654,-0.0263816698679379,0.00502444382747366,-0.0362295797697863,-0.0165337599660895,1.53592362961355e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39541,0.0317023560711114,0.00604532788028977,0.0198535134257434,0.0435511987164793,1.5916021249688e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39428,0.0356597515537113,0.00680399688456632,0.0223239176599613,0.0489955854474612,1.61876157301088e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39531,0.0189886916347583,0.00363135339779369,0.0118712389750827,0.026106144294434,1.72618058878164e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39104,-0.0124677713653117,0.00238740642466153,-0.0171470879576483,-0.00778845477297514,1.79125027870607e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39485,0.0327359092936467,0.00626977033263993,0.0204471594416725,0.045024659145621,1.80107599647957e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39485,0.0213383904345579,0.00408915821686329,0.0133236403295058,0.02935314053961,1.82989149448074e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36955,-0.0174035897241064,0.00333485128093045,-0.02393989823473,-0.0108672812134827,1.83067496538196e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39415,-0.0329402507582234,0.00632126459631819,-0.0453299293670071,-0.0205505721494398,1.90298097570311e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39123,-0.0277420274670975,0.00532576859881857,-0.0381805339207819,-0.0173035210134131,1.92411075750389e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39413,0.0150407752128657,0.00288928151866701,0.00937778343627832,0.020703766989453,1.9580918528099e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36483,-0.057075049276871,0.01096292213816,-0.0785623766676646,-0.0355877218860774,1.95935780675458e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36916,-0.0339220518690932,0.00651678383053235,-0.0466949481769366,-0.0211491555612498,1.9672445790356e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39636,-0.0139186845837942,0.00267845695264275,-0.019168460210974,-0.0086689089566144,2.05671343937818e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39427,0.0127190487246581,0.00244849091697405,0.00792000652738891,0.0175180909219272,2.07797241108338e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39303,0.0122399035684765,0.00236070127810898,0.00761292906338294,0.0168668780735701,2.19016117644074e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36916,-0.0133597901461858,0.00257963274370703,-0.0184158703238516,-0.00830370996852007,2.26616096003022e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,37269,0.0106342289700373,0.00205810603561133,0.00660034114023908,0.0146681167998355,2.41457519664647e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,37269,0.0297679614215324,0.00576250109244296,0.0184734592803442,0.0410624635627206,2.42998132728799e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37203,-0.0347952933592938,0.00676111960695234,-0.0480470877889203,-0.0215434989296672,2.69508496688424e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39478,0.0229984928003451,0.00446987815155355,0.0142375316233001,0.03175945397739,2.70576747600679e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39123,0.0214559998259412,0.00417963863348617,0.0132639081043083,0.0296480915475741,2.88103235167483e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39531,0.0169999056678587,0.00331240921839684,0.0105075835998009,0.0234922277359165,2.89952270820233e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36916,-0.0106803079706786,0.0020809959094322,-0.0147590599531658,-0.00660155598819154,2.90520872930152e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39462,-0.032489535530932,0.0063384369813113,-0.0449128720143021,-0.0200661990475619,2.99963669539191e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,37255,-0.0339307803031808,0.00662488599604317,-0.0469155568554254,-0.0209460037509362,3.07168337568994e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37247,-0.0295347856236301,0.00578722926861174,-0.0408777549901091,-0.0181918162571511,3.38314581784839e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39477,0.0181093659541695,0.00355568204211958,0.0111402291516152,0.0250785027567239,3.56561309184018e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39485,-0.0159625513315684,0.00314013455915286,-0.022117215067508,-0.00980788759562877,3.75195726620905e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39622,0.0246456100065949,0.00485029719147046,0.0151390275113128,0.034152192501877,3.79398854772154e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39654,0.0105963403079669,0.00208685847708302,0.00650609769288415,0.0146865829230496,3.86646678160135e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,39123,0.0242129652621792,0.00478731001000635,0.0148298376425668,0.0335960928817917,4.29376226822383e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39566,-0.0138745343141582,0.00274684390370479,-0.0192583483654196,-0.00849072026289683,4.44433370080776e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39462,0.0272929508672117,0.00541419856416394,0.0166811216814504,0.0379047800529731,4.68508600715125e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39654,0.012806205614013,0.00254864913721466,0.0078108533050723,0.0178015579229538,5.09935626046049e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39123,-0.0361631930858305,0.00720233114898492,-0.050279762137841,-0.0220466240338201,5.19953873723554e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37203,-0.0318153680901819,0.0063409072377643,-0.0442435462762,-0.0193871899041639,5.30592265298992e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36916,-0.0271022152360193,0.00541124492831263,-0.0377082552955121,-0.0164961751765266,5.56069882259479e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37203,-0.028585938850345,0.0057101307385751,-0.0397777950979522,-0.0173940826027378,5.6262435537024e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,37164,0.050346047164784,0.0100639106714883,0.0306207822486669,0.0700713120809011,5.73081166428767e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38967,-0.0346986816680685,0.00695859978098059,-0.0483375372387905,-0.0210598260973466,6.2210137710229e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39104,-0.0204412981441933,0.00410227702408327,-0.0284817611113965,-0.0124008351769901,6.33477998763899e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,39104,-0.0175577631055023,0.00352664930074714,-0.0244699957349667,-0.0106455304760379,6.47751177925536e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39400,-0.0148808949936808,0.0029914036017023,-0.0207440460530173,-0.00901774393434429,6.61247803633988e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39411,0.0182406528805755,0.0036737345163375,0.011040133228554,0.025441172532597,6.94033121348046e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39462,-0.0290261369023277,0.00584889449110986,-0.040489970104903,-0.0175623036997524,7.02923573388732e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39434,-0.0388547626736577,0.00783974220905648,-0.0542206574034084,-0.023488867943907,7.2697476017737e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36955,-0.0168941784075403,0.0034110523699463,-0.023579841052635,-0.0102085157624455,7.41180612196859e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39391,-0.0250538854187224,0.00505975210265317,-0.0349709995399227,-0.0151367712975222,7.44079541332774e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39428,-0.0217841571829017,0.0043996317837253,-0.0304074354790033,-0.0131608788868001,7.4499240439707e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,37203,-0.0312462029846269,0.00632202630530597,-0.0436373745430266,-0.0188550314262272,7.81332575294913e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37102,-0.0144563601622004,0.00292997277403864,-0.0201991067993161,-0.00871361352508467,8.16053991493326e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,37247,-0.0161563724998423,0.00328081254951,-0.0225867650968819,-0.00972597990280271,8.56308441673852e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37164,-0.0409958440014209,0.00833827641801412,-0.0573388657807286,-0.0246528222221132,8.91669293507531e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39459,-0.032711311202342,0.00666601321308341,-0.0457766970999855,-0.0196459253046985,9.33658858085793e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39104,-0.0230194186225742,0.00469753150589985,-0.032226580374138,-0.0138122568710105,9.6702434313044e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36916,-0.0297220499567812,0.0060672134083552,-0.0416137882371574,-0.017830311676405,9.76362207797391e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,37141,-0.0181796347558855,0.00371251661630121,-0.0254561673238359,-0.0109031021879351,9.8585104667302e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39462,-0.0240194393174579,0.00490870291053778,-0.033640497022112,-0.0143983816128039,1.00220862632366e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39499,-0.0115900102144294,0.00236913591028128,-0.0162335165985807,-0.00694650383027808,1.00806013730046e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39485,-0.0280112150558432,0.00572964398922748,-0.0392413172747291,-0.0167811128369574,1.02487999653482e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,37203,-0.027014970064392,0.0055333100257213,-0.0378602577148058,-0.0161696824139783,1.06156308423131e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39633,0.0182498390560175,0.0037387180337968,0.0109219517097758,0.0255777264022592,1.06454807059504e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39016,0.0165235294211603,0.00338547736922838,0.00988799377747268,0.0231590650648479,1.06824626062506e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39636,0.0332685962619338,0.00682703759090417,0.0198876025837616,0.0466495899401059,1.10989386319481e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39462,0.0185855492285124,0.00381868828358781,0.0111009201926803,0.0260701782643445,1.1445756232855e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39485,-0.0120862753167437,0.00248528873568989,-0.0169574412386959,-0.00721510939479151,1.16714415964547e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39485,-0.0246245875679895,0.00507097756767871,-0.0345637036006397,-0.0146854715353392,1.20995145584004e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37247,-0.0167330519430841,0.0034497213931659,-0.0234945058736893,-0.00997159801247893,1.24568329080755e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39123,-0.0238403298609757,0.00493328932363252,-0.0335095769352954,-0.014171082786656,1.36164188979136e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39458,-0.0315959903195316,0.00654167856276199,-0.0444176803025451,-0.0187743003365181,1.37914205405296e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37255,-0.0150017706279216,0.00311205485014719,-0.02110139813421,-0.00890214312163307,1.44818364780937e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36955,-0.0301161107396403,0.00625103781928527,-0.0423681448654394,-0.0178640766138412,1.46870210426963e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37162,-0.0218399211487642,0.0045385277427427,-0.0307354355245399,-0.0129444067729885,1.51057521900915e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36861,-0.0144040750969548,0.00299643719689293,-0.020277092002865,-0.00853105819104466,1.54956760604286e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39589,-0.0157953939612817,0.00328732901963219,-0.0222385588397608,-0.00935222908280265,1.56288303023989e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39455,0.0325051386362168,0.00677985973712993,0.0192166135514421,0.0457936637209914,1.6475458821546e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39477,0.0144369690363681,0.00301206533707464,0.0085333209757018,0.0203406170970344,1.65839583685576e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,37203,-0.0157470638382663,0.00328638630385513,-0.0221883809938224,-0.00930574668271027,1.67317497226976e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38961,-0.0171808051579309,0.00358975719574518,-0.0242167292615914,-0.0101448810542703,1.71760754584896e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39123,-0.0261628598506131,0.00546764072189292,-0.0368794356655232,-0.015446284035703,1.72621207379746e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39123,-0.0269112542348459,0.00565027979890109,-0.037985802640692,-0.0158367058289998,1.92734087486472e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39601,0.0246085658792494,0.0051710873049545,0.0144732347615386,0.0347438969969602,1.96470849444104e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,39194,-0.0128070722749483,0.00270208444286927,-0.018103157782972,-0.0075109867669245,2.16033326845159e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,39344,0.009751814647828,0.00205937569083634,0.00571543829378877,0.0137881910018672,2.20718846941958e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39428,-0.0369428774472804,0.00781523734480641,-0.0522607426431009,-0.0216250122514598,2.29898745035232e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39389,0.0102578031435022,0.00217121332499281,0.00600222502651628,0.0145133812604881,2.32832437928192e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37162,-0.0200792073762749,0.00425056783856928,-0.0284103203398707,-0.0117480944126791,2.33854015662284e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36916,-0.0123341516633508,0.00261376690369826,-0.0174571347945994,-0.00721116853210217,2.39679853456014e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36955,-0.0174683389393183,0.00370490867121175,-0.0247299599348933,-0.0102067179437433,2.44420484256458e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39475,0.0213737692423455,0.00453455882378159,0.0124860339477336,0.0302615045369574,2.45649030240038e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,37164,-0.0235068516459004,0.00498777557009912,-0.0332828917632947,-0.0137308115285061,2.46814772836548e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39355,-0.0227441790703416,0.00484070913801245,-0.032231968980846,-0.0132563891598372,2.64392187502418e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39428,-0.0394316604394473,0.00840594165168791,-0.0559073060767556,-0.022956014802139,2.74372836519854e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39123,-0.02936307429593,0.00626747102510286,-0.0416473175051316,-0.0170788310867284,2.82479019342743e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39499,-0.0123944596740147,0.00264600100213466,-0.0175806216381987,-0.00720829770983079,2.83481226026611e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36955,-0.00882806940009111,0.00188938678706548,-0.0125312675027395,-0.00512487129744277,3.0072934971911e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36990,-0.0174371086786645,0.00373901466860251,-0.0247655774291255,-0.0101086399282036,3.1399888574123e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37162,-0.0238794436528256,0.00512843000868864,-0.0339311664698554,-0.0138277208357959,3.25222176185978e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39654,0.00645225331059535,0.00138900471680958,0.00372980406564856,0.00917470255554213,3.42536915052127e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,39194,-0.0198032748927119,0.00426616563188444,-0.0281649595312054,-0.0114415902542184,3.4813261854134e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39455,-0.0184680014780001,0.00399285878127468,-0.0262940046892985,-0.0106419982667018,3.77258154999509e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39428,-0.0226442768059528,0.00490883879255329,-0.0322656008393573,-0.0130229527725483,4.00263267570917e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39355,-0.0148487113872578,0.0032209670993569,-0.0211618069019974,-0.0085356158725183,4.05980613824621e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39520,-0.0263550608500189,0.00572240733552484,-0.0375709792276475,-0.0151391424723902,4.14663942678768e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,37164,-0.0126685797057616,0.00275075849150662,-0.0180600663491146,-0.00727709306240866,4.15496908497003e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39601,-0.0149819820205904,0.00325573394918964,-0.021363220561002,-0.00860074348017866,4.22411774458786e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37164,0.035694511836186,0.0077670715679478,0.0204710515630083,0.0509179721093637,4.35616261571203e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39470,0.0381523970666522,0.00831025218055412,0.0218643027927661,0.0544404913405383,4.44697539493113e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39462,0.0169806734440004,0.00371764635496943,0.00969408658826031,0.0242672602997405,4.9729638336269e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,37255,-0.0166101870987559,0.00364282443589556,-0.0237501229931112,-0.00947025120440065,5.17016615551102e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39455,0.0198056348513085,0.00434541946305234,0.0112886127037259,0.028322656998891,5.20956684897559e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39458,-0.0121067786223778,0.00265665025411428,-0.0173138131204418,-0.00689974412431383,5.22591409887102e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39498,0.00980408202533049,0.00215245300363518,0.00558527413820553,0.0140228899124554,5.28368094879735e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39354,0.0237765780669878,0.00522370649674207,0.0135381133333733,0.0340150428006022,5.36431282458928e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36916,0.0368335233040197,0.00809854214747921,0.0209603806949605,0.052706665913079,5.46255786231929e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37203,-0.0348272120774934,0.00766653674099418,-0.049853624089842,-0.0198008000651448,5.60328340271859e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39462,-0.0325065008015741,0.00716447837642811,-0.0465488784193732,-0.018464123183775,5.74546103105779e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39498,0.010839790332504,0.00239073960969547,0.00615394069750092,0.0155256399675071,5.83031778207891e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39601,-0.0241730139495971,0.00533231135837686,-0.0346243442120158,-0.0137216836871785,5.85115453273299e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39194,-0.0234969751118701,0.00518433363588317,-0.0336582690382011,-0.0133356811855391,5.88026729047013e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39187,-0.0145798367136225,0.00321793485672069,-0.0208869890327951,-0.00827268439444997,5.92209561971282e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,37243,-0.014676443414797,0.00324164100179029,-0.021030059778306,-0.00832282705128801,6.02321776443592e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39654,-0.0230339576754398,0.00509993144830424,-0.0330298233141161,-0.0130380920367635,6.33362727687685e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39462,-0.0370055190485659,0.00819671891141408,-0.0530710881149375,-0.0209399499821943,6.38965310656168e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,37203,-0.0268496162456416,0.00594952704503406,-0.0385106892539084,-0.0151885432373748,6.45195694726068e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37057,-0.0224654829255028,0.00498547516144533,-0.0322370142419357,-0.01269395160907,6.65969744045744e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36880,-0.0226427744892293,0.00502616430277721,-0.0324940565226726,-0.0127914924557859,6.69842137805584e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39636,-0.0136775000408294,0.00304239883143436,-0.0196406017504408,-0.00771439833121806,6.98774974103342e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36861,-0.0181073860458225,0.0040293087952225,-0.0260048312844586,-0.0102099408071864,7.05569708521425e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39532,-0.0268813259288537,0.0059827991432132,-0.0386076122495516,-0.0151550396081558,7.07150864375226e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39589,-0.0262124510308815,0.00584821877682032,-0.0376749598334494,-0.0147499422283137,7.44455203750757e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,39319,-0.0219310645022814,0.00490177896217546,-0.0315385512681452,-0.0123235777364175,7.73020923908583e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,37162,-0.0162955905740625,0.00364967837204917,-0.0234489601832789,-0.00914222096484609,8.07816901718054e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39636,-0.0176538379302034,0.00397614492111205,-0.025447081975583,-0.00986059388482376,9.06194968950198e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39589,0.0118886519592508,0.00268200232410366,0.00663192740400768,0.017145376514494,9.3692044562662e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39601,-0.017979345154262,0.00405936787656961,-0.0259357061923384,-0.0100229841161856,9.52901259242267e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39428,-0.0211997505124071,0.00478847506338518,-0.030585161636642,-0.0118143393881721,9.61197141447977e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,37255,-0.0442457117677332,0.0099939174497702,-0.0638337899692828,-0.0246576335661836,9.62260178407521e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39499,0.0129547461159198,0.00293105940188795,0.00720986968821939,0.0186996225436201,9.94756372598813e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,37247,-0.0138211112597444,0.00313152533119806,-0.0199589009088926,-0.00768332161059625,1.02526606067294e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39601,-0.0133425811056593,0.00302568009378573,-0.0192729140894793,-0.00741224812183925,1.0418888666185e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,37077,0.0419004997000984,0.00950797642848167,0.0232648659002744,0.0605361334999225,1.05735943319686e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39537,-0.040826126317026,0.00927016937299521,-0.0589956582880966,-0.0226565943459554,1.06988480184874e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39455,0.0141227604942118,0.0032193879524831,0.00781276010734492,0.0204327608810787,1.15823108230073e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36847,-0.0265092559865663,0.00604709224422513,-0.0383615567852476,-0.0146569551878851,1.17586173101962e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,39104,0.0287752461592625,0.00656672677529587,0.0159044616796826,0.0416460306388424,1.18424852913904e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39194,-0.027340206424001,0.00624096034109384,-0.039572488692545,-0.0151079241554571,1.19077437574414e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37162,-0.0236134544335544,0.00539184055511293,-0.0341814619215757,-0.013045446945533,1.19914952333818e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39601,0.0288810022166257,0.0066011164038747,0.0159428140650313,0.0418191903682201,1.22149251875268e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39485,-0.0208832674828184,0.00478437869603233,-0.0302606497270418,-0.0115058852385951,1.28038103905084e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39458,-0.0403806799802977,0.00925696808901449,-0.0585243374347661,-0.0222370225258293,1.29624350967255e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37243,0.0203968449773655,0.00469469520838924,0.0111952423689226,0.0295984475858085,1.40568377691406e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,37255,0.0145525854915703,0.00335667740103812,0.00797349778553561,0.021131673197605,1.46597794165355e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,37162,-0.0185167075515684,0.00427852913964159,-0.0269026246652659,-0.0101307904378709,1.51743205316912e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39123,-0.0192188396386348,0.00444677018086138,-0.0279345091931231,-0.0105031700841465,1.55655676945627e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39654,0.0122005522551853,0.00282689829896094,0.00665983158922181,0.0177412729211487,1.59973711063405e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,37196,0.0179335464249274,0.00415856146223183,0.00978276595895307,0.0260843268909018,1.62677245626725e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,39162,0.0153843987625439,0.00356796824845626,0.00839118099556965,0.0223776165295182,1.62978226146505e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39355,-0.0109256848722743,0.00253740902768053,-0.0158990065665281,-0.00595236317802042,1.6741432164134e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36668,-0.0122563349438068,0.00285060204141337,-0.017843514944977,-0.00666915494263661,1.72465193389016e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37216,0.0056351607272088,0.00131066474929468,0.00306625781859123,0.00820406363582637,1.72479874422523e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39428,-0.020890316351616,0.0048632557957615,-0.0304222977113085,-0.0113583349919235,1.75365913031227e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39355,-0.0184571307931658,0.00430661428123067,-0.0268980947843779,-0.0100161668019537,1.83255996593813e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,39187,-0.0195187319252598,0.00456716654277467,-0.0284703783490981,-0.0105670855014214,1.93457399926502e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,37247,0.0104042309713312,0.00243503844622032,0.0056315556167394,0.015176906325923,1.94501589621073e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,37183,-0.0120564316590677,0.00283190612103521,-0.0176069676562967,-0.00650589566183872,2.0834195355195e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36955,0.00823098006081693,0.00193465693928923,0.00443905245981003,0.0120229076618238,2.11050823654268e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39531,0.0111135830122629,0.00261916843824976,0.00598001287329334,0.0162471531512324,2.21698460374758e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37203,-0.0119550348571172,0.00281992285060815,-0.0174820836443091,-0.00642798606992519,2.25605995401971e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39485,-0.0271376553326476,0.0064106880844835,-0.0397026039782352,-0.0145727066870599,2.31768643177326e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,37247,-0.0114820192005811,0.00271253545998375,-0.0167985887021493,-0.00616544969901298,2.32258120292876e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39194,-0.0227701038956329,0.00538222281051943,-0.0333192606042509,-0.0122209471870148,2.34462883678979e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39428,-0.0140173786618705,0.00331467142096399,-0.0205141346469599,-0.00752062267678107,2.36242211909684e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39401,0.0127227481318989,0.00300923538276456,0.00682464678168038,0.0186208494821175,2.372837592549e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39462,-0.0162928318832857,0.00385492189197212,-0.023848478791551,-0.00873718497502032,2.38756090204375e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,39107,0.0212298729230953,0.00502370090272719,0.01138341915375,0.0310763266924406,2.39382333167431e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36847,-0.0255409167109455,0.0060439426475554,-0.037387044300154,-0.0136947891217369,2.39722875574098e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37164,-0.011295700621494,0.00267334822454528,-0.0165354631416028,-0.00605593810138525,2.40286123969197e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,39251,0.0103880713570332,0.00246531874210254,0.00555604662251218,0.0152200960915541,2.52728998870915e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39462,0.0123693908050337,0.00293611280094643,0.00661460971517875,0.0181241718948887,2.53645475014135e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39571,0.0160677048933568,0.00381663200862304,0.00858710615645561,0.0235483036302579,2.56941139725609e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39526,0.0104033680657787,0.00247456556115943,0.00555321956590618,0.0152535165656511,2.63612864203545e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37162,-0.0245276223112831,0.00583810856245103,-0.0359703150936871,-0.0130849295288791,2.67202890426167e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36880,-0.0173851475641835,0.00414180344505702,-0.0255030823164953,-0.00926721281187176,2.7177624057294e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39531,0.0103279535512132,0.00246282795117096,0.0055008107669181,0.0151550963355083,2.76209987382038e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37144,0.0326632244293941,0.00779849352976251,0.0173781771110596,0.0479482717477286,2.82823791721503e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39636,-0.012337348737942,0.00294807320302155,-0.0181155722158642,-0.00655912526001976,2.86915350596568e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39309,-0.0111417915853103,0.002663045263698,-0.0163613603021584,-0.00592222286846225,2.88255468653541e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36916,-0.0152292648216552,0.00364227275659373,-0.0223681194245789,-0.00809041021873149,2.91888374155194e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37255,0.00784399084509163,0.00187688551717179,0.00416529523143492,0.0115226864587483,2.9440284882809e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39541,0.04421601696075,0.0105826435074489,0.0234740356861503,0.0649579982353498,2.95526016596488e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36642,-0.0183009528283577,0.00438174267712435,-0.0268891684755215,-0.00971273718119402,2.97908466144514e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39531,0.0102194009589948,0.00245439936176932,0.00540877820992692,0.0150300237080627,3.14861514362924e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39455,0.0188711687593913,0.00453267525735316,0.00998712525497907,0.0277552122638035,3.15346540601657e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39428,0.0133879032191201,0.00321627762138402,0.00708399908120742,0.0196918073570328,3.16478194840935e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37164,0.0418834461204346,0.0100622589980579,0.0221614184842411,0.0616054737566281,3.16953304074529e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39513,0.00860566452696127,0.00206801492446972,0.00455235527500062,0.0126589737789219,3.18175119768247e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39123,-0.0248937211986724,0.00598284574966151,-0.036620098868009,-0.0131673435293359,3.18872460319132e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39436,0.0227643957262133,0.00547829456180931,0.012026938385067,0.0335018530673595,3.26549898617215e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36880,-0.0125532291515656,0.00302152416925042,-0.0184754165232964,-0.00663104177983475,3.28034849536699e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36955,0.01894688470924,0.00457114367428538,0.00998744310764062,0.0279063263108393,3.42218636014256e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36847,-0.013540364928175,0.00327594518749891,-0.0199612174956729,-0.00711951236067716,3.5999116530469e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39499,0.0126863644669613,0.00307287250948413,0.00666353434837241,0.0187091945855502,3.67101096226178e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39636,-0.0186743617796648,0.00453242703934896,-0.0275579187767888,-0.00979080478254085,3.80603541092327e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36847,-0.0145308901722041,0.00352756258039361,-0.0214449128297756,-0.00761686751463263,3.82586071856403e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36955,-0.0229598727943554,0.00557698577717457,-0.0338907649176175,-0.0120289806710932,3.86475080832604e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37247,-0.0290542290762624,0.00707920320776169,-0.0429294673634753,-0.0151789907890495,4.08291948188696e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39636,-0.0142915722336495,0.00348977425551659,-0.021131529774462,-0.00745161469283695,4.23859486230598e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39434,0.0321477892283117,0.0078551597836136,0.016751676052429,0.0475439024041943,4.28853870378332e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37221,-0.0145097868382244,0.00354628375331464,-0.0214605029947211,-0.00755907068172772,4.31137271163308e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36955,-0.0164959981562919,0.00403882741271576,-0.0244120998852148,-0.00857989642736905,4.44751926876944e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39485,0.0306811569173041,0.00752074073729072,0.0159405050722142,0.0454218087623939,4.53578147921848e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39337,0.0146668917877811,0.003599884891842,0.00761111739977079,0.0217226661757914,4.63988143594755e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39601,0.0229690166992781,0.00563840063571849,0.0119177514532699,0.0340202819452864,4.65124533009452e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39505,0.0205474886133566,0.00504655267537651,0.0106562453696187,0.0304387318570946,4.69322594911252e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39601,0.0118387962651428,0.00290956774870215,0.00613604347768659,0.017541549052599,4.74710847598228e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39428,0.0153478186278845,0.00377309174954097,0.00795255879878424,0.0227430784569848,4.77218704856059e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,39356,0.0103089723811081,0.00253448019987783,0.0053413911893476,0.0152765535728687,4.77667750950239e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39123,-0.0147746483364552,0.00363975957463095,-0.0219085771027319,-0.00764071957017853,4.9488575515445e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37221,-0.0156942603144243,0.00386930421510087,-0.023278096576022,-0.00811042405282655,5.0196816045862e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39291,-0.0213002613402492,0.00525351589377553,-0.0315971524920493,-0.0110033701884492,5.05030101140974e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36847,0.011780515882386,0.00290788026388656,0.00608107056516831,0.0174799611996036,5.12578112450652e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39636,0.0164894677053713,0.00407550133266713,0.00850148509334377,0.0244774503173989,5.2358667085229e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37247,-0.0200253565919716,0.00495561699446628,-0.0297383659011255,-0.0103123472828177,5.35484103812942e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37249,0.00696931678992911,0.00172605361424645,0.00358625170600607,0.0103523818738522,5.42884010052267e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39403,-0.0271388483245059,0.00674811200335266,-0.0403651478510771,-0.0139125487979347,5.80647045594929e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,39355,0.0125023739899137,0.00311051041663092,0.00640577357331706,0.0185989744065103,5.86344069359026e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39654,-0.0159682330114187,0.0039754432942739,-0.0237601018681956,-0.00817636415464187,5.92981629380535e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39104,-0.0147346140529012,0.00366852050317997,-0.021924914239134,-0.00754431386666849,5.93634357799503e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37164,-0.0281871238249818,0.0070188234244261,-0.041944017736857,-0.0144302299131067,5.95514743156622e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39516,0.0109153130154406,0.0027191857504828,0.00558570894449433,0.0162449170863869,5.99404934051694e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39123,-0.01848618165782,0.00460950693814718,-0.0275208152565885,-0.00945154805905153,6.09042079624611e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39428,-0.0348665970360229,0.00869512172434631,-0.0519090356157416,-0.0178241584563041,6.10382428956311e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36880,0.0114307117273887,0.00285979903483026,0.0058255056191214,0.017035917835656,6.45117662976705e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37269,0.0066388095048364,0.00166416195665797,0.00337705206978679,0.00990056693988601,6.66423189599401e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39455,0.0130156029031398,0.00326538830903271,0.0066154418174357,0.0194157639888439,6.75349828959536e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39516,0.0315151240156615,0.00791480963219071,0.0160020971365677,0.0470281508947553,6.87188011347261e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39462,-0.025794463205367,0.00648048927498378,-0.0384962221843352,-0.0130927042263988,6.91444927664508e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37203,-0.0228528413994528,0.00576041519093707,-0.0341432551736894,-0.0115624276252161,7.31133584189792e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,39270,-0.027005578675079,0.00681031876459539,-0.040353803453686,-0.013657353896472,7.36199546002741e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39123,-0.0182391949231017,0.00459982980100885,-0.0272548613330791,-0.00922352851312437,7.36857818944085e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39654,0.00766534916904811,0.00193424453739536,0.0038742298757532,0.011456468462343,7.43619536643798e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,37269,0.00974686089076332,0.0024595341455391,0.00492617396550669,0.0145675478160199,7.44496087081249e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39564,0.0259129149181415,0.00654530792923011,0.0130841113768505,0.0387417184594326,7.56069147629757e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39482,0.0140110104532417,0.00354413723663938,0.0070645014694285,0.0209575194370549,7.74361502668536e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39458,0.0111152966889123,0.00281970667330019,0.00558867160924388,0.0166419217685806,8.11700361141757e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39473,-0.0150168213828815,0.00380953310475718,-0.0224835062682056,-0.00755013649755746,8.12030211230747e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38859,-0.0131007048180313,0.00333149932198811,-0.019630443489128,-0.00657096614693464,8.45045461292106e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36992,-0.0117861543319132,0.00300188635325335,-0.0176698515842898,-0.00590245707953668,8.67422509917113e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39123,-0.0159367856400634,0.00406315771207391,-0.0239005747557282,-0.0079729965243985,8.81194769812945e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39462,0.0287525474452466,0.00734480347663325,0.0143567326310454,0.0431483622594478,9.09245221539716e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39532,0.0394285839915593,0.0100856448902416,0.0196607200066858,0.0591964479764328,9.29394509452034e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39601,-0.0455152662665234,0.0116678980939408,-0.0683843465306474,-0.0226461860023995,9.62509617253373e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36823,-0.0136605441063659,0.00350702893860571,-0.0205343208260331,-0.00678676738669871,9.86380844903439e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39404,0.0210067112303155,0.00540098930760543,0.0104207721874088,0.0315926502732221,0.000100919324254696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39516,0.0199597185909075,0.00513227047435321,0.00990046846117526,0.0300189687206398,0.000101064501094758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37203,-0.016207851553714,0.00416751207526981,-0.0243761752212429,-0.00803952788618521,0.000101129217154761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39428,-0.0357330501485189,0.00919656666086405,-0.0537583208038125,-0.0177077794932254,0.000102568680793326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39329,-0.0117554397328586,0.00303034275140495,-0.0176949115256123,-0.00581596794010492,0.000105232778688505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39654,0.00913447043576449,0.00235592764494677,0.00451685225166882,0.0137520886198602,0.000106097426733095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39426,0.0200615476612672,0.00517644698487828,0.00991571157090575,0.0302073837516286,0.000106840369943009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37203,-0.0214319519736945,0.00554876870907469,-0.0323075386434809,-0.0105563653039081,0.000112801421291347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,37146,0.012267081063822,0.00317702519406818,0.00604011168344833,0.0184940504441956,0.000113398304831579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37203,-0.0214298819948529,0.00556014867190756,-0.0323277733917918,-0.0105319905979141,0.000116681816876931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39485,-0.0121579143115879,0.00315490769765728,-0.0183415333989962,-0.00597429522417963,0.000116853002431587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37203,-0.00751738006003246,0.00195166466044488,-0.0113426427945044,-0.00369211732556049,0.000117836822324059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39428,-0.0360110201124181,0.0093659518150101,-0.0543682856698379,-0.0176537545549983,0.000121107285881117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36880,0.00903722901060974,0.00235041351806362,0.00443041851520504,0.0136440395060144,0.000121176951752283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,39351,-0.0246994154646337,0.00646827567640367,-0.0373772357903849,-0.0120215951388825,0.00013478386907577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39526,-0.0170844470302762,0.00448096004053169,-0.0258671287097183,-0.00830176535083408,0.000138017843482966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39582,-0.0067987140329427,0.0017853460355813,-0.010297992262682,-0.00329943580320336,0.000140611431546893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39568,0.0149309437668558,0.0039226844852822,0.00724248217570268,0.0226194053580089,0.000141613479561206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39636,0.0248196081864245,0.0065277994391216,0.0120251212857462,0.0376140950871029,0.000144012684910742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39549,-0.0204069860807854,0.00537940910505468,-0.0309506279266925,-0.00986334423487821,0.000149095975435237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39431,-0.0230375505226596,0.00607385220447019,-0.0349423008434211,-0.011132800201898,0.000149479545471863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39479,-0.0197030047693118,0.00520140802711383,-0.0298977645024549,-0.00950824503616872,0.000152448351861053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37203,-0.0297387871102214,0.00786464813724292,-0.0451534974592175,-0.0143240767612253,0.000156708074339312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39462,0.0212572637795525,0.00562458039739569,0.0102330862006569,0.032281441358448,0.00015784588212313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39601,0.0205305666247992,0.00543325891869974,0.00988137914414774,0.0311797541054507,0.000158263447183248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39526,0.0160126913899054,0.0042389000027207,0.00770444738457282,0.024320935395238,0.000158982472788382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36847,0.0193478300447403,0.00514798742225476,0.00925777469712092,0.0294378853923596,0.000171836775378508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39410,0.00920270356687597,0.0024567695680321,0.00438743521353305,0.0140179719202189,0.000180454996582247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36916,-0.0189616850343359,0.00506315500225839,-0.0288854688387624,-0.00903790122990951,0.000181181817127307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39428,-0.00708033929149751,0.00189294870709731,-0.0107905187574082,-0.00337015982558679,0.000184430559018253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39654,-0.0176768248133784,0.00472931910768371,-0.0269462902644385,-0.00840735936231833,0.000186384041151934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36847,-0.0157585541744145,0.00421934526974645,-0.0240284709031176,-0.00748863744571146,0.000188680805377087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,39187,-0.0178310679686609,0.00477689336541867,-0.0271937789648815,-0.00846835697244031,0.000190094027606536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39428,-0.0110086970738301,0.00294967275853509,-0.0167900556805589,-0.00522733846710133,0.000190535008866097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39589,-0.0221931993049943,0.00595432713902178,-0.033863680497477,-0.0105227181125117,0.000194293763329254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39187,-0.0190704688756177,0.00512077341588751,-0.0291071847707572,-0.00903375298047817,0.000196714081445704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,37243,-0.023979873005466,0.00644316107215621,-0.0366084687068921,-0.0113512773040398,0.000198690027895522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,37255,0.00761729073995634,0.00205187171009093,0.00359562218817812,0.0116389592917346,0.000206204743993878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39485,0.0256714570107135,0.00691700919004461,0.0121141189982261,0.039228795023201,0.000206898724248865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39428,0.00937770459430357,0.00253611475835899,0.00440691966791995,0.0143484895206872,0.000218368211372548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36916,0.0255352285755246,0.00690765653421921,0.011996221768455,0.0390742353825943,0.000219394844581405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36916,-0.0275933964643236,0.00748947666209864,-0.042272770722037,-0.0129140222066103,0.000230312902901486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39355,0.018911921433535,0.00513796387041301,0.00884151224752555,0.0289823306195445,0.000233304971951077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39387,0.0219524331721232,0.00596607064441794,0.0102589347090641,0.0336459316351824,0.000234470644978207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39485,-0.0253279113590399,0.00689314762872542,-0.0388384807113417,-0.0118173420067381,0.000239273974537088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39654,0.00971224207409279,0.00264579523644022,0.00452648341066996,0.0148980007375156,0.000242599711880668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39391,0.0122118851220304,0.00334107597073247,0.00566337621939474,0.018760394024666,0.000257987481719447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39123,-0.00967285860042964,0.00264835361900599,-0.0148636316936814,-0.0044820855071779,0.000260700513144742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39462,-0.0277204583339819,0.00760547035874796,-0.0426271802371279,-0.0128137364308359,0.00026849760728853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37255,-0.0160947197853607,0.00442003161195413,-0.0247579817447908,-0.00743145782593059,0.000272320604111146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39582,-0.0199038281680702,0.00547211271766642,-0.0306291690946963,-0.00917848724144397,0.000276404404490841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39455,-0.0113383589368613,0.00312219623540928,-0.0174578635582635,-0.00521885431545909,0.000282681047849245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39502,-0.0153876106251668,0.00424620822733162,-0.0237101787507368,-0.00706504249959686,0.000291209122957988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36916,-0.0134444247202102,0.00371317676581229,-0.0207222511812023,-0.00616659825921809,0.00029493372094726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39485,-0.0207115830513204,0.00572533776189427,-0.0319332450646332,-0.00948992103800762,0.000298402047945802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39623,-0.0171144278565183,0.00473909125705948,-0.0264030467203548,-0.00782580899268168,0.000305612138333527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39440,0.00911351094323512,0.00252505085293831,0.00416441127147603,0.0140626106149942,0.000308097717639275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36880,-0.0139677045683588,0.0038717452321342,-0.0215563252233418,-0.00637908391337575,0.000310256130160737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39601,-0.0101297350753243,0.00281166853596045,-0.0156406054058068,-0.00461886474484185,0.000315878166175499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,37203,-0.0181641851531271,0.00504173239771987,-0.0280459806526581,-0.00828238965359615,0.000316046208919043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36880,-0.0155816848377217,0.00433305369202682,-0.0240744700740943,-0.00708889960134913,0.000324393702178174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39455,0.0110925358564436,0.00308612314117405,0.00504373449974248,0.0171413372131448,0.000326273478191047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39462,0.0110269291972963,0.00306804881099877,0.00501355352773867,0.0170403048668538,0.000326534903760991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39458,-0.0116613876055063,0.00324768460796025,-0.0180268494371084,-0.0052959257739042,0.000330872550898186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39531,-0.0264646486361464,0.00737688844989151,-0.0409233499979338,-0.0120059472743591,0.000334910150610211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,39355,-0.0167122854211057,0.00466630539639054,-0.0258582439980311,-0.0075663268441802,0.000342739291616361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,37243,-0.021858812772976,0.00610403430990896,-0.0338227200203975,-0.00989490552555442,0.000343493603699501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36719,-0.0170506596866213,0.00477013422212588,-0.026400122761988,-0.00770119661125456,0.000352297569307044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36880,-0.0155608571777713,0.00435655572412617,-0.0240997063970586,-0.00702200795848404,0.000355841480083976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36955,-0.018041317546573,0.0050651376115288,-0.0279689872651695,-0.0081136478279766,0.000369604096371445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39428,-0.0244669239639647,0.00687779092220476,-0.0379473941714861,-0.0109864537564434,0.000375727480822103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39526,-0.0131621034080229,0.00370009891600658,-0.0204142972833958,-0.00590990953265001,0.000375935772733927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,37162,-0.0125722845729935,0.00354104729368958,-0.0195127372686251,-0.00563183187736193,0.000385974060889596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39123,-0.0139592533657796,0.0039342838758869,-0.021670449762518,-0.00624805696904131,0.00038922471930194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39549,0.0106983951815799,0.00302466854436636,0.00477004483462184,0.016626745528538,0.000405841021697768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39462,-0.0300866812543025,0.00850677256033022,-0.0467599554725497,-0.0134134070360553,0.000406240658514158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39462,-0.00772484413452022,0.00218580691963629,-0.0120090256970074,-0.00344066257203309,0.000410408122262026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36823,0.0286968189077413,0.00815905765598878,0.0127050659020032,0.0446885719134793,0.000437732557670634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39455,0.00746821016262399,0.002123851711397,0.00330546080828588,0.0116309595169621,0.00043881235116348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39462,0.0202111751629862,0.00574852611361432,0.00894406398030217,0.0314782863456703,0.000439578313340961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37162,-0.0226148774620061,0.00643570942052176,-0.0352288679262287,-0.0100008869977835,0.000443000836778761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39381,0.00902446798064335,0.00256980043570519,0.00398765912666117,0.0140612768346255,0.000446499747396778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39187,0.0153930429071731,0.00438608215203463,0.0067963218891852,0.023989763925161,0.000450256157598581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36880,0.0134335596772028,0.00383648739625424,0.00591404438054447,0.0209530749738611,0.000464225496359395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,37247,0.0302478496074403,0.00864319539186582,0.0133071866393833,0.0471885125754973,0.000467516772003127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36861,-0.0189711824255175,0.00542124646585336,-0.0295968254985901,-0.00834553935244491,0.000467918163117888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39549,-0.0229996010692923,0.00658167960898995,-0.0358996931029126,-0.010099509035672,0.000476333342533551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39654,0.0125226492743562,0.00359021670821556,0.00548582452625372,0.0195594740224587,0.000488037404207316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37203,-0.0126025977160884,0.00361855616616448,-0.0196949678017707,-0.00551022763040599,0.000497918698593804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39485,0.00945769755507353,0.00271601470355958,0.00413430873609675,0.0147810863740503,0.000498731148713137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39462,0.021309225951275,0.00612348571296415,0.00930719395386528,0.0333112579486847,0.000502991713492955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39428,0.0140013001809914,0.00402880063294522,0.00610485094041876,0.021897749421564,0.000511722541957763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37221,0.0238119860274609,0.00685287685344066,0.0103803473947172,0.0372436246602046,0.000513040033146843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39104,-0.0156451411450087,0.00450414152227888,-0.0244732585286753,-0.00681702376134212,0.000515198660769757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37164,-0.0157685599383096,0.00454456304662506,-0.0246759035096947,-0.00686121636692448,0.000522643767852285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39554,0.0123536108513366,0.00356525852634285,0.00536570413970457,0.0193415175629686,0.000531709168551413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36916,-0.0184547361726793,0.00532757393494667,-0.0288967810851748,-0.00801269126018381,0.000533987857804498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36847,-0.0245133736381652,0.00708369996276081,-0.0383974255651763,-0.010629321711154,0.000540923557874083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37203,-0.0231200483736126,0.00668354475120492,-0.0362197960859742,-0.0100203006612509,0.000543453580894281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38998,-0.0274703326499798,0.00794717702044647,-0.0430467996100549,-0.0118938656899048,0.000548568083686908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39123,-0.0208210199264913,0.00603279407545627,-0.0326452963143856,-0.00899674353859706,0.000559451266533134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,39104,-0.0254408556093842,0.0073717476068921,-0.0398894809188927,-0.0109922302998756,0.000559819545683694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39322,-0.00878847388740527,0.00254781888552895,-0.013782198903042,-0.00379474887176853,0.000563369200041133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,37255,0.0160297537864527,0.00464704119835296,0.00692155303768088,0.0251379545352245,0.000563531270507261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36847,0.0136105182800507,0.00394631341607531,0.00587574398454311,0.0213452925755583,0.000564705554418487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39531,0.0107005404236774,0.00310439219759999,0.00461593171638144,0.0167851491309734,0.000568597362875825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39428,-0.0135319268167683,0.00392944915001221,-0.0212336471507923,-0.00583020648274441,0.000575337324529256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36880,-0.0242309175730916,0.00705632546103363,-0.0380613154767176,-0.0104005196694657,0.000596842170701969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,39355,0.0104669522090694,0.00305057011877122,0.00448783477627778,0.016446069641861,0.000602666804840362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37221,-0.0168368576132594,0.0049125896646998,-0.026465533356071,-0.0072081818704478,0.000611565271754332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37247,0.0102078588881421,0.00298226488031632,0.00436261972272214,0.0160530980535621,0.00062161279138751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36968,-0.0195769409118373,0.00572533985053219,-0.0307986070188804,-0.00835527480479423,0.000629711155619795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36880,0.0179537991265477,0.0052576657587333,0.00764877423943041,0.028258824013665,0.000640363329101316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39123,-0.0261102272945302,0.00764656756534163,-0.0410974997225998,-0.0111229548664606,0.000640406924029981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39526,-0.0139549323485235,0.00409407917078257,-0.0219793275232574,-0.00593053717378967,0.000654765584127911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37164,0.0288498059042432,0.00846381117102973,0.0122607360090249,0.0454388757994615,0.000654981148674298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39520,-0.0103267992045362,0.00303893176944467,-0.0162831054726477,-0.00437049293642463,0.000680144415242168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37203,0.00934895884542977,0.00275109437839876,0.0039568138637682,0.0147411038270913,0.000680211484928078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36955,-0.0238570714359587,0.00702161209174111,-0.0376194311357713,-0.0100947117361461,0.00068175992255201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36916,-0.0168157138209042,0.00495026659613142,-0.0265182363493218,-0.0071131912924866,0.00068359122410111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,37255,-0.0274572772348102,0.00808477983173683,-0.0433034457050144,-0.011611108764606,0.000685439191678372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39601,-0.0105377064476464,0.00310412315923044,-0.016621787839738,-0.0044536250555547,0.000688687280846015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,37247,-0.0276361222068855,0.00814831118928315,-0.0436068121378805,-0.0116654322758905,0.000696864294727705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39460,0.019819639134635,0.00585320059724634,0.0083473659640322,0.0312919123052379,0.000710701820597318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,39355,-0.0268772731213998,0.00795365750964731,-0.0424664418403086,-0.0112881044024911,0.000728743003560507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39123,-0.015975417557009,0.00472825088733441,-0.0252427892961844,-0.00670804581783351,0.000730146574458652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39654,-0.00781891505383718,0.00231671380874452,-0.0123596741189764,-0.00327815598869793,0.000739996028495135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39462,0.0357524253360704,0.010599880859272,0.0149766588518972,0.0565281918202435,0.000745666971832316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39187,-0.0123311645347344,0.00365667554081503,-0.0194982485947318,-0.00516408047473692,0.000747529439043626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39654,-0.0168468717315011,0.00499645240996104,-0.0266399184550247,-0.00705382500797744,0.000748738118611101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39462,0.0367736599039704,0.0109066581167849,0.0153966099950719,0.0581507098128688,0.000749022622344795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,37255,0.0149645025907228,0.00444784452952595,0.00624672731285192,0.0236822778685936,0.000769245262078126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39606,-0.0208521409544595,0.00622054334053164,-0.0330444059019015,-0.00865987600701749,0.000803852096480763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39428,-0.0183080072689313,0.00547054636457668,-0.0290302781435016,-0.00758573639436102,0.000819954774241694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39485,0.0119801306274523,0.00358724571685519,0.00494912902241616,0.0190111322324885,0.000840892701267197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39601,0.0181304961118108,0.00545159294099689,0.00744537394745684,0.0288156182761647,0.000883986160749294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36955,-0.0160382511752207,0.00482528497065874,-0.0254958097177118,-0.00658069263272957,0.000890570655706777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,39079,-0.0183775059104824,0.00553259467616899,-0.0292213914757736,-0.00753362034519116,0.00089696657339533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,37269,0.0097221045369261,0.0029358921403966,0.00396775594174877,0.0154764531321034,0.000930653756079401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,37162,-0.0114370597273053,0.0034612149989576,-0.0182210411252622,-0.00465307832934839,0.00095460790991642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36847,0.017780216230506,0.00538651984400168,0.00722263733626275,0.0283377951247493,0.000966569018560475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36916,0.00756976969777795,0.00229357032667789,0.00307437185748928,0.0120651675380666,0.000968076622017342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,37221,0.00962209660900939,0.00291794052377587,0.00390293318240868,0.0153412600356101,0.000977937820225232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36955,-0.00822507939639218,0.00250228877238504,-0.0131295653902669,-0.0033205934025175,0.00101531949363589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,37196,-0.00753212347126778,0.00229241695648177,-0.0120252607059721,-0.00303898623656352,0.00102015274464123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,37269,0.00559359999960596,0.0017027833403295,0.00225614465256013,0.00893105534665179,0.00102265271831705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39578,0.00882419332839504,0.00268745722596884,0.00355677716549612,0.014091609491294,0.00102769191203138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36916,0.0200080447006463,0.0060944660221074,0.00806289129731581,0.0319531981039768,0.00102996699603507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37186,-0.011919760022067,0.00363152006976661,-0.0190375393588095,-0.00480198068532442,0.00103239087650728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,39123,-0.0122159288796383,0.0037225555239237,-0.0195121377065288,-0.00491972005274788,0.0010346188498488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36823,0.0141771545092193,0.00432387686121352,0.00570235586124077,0.0226519531571978,0.00104535018253609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39589,-0.00905441391495928,0.00276500363275565,-0.0144738210351603,-0.0036350067947582,0.00106031243273075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39461,0.0274764567203709,0.00839266875906952,0.0110268259525946,0.0439260874881471,0.00106327687786908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36916,-0.0154198408979618,0.00471146580492068,-0.0246543138756063,-0.00618536792031726,0.00106765189822348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,37247,-0.016295380326256,0.00497942366586319,-0.0260550507113478,-0.00653570994116413,0.00106867013394765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39654,0.0123845817360612,0.00378679456166208,0.00496246439520353,0.0198066990769189,0.00107609516035277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36637,0.0129326543533025,0.00395531909470581,0.00518022892767909,0.0206850797789259,0.0010796537654757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36823,-0.0182406311894651,0.00557953811110734,-0.0291765258872355,-0.00730473649169471,0.00108146259216443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39520,-0.0152235552595696,0.00466262042524721,-0.0243622912930541,-0.00608481922608508,0.00109700077236402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37221,-0.0109026172269768,0.00333966548960637,-0.0174483615866053,-0.00435687286734835,0.00109913669038102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36880,-0.0128922052604358,0.00395069420968344,-0.0206355659114153,-0.00514884460945624,0.00110429661981007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39654,0.0100847221795682,0.00309750419571066,0.0040136139559753,0.0161558304031611,0.00113337863244336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36992,0.0104704256485218,0.0032162347223941,0.00416660559262938,0.0167742457044143,0.00113496479081164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39433,0.0113383191724541,0.00348766307727555,0.00450249954099402,0.0181741388039142,0.00115262435792864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,39213,-0.0159997522912468,0.00492717089149836,-0.0256570072385836,-0.00634249734391,0.00116786407215479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36916,-0.012852706898602,0.00395856097245178,-0.0206114864046075,-0.00509392739259656,0.00117013515265509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39654,-0.0125166213410176,0.0038581230690786,-0.0200785425564116,-0.00495470012562352,0.00118024868280605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,39312,0.0300404621261171,0.00926550657917103,0.0118800692309419,0.0482008550212923,0.00118879619798162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39432,-0.00868292553177099,0.00268092611274768,-0.0139375407127564,-0.00342831035078554,0.00120304344502286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36847,-0.0103171908627745,0.00319402233362988,-0.0165774746366891,-0.00405690708885997,0.00124045246221528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37162,-0.0327268202373879,0.010145602798709,-0.0526122017228575,-0.0128414387519183,0.00125976461067324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39455,0.0117694730753361,0.00365622486127407,0.00460327234723887,0.0189356738034332,0.00128901584387053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,39319,-0.0185473775272272,0.00576652862924012,-0.0298497736405378,-0.00724498141391657,0.00130094215918363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39455,0.0343561119914161,0.0107068864361862,0.0133706145764912,0.0553416094063409,0.0013357663560989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36848,-0.00815653414880163,0.00254286975110987,-0.013140558860977,-0.00317250943662628,0.00134182989758284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39462,0.00825634209674376,0.00257876976244126,0.0032019533623589,0.0133107308311286,0.00136923239028505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39485,-0.0169332038096368,0.00529130745488715,-0.0273041664212157,-0.00656224119805803,0.00137620956912811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36847,0.00732467412805275,0.00229186178535947,0.0028326250287482,0.0118167232273573,0.00139721008608861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39531,0.00777841400363122,0.002435948880838,0.00300395419718874,0.0125528738100737,0.00141006086682046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36955,-0.0199281143029466,0.00625571602581811,-0.03218931771355,-0.00766691089234305,0.00144816504382209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39123,-0.0281373378145265,0.00883897201965877,-0.0454617229730577,-0.0108129526559954,0.00145897006070805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39431,-0.0179987356797136,0.00566397206899862,-0.0291001209349509,-0.00689735042447634,0.00148719756569283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36972,0.00868869332910174,0.00273745877780185,0.00332327412461011,0.0140541125335934,0.00150717677406614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,39095,0.0312079664227672,0.00984172135392991,0.0119181925690646,0.0504977402764698,0.00152235352588298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36916,0.0105643000116704,0.00333280380338812,0.00403200455702964,0.0170965954663111,0.0015291626987599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,37269,0.00433441381244618,0.00136776587935888,0.00165359268890278,0.00701523493598959,0.00153337839315257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39194,-0.0123701196602983,0.00390371358062483,-0.020021398278323,-0.00471884104227366,0.0015337800075153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37183,0.0108898782846477,0.00343739177574597,0.00415259040418562,0.0176271661651098,0.00153820230494581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36835,-0.01941539138316,0.00613245744364104,-0.0314350079726965,-0.00739577479362361,0.00154922720760982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39104,-0.0190998397807064,0.00603536956634369,-0.03092916413074,-0.00727051543067278,0.00155586494310147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39123,-0.0167760957381831,0.00530340451161875,-0.0271707685809559,-0.00638142289541039,0.00156326177310397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39568,-0.00783912789555803,0.00248223650396101,-0.0127043114433216,-0.00297394434779445,0.00159118581674068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37269,0.00497359419979564,0.00157590172341804,0.00188482682189628,0.00806236157769499,0.00160302244832457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36916,-0.00890485283408265,0.00282452809577139,-0.0144409279017946,-0.00336877776637073,0.0016215879324776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36880,-0.0100616325456179,0.00319192471506383,-0.016317804987143,-0.0038054601040928,0.00162422102704596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39636,-0.0153406541735373,0.004867314762405,-0.0248805911078511,-0.00580071723922348,0.00162599822446804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39383,-0.0163726878702894,0.00519900638915829,-0.0265627403930396,-0.00618263534753914,0.0016404330038764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39654,-0.00825403194019608,0.00262156684545866,-0.0133923029572951,-0.0031157609230971,0.00164422012628443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39462,-0.0232897876896689,0.00740588451133451,-0.0378053213318845,-0.00877425404745327,0.00166542884654268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36880,-0.0125513645631362,0.00399215888986736,-0.0203759959872762,-0.00472673313899614,0.00167045315068138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,37203,-0.00852157564261413,0.00271113095953737,-0.0138353923233074,-0.00320775896192089,0.00167505462951362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39541,0.0240286917968246,0.00764523214311163,0.00904403679632578,0.0390133467973234,0.0016757006483431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,37203,0.0110629365380303,0.00352073545570269,0.00416229504485301,0.0179635780312076,0.00168054071883625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39428,-0.0190903047728331,0.00609025963309132,-0.031027213653692,-0.00715339589197408,0.00172442555885276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39541,0.00919756689474514,0.00293705371469173,0.00344094161394936,0.0149541921755409,0.0017421105798679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,37221,-0.0121932926369834,0.00389363582227588,-0.0198248188486441,-0.00456176642532262,0.00174251776481001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37221,0.0166729408212346,0.00532545044358627,0.00623505795180549,0.0271108236906637,0.00174721819568769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36916,-0.00623291740804244,0.00199247399637414,-0.0101381664409358,-0.00232766837514912,0.00176267581324202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39462,-0.0218137417728641,0.00699104480075584,-0.0355161895823456,-0.00811129396338268,0.00181045858204627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37221,-0.0169397191148233,0.00542882209609544,-0.0275802104231703,-0.00629922780647622,0.00181050776550077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39485,0.0220497682589599,0.00707635736873104,0.00818010781624708,0.0359194287016728,0.00183681641521442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39194,0.0200462100055114,0.00643691776876691,0.00742985117872823,0.0326625688322945,0.00184762748371965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39401,0.0165688614688633,0.00532594363837537,0.00613001193764758,0.027007711000079,0.001868236258487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39636,-0.0215595377443867,0.0069383900298928,-0.0351587822029765,-0.00796029328579676,0.00189164269565474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,39187,-0.0164318359603827,0.0052909454690778,-0.0268020890797752,-0.00606158284099023,0.0019022023827201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,39161,-0.0200349331398239,0.00645286512176847,-0.0326825487784901,-0.00738731750115773,0.00190761594602055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39453,0.00620503649110224,0.00200026701716868,0.00228451313745162,0.0101255598447529,0.0019250705591819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36916,-0.0135817118017888,0.00437904394178012,-0.0221646379276778,-0.00499878567589978,0.00192956844504226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,37203,-0.0103908647251051,0.00335363142113625,-0.0169639823105321,-0.00381774713967803,0.00194996960503791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39182,0.0115053625766739,0.00371542549935315,0.00422312859794174,0.0187875965554061,0.00196090161202377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,37052,-0.0066155370400291,0.00213843782012417,-0.0108068751674725,-0.00242419891258572,0.00198156026458406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39462,-0.0285722312141667,0.00923811453384881,-0.0466789357005103,-0.010465526727823,0.00198598749477836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,39294,0.0107287334427819,0.00347162484243697,0.00392434875160543,0.0175331181339583,0.00200252282291463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37221,0.0118244160562138,0.00382655565744475,0.00432436696762213,0.0193244651448055,0.00200523478402326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39498,0.00697715410974911,0.00225847263227549,0.00255054775048915,0.0114037604690091,0.00200978093056939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36894,-0.0113475567202997,0.00367460438228601,-0.0185497813095803,-0.00414533213101908,0.00201882101688806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39427,0.00618403125878511,0.0020038949293696,0.0022563971972207,0.0101116653203495,0.00203234987551071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39151,0.0142865475163344,0.00463053939160377,0.00521069030879107,0.0233624047238778,0.00203732777186736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39403,-0.00706105530506016,0.00228898208378088,-0.0115474601892707,-0.00257465042084963,0.00204059712572918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39455,0.0333405917084892,0.0108350477624447,0.0121038980940977,0.0545772853228808,0.00209397470325662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39462,-0.0290355352454115,0.0094609231119265,-0.0475789445447874,-0.0104921259460355,0.00215162525773254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39516,-0.0155487294515942,0.00506845508229742,-0.0254829014128972,-0.0056145574902913,0.00216063052675463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39324,0.00789849247280006,0.00257515568438141,0.0028511873314125,0.0129457976141876,0.00216469386973013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,37243,0.0176376578172096,0.00575169618217563,0.00636433330014541,0.0289109823342739,0.00217022509002047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37243,0.0170241690976559,0.00556370260689156,0.00611931198814846,0.0279290262071634,0.0022189653925178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39462,0.0124912323535946,0.0040837572659051,0.00448706811242063,0.0204953965947686,0.00222646884881806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39330,-0.0242262511568422,0.00792125983655055,-0.0397519204364812,-0.0087005818772031,0.00222929882818861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39194,0.0181445390058415,0.00593351958204563,0.00651484062503205,0.0297742373866509,0.00223239481699368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39428,-0.0333310756901954,0.0109230663531405,-0.0547402857423508,-0.01192186563804,0.00228145618578438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36880,0.0280842988742909,0.00922056371231374,0.010011993998156,0.0461566037504258,0.00232522727326586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39123,-0.0224377274762162,0.00737284205225934,-0.0368884978986445,-0.00798695705378786,0.00234417482434661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39636,-0.0165106422278504,0.00544619572504443,-0.0271851858489375,-0.00583609860676337,0.00243678016134949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39456,-0.00478152903216955,0.00157829374208575,-0.00787498476665762,-0.00168807329768149,0.00245330393250661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36823,0.0126529697698067,0.00417831678206661,0.00446346887695611,0.0208424706626572,0.00246484938437101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39532,-0.00907080609533213,0.0029981789683622,-0.014947236873322,-0.00319437531734221,0.00248691160202805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39498,0.00733977320435742,0.00242649283342815,0.00258384725083824,0.0120956991578766,0.00249177439008304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39438,0.0143067366061364,0.00473139049938254,0.00503321122734666,0.0235802619849262,0.00250051077019581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39355,0.0110212278388439,0.00365183733038511,0.00386362667128906,0.0181788290063987,0.00254882755862286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39636,-0.0253015604936697,0.00838753092322162,-0.0417411211031841,-0.00886199988415531,0.00256076747054807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39499,-0.0080398857439411,0.00267621707592296,-0.0132852712127501,-0.0027945002751321,0.00266720220978951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39492,0.00995010696795642,0.00331329557558889,0.0034560476398022,0.0164441662961106,0.00267697499998511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39499,0.00797694322918135,0.00265926711048452,0.0027647796926317,0.013189106765731,0.00270708049460011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36955,0.00711597476889245,0.00237354867227394,0.00246381937123553,0.0117681301665494,0.00272263317985008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,37243,0.0059694672033253,0.0019939937922969,0.00206123937042336,0.00987769503622723,0.00276121825898129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37164,-0.00797634448274189,0.00266648475893104,-0.0132026546102467,-0.00275003435523705,0.0027829485142119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36919,-0.0128422965152698,0.00430780894970547,-0.0212856020566926,-0.00439899097384712,0.00287707001863172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39428,0.022884047875892,0.00768011084714812,0.00783103061548173,0.0379370651363024,0.00289040251572446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37247,-0.00701543132530455,0.00235534252279279,-0.0116319026699784,-0.00239895998063068,0.00290188779142989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37162,-0.0121110603309579,0.00406630517175052,-0.0200810184675889,-0.00414110219432685,0.00290309938222322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39448,0.0273044744727854,0.00917324389697147,0.00932491643472134,0.0452840325108495,0.00291991898462571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39455,-0.0115359089286394,0.00387755208233758,-0.0191359110100211,-0.00393590684725779,0.00293407939785367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39462,0.0153827737583274,0.00517673648292062,0.00523637025180298,0.0255291772648518,0.00296799682485876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,37221,0.0117750326341721,0.00396318045178309,0.00400719894867729,0.019542866319667,0.00297281140790128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39654,0.00433752697929045,0.00146455185267732,0.0014670053480429,0.007208048610538,0.00306443398660529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37164,-0.0276721788183318,0.00934848220889363,-0.0459952039477633,-0.00934915368890024,0.0030813495746661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39355,-0.00775294033468975,0.00262185361294631,-0.0128917734160645,-0.00261410725331499,0.00311089422011163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36847,-0.009385404893931,0.00317543888913518,-0.0156092651166359,-0.00316154467122605,0.0031262414870222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39432,-0.0173304750513326,0.00586609711774484,-0.0288280254021125,-0.00583292470055274,0.00313820682450677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39462,-0.0143182833998879,0.00484969071386286,-0.0238236771990591,-0.00481288960071669,0.00315790430097654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39319,-0.00625133810544256,0.00211937490390124,-0.010405312917089,-0.00209736329379613,0.0031866668273018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39462,0.013893892067505,0.00471271478899707,0.00465697108107076,0.0231308130539393,0.00320151849534099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39485,0.00699631233178211,0.0023732748949606,0.00234469353765933,0.0116479311259049,0.00320373332946642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36880,-0.0114829449651855,0.0038968008709667,-0.0191206746722802,-0.00384521525809076,0.00321716516777503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36763,-0.0135596250366352,0.00460340918793342,-0.0225823070449847,-0.00453694302828573,0.00322972457765559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36989,-0.00659998770172369,0.00224066652307834,-0.0109916940869572,-0.00220828131649014,0.00322977136604486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39531,0.00871647002380898,0.00295934472777287,0.00291615435737415,0.0145167856902438,0.00323024509272478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39541,0.0347670884729028,0.0118048478169648,0.0116295867516517,0.0579045901941538,0.00323287210423354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39428,0.0183277067024361,0.0062286153572961,0.00611962060213578,0.0305357928027365,0.00326071822506012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37221,-0.0124007884647636,0.00421664245759772,-0.0206654076816551,-0.00413616924787206,0.00327831164500486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36955,-0.0235838295931773,0.00802080282886376,-0.0393046031377503,-0.00786305604860435,0.00328460294561766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36916,-0.00858502101694292,0.00292109436104739,-0.0143103659645958,-0.00285967606929004,0.00329904367914829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39400,0.0207047719992682,0.00704864838838079,0.00688942115804187,0.0345201228404946,0.00331471035109199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36847,0.0129677301466657,0.00441865783952277,0.00430716078120106,0.0216282995121303,0.00334410854326256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39549,0.0189090241605611,0.00646759163353264,0.00623254455883713,0.0315855037622851,0.00346458801046467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39482,-0.00943957506894504,0.00323264159713009,-0.01577555259932,-0.00310359753857006,0.00350460310174812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,39355,-0.0175088728510373,0.00599749964793276,-0.0292639721609855,-0.00575377354108909,0.00351273581450068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37164,-0.0120732535064848,0.00414376647555531,-0.0201950357985732,-0.00395147121439642,0.00357916650829059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37221,-0.0125564513661238,0.00431232243137122,-0.0210086033316114,-0.00410429940063625,0.00360019699169902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39123,-0.0159844134064058,0.00549382694643342,-0.0267523142214154,-0.00521651259139635,0.00362524921663079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,37247,-0.00757130110794824,0.00260220946916974,-0.0126716316675209,-0.00247097054837555,0.00362553899122122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39434,-0.0237607094613125,0.00817311810849357,-0.0397800209539599,-0.00774139796866513,0.00365240363190012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39462,0.0238119478300689,0.00819111374201733,0.00775736489571492,0.0398665307644229,0.00365392997714207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39601,-0.0152908350400025,0.00526670699193708,-0.0256135807441992,-0.0049680893358058,0.00369784605470212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,37216,-0.00933868767356122,0.00321873130208367,-0.0156474010256452,-0.00302997432147722,0.00372185575055577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,39123,-0.0119560996867733,0.00412184827878393,-0.0200349223131898,-0.00387727706035682,0.00372925224962971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39187,-0.0238392956854932,0.00821991213210221,-0.0399503234644136,-0.0077282679065729,0.00373489363681906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39654,0.00716155742880567,0.00247042850821286,0.00231951755270847,0.0120035973049029,0.00374994316370824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,37162,0.00980338049834277,0.0033826854241826,0.00317331706694486,0.0164334439297407,0.00376065478093125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39464,0.0117906091243913,0.00406937386688533,0.00381463634529601,0.0197665819034865,0.00376812073501403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36916,-0.00802384137852888,0.00277218266407897,-0.0134573194001237,-0.00259036335693411,0.00380527235041134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39390,-0.02005785774093,0.00694478574273183,-0.0336696377966844,-0.00644607768517561,0.00388022732170689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39168,-0.00992270701004944,0.00344247208074236,-0.0166699522883045,-0.00317546173179443,0.00395183847115644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,37224,-0.0144215414957789,0.00500668339374507,-0.0242346409475192,-0.00460844204403853,0.00397758375790939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36847,0.00519621275026004,0.00180574425715128,0.00165695400624354,0.00873547149427654,0.00401395131624763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39194,-0.00818449460334042,0.00284602794771536,-0.0137627093808625,-0.00260627982581831,0.00403632910988397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39104,-0.0128306837517603,0.00446244163754634,-0.0215770693613512,-0.0040842981421695,0.00404275366825775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36955,0.0161563124082619,0.00563373471187063,0.00511419237299542,0.0271984324435283,0.00414053997834199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39187,0.0053609104763104,0.00186951392328062,0.00169666318668039,0.00902515776594042,0.00414260156852385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37164,-0.0277282041612949,0.00968137454280179,-0.0467036982651864,-0.0087527100574034,0.00418910771387549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39378,-0.01139093375073,0.00397834462645039,-0.0191884892185727,-0.00359337828288719,0.00419924073654023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37255,-0.0102333712940091,0.00357704202726275,-0.0172443736674441,-0.00322236892057409,0.00423194406445261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36861,-0.0125689505540353,0.00439629261308393,-0.0211856840756798,-0.0039522170323908,0.00425702241600889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39498,0.0057406564944296,0.00200997994336135,0.00180109580544136,0.00968021718341785,0.00429499027109525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36955,0.0225632151490361,0.00791748382425454,0.0070449468534972,0.038081483444575,0.00438187668208209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39462,-0.0207487953786656,0.00729461619363359,-0.0350462431181875,-0.00645134763914376,0.00445555286789208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37164,-0.0131566743653737,0.00462701267482956,-0.0222256192080396,-0.00408772952270773,0.00446993335783358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36880,-0.0141942517701766,0.00499746443490974,-0.0239892820625997,-0.0043992214777535,0.0045145672362661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37184,-0.0210822259440242,0.00742269659091229,-0.0356307112622123,-0.00653374062583614,0.00451513582925897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37164,-0.0193395920694916,0.00682891165412367,-0.032724258911574,-0.00595492522740925,0.00463281323804829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39530,-0.0150828881432214,0.00532983118387264,-0.0255293572636117,-0.00463641902283101,0.00466241182026695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39470,0.00811712750846879,0.00286971794310226,0.00249248033998837,0.0137417746769492,0.00468220002220751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39541,0.0279345442659771,0.00987676797477543,0.00857607903541724,0.0472930094965369,0.00468563945418951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36763,-0.0138693604001071,0.00490697968321294,-0.0234870405792045,-0.00425168022100977,0.00471421109119992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,37224,-0.0111832057941304,0.00395931971053059,-0.0189434724267704,-0.00342293916149044,0.00474238146058552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39654,0.00567379358252536,0.00201938171854835,0.0017158054141706,0.00963178175088012,0.00496558607610488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37247,0.00746014459959678,0.00265777331011494,0.0022509089117715,0.0126693802874221,0.00500940251462638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39654,-0.00976952605922113,0.00348193687303296,-0.0165941223303657,-0.00294492978807653,0.00502597575121722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39123,-0.013504619965481,0.00481543320954922,-0.0229428690561974,-0.00406637087476451,0.00504694663466068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36861,-0.0171156962288217,0.00610593842472432,-0.0290833355412813,-0.00514805691636199,0.0050688896802854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,37162,-0.0157671775999649,0.00563846378724914,-0.0268185666229732,-0.00471578857695661,0.00517593223562474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,39019,0.017367640730033,0.00623891322952993,0.00513937080015429,0.0295959106599116,0.00538019443199982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39424,0.0196793063180776,0.00707162666881283,0.00581891804720443,0.0335396945889507,0.00539505048425738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39428,-0.00804884236551405,0.00289380928987561,-0.0137207085736702,-0.00237697615735786,0.00541925891398751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37164,-0.0105279717292491,0.00379078725274739,-0.017957914744634,-0.00309802871386424,0.00549009474153533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36992,-0.0130432687167781,0.00469883026746139,-0.0222529760410024,-0.00383356139255379,0.00551384620901029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36763,-0.0102608017053892,0.00369719573035776,-0.0175073053368905,-0.00301429807388804,0.00552351899588315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,39104,0.0110040531474052,0.00396547668347745,0.00323171884778944,0.018776387447021,0.00552778491164909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39079,0.0133355844644399,0.00480717279496398,0.0039135257863105,0.0227576431425693,0.00554246093871423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39428,-0.0095269706420386,0.00343944634444878,-0.0162682854771582,-0.00278565580691898,0.00561401435021355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39118,-0.0121284928517383,0.0043801507128105,-0.0207135882488469,-0.00354339745462972,0.00563049571543102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,37019,-0.00693749520243452,0.00250762890318439,-0.0118524478526759,-0.00202254255219312,0.00567346766936465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,37162,-0.0241802610745876,0.0087528607991588,-0.0413358682409388,-0.0070246539082363,0.00574332936424666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39455,-0.0139796276365824,0.00506082038967797,-0.0238988356003512,-0.00406041967281359,0.00574612807833457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39388,0.0103670171822387,0.00375559721403945,0.00300604664272135,0.017727987721756,0.00577978986363024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39541,0.010075717746661,0.00365493562997642,0.00291204391190717,0.0172393915814147,0.00584503812136335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,39187,0.0185024228021831,0.00671209426063419,0.00534671805134012,0.0316581275530262,0.00584812238820742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36847,-0.0182253162310229,0.00661924552678108,-0.0311990374635138,-0.00525159499853198,0.00590687955094641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39654,-0.0120629226991022,0.00438497363597403,-0.0206574710256113,-0.00346837437259307,0.00594897519381993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,37247,-0.0169081014150263,0.00614738109714316,-0.0289569683654269,-0.00485923446462571,0.0059596013688711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,39163,0.0137840742635118,0.00501227280006845,0.00396001957537765,0.023608128951646,0.0059656296623451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36823,0.0151967042755045,0.00552603771970402,0.00436567034488466,0.0260277382061244,0.00596785251546169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39589,-0.00720126845531771,0.00262143663646714,-0.0123392842627933,-0.00206325264784212,0.00602015137094351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,37187,0.00467005888219703,0.00170102522169609,0.00133604944767269,0.00800406831672137,0.00605149954919625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36955,-0.0101230696142689,0.00368955538234619,-0.0173545981636675,-0.00289154106487041,0.00608357979073907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37229,0.0118052320187433,0.00431428745474438,0.00334922860744433,0.0202612354300423,0.00622181178871203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,36360,0.00604662536057962,0.00221072915863429,0.00171359620965642,0.0103796545115028,0.00624484712838703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39623,-0.00494922326946345,0.00181001304176875,-0.00849684883133019,-0.0014015977075967,0.00625746165183005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39194,-0.0168481487170455,0.00616245346489819,-0.028926557508246,-0.00476973992584509,0.00626447024040268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36861,0.00785743203099684,0.00287627894740521,0.00221992529408263,0.0134949387679111,0.00630775571994909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39416,-0.00762918621723048,0.00279348248317001,-0.0131044118842437,-0.00215396055021726,0.00632036974968203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37162,-0.0165509748844545,0.0060663429898125,-0.028441007144487,-0.00466094262442198,0.00637437114551815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,37221,-0.00723105380785753,0.00265267496385677,-0.0124302967370168,-0.00203181087869827,0.00642045452461234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36916,0.0140330110955792,0.00515144922988094,0.00393617060501257,0.0241298515861459,0.00645687988354767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39531,-0.00627391549919222,0.00230601342674142,-0.0107937018156054,-0.00175412918277903,0.00652232751970961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36899,-0.0193746428716387,0.00713479964050851,-0.0333588501670354,-0.00539043557624206,0.00662644349951145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36916,0.015253726383508,0.00561911568572133,0.00424025963949423,0.0262671931275218,0.00664445104736419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39355,-0.0117848179682299,0.00434505979960861,-0.0203011351754628,-0.00326850076099705,0.00669081188937903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39589,-0.010016163674088,0.00369383172236155,-0.0172560738499166,-0.00277625349825936,0.00670365791904847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37162,-0.0106538694267196,0.00393135057862617,-0.0183593165608268,-0.00294842229261228,0.00673781423100039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39355,-0.0142664045343668,0.00527027463661242,-0.0245961428221272,-0.0039366662466065,0.00679805063001179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39390,0.0174328369804393,0.00646601263623822,0.00475945221341235,0.0301062217474662,0.00702410634236819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39123,-0.0154441661942445,0.00574252548170747,-0.0266995161383912,-0.0041888162500979,0.0071653373131077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,39194,-0.0113801587108874,0.00423439018179674,-0.019679563467209,-0.00308075395456583,0.00720579281156204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36880,0.0119715084054158,0.00445550714748878,0.00323871439633782,0.0207043024144939,0.00722141817742872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39589,0.00819798803986071,0.00305142221923974,0.00221720049015082,0.0141787755895706,0.0072259517382419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37044,0.00194296550387913,0.000724103420221353,0.000523722800245278,0.00336220820751298,0.00730012138016465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39499,0.00800888940398631,0.00298901971799257,0.00215041075672086,0.0138673680512518,0.00738263510928828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39485,-0.00711515470605109,0.0026683402348369,-0.0123451015663314,-0.00188520784577077,0.00767254534962219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37221,0.0234570329680897,0.00880082135215153,0.00620742311787271,0.0407066428183067,0.00770111302759558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39462,0.0126742294921594,0.00476011954225708,0.0033443951893355,0.0220040637949832,0.00776253393996275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,37221,-0.00605144526873513,0.00228133448141935,-0.0105228608523171,-0.0015800296851532,0.0079975584253576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39636,-0.00882968473860608,0.00333093852088194,-0.0153583242395347,-0.00230104523767748,0.00803823317001013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36823,0.0145735200568788,0.00550215248019506,0.00378930119569645,0.0253577389180611,0.0080905979547885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39531,-0.0106116404328042,0.0040111916576111,-0.018473576081722,-0.00274970478388649,0.00816529117460492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39428,0.00820476684098418,0.00310225248549479,0.0021243519694144,0.014285181712554,0.00818299900754461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39123,-0.012499772617041,0.00472718125378339,-0.0217650478744564,-0.00323449735962551,0.00819632054429462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37255,0.0194096345465941,0.00734177944022693,0.0050197468437493,0.0337995222494389,0.00820995514161223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36893,0.00804093559872134,0.00304162877426186,0.0020793432011681,0.0140025279962746,0.00821255542625637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36916,0.0123817845613882,0.00468853750806832,0.00319225104557426,0.0215713180772021,0.00827983080366093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39428,0.00561449013901234,0.00212660341550228,0.00144634744462786,0.00978263283339682,0.00829623770223299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,39355,-0.01451513578437,0.00550266744601945,-0.0253003639785681,-0.00372990759017188,0.00835235145560246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39582,-0.00690281525318387,0.00262506537016673,-0.0120479433787107,-0.00175768712765708,0.0085577298275146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36736,-0.0166613149941268,0.00634928587956819,-0.0291059153180805,-0.00421671467017315,0.00869795418550542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39319,0.022237804557438,0.00850854505951739,0.00556105624078395,0.0389145528740921,0.00896880905697033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36823,0.0222294845066447,0.00851744704291328,0.00553528830253466,0.0389236807107547,0.00906840325879007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36823,0.00665039775783349,0.00255845514431204,0.0016358256749819,0.0116649698406851,0.00935031552189506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37247,-0.0171869111696196,0.00661270471444041,-0.0301478124099228,-0.00422600992931635,0.00935827977858698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,37269,-0.00502491564746995,0.00193940166104295,-0.00882614290311413,-0.00122368839182576,0.00958165424132757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37164,-0.0110594451484741,0.00427614492108001,-0.0194406891937909,-0.00267820110315732,0.00971191680438304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39582,0.0139289893903614,0.00538800545162167,0.00336849870518292,0.0244894800755399,0.00974195046573663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39455,-0.0122204369087883,0.00473776732051895,-0.0215064608570055,-0.00293441296057116,0.00990760761490357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39462,0.00600693561439523,0.00232897300596668,0.00144214852270054,0.0105717227060899,0.00991177298835879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,39068,-0.0102409414278806,0.00398503993836668,-0.0180516197070792,-0.00243026314868186,0.0101841731045011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36847,0.00656005965311937,0.00255691691019223,0.0015485025091426,0.0115716167970961,0.0103110138726653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39355,-0.010277715987256,0.00400946306408073,-0.0181362635928542,-0.00241916838165777,0.0103760333436008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37203,-0.00920932867033136,0.0035931331427539,-0.016251869630129,-0.0021667877105337,0.010387506623004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36916,0.00965990829533401,0.00376961856724856,0.00227145590352685,0.0170483606871412,0.0104017291032776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36880,-0.00988891026082489,0.00386293136169663,-0.0174602557297503,-0.00231756479189949,0.0104804486808414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39477,0.0421754258581378,0.0164967976802629,0.00984170240482248,0.0745091493114532,0.0105803393672576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39355,0.0115318448136962,0.00451246770002062,0.00268740812165579,0.0203762815057366,0.010611795872766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39194,0.0111432267685949,0.00436318775464635,0.00259137876948801,0.0196950747677017,0.0106617812059949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36880,-0.00806956452120924,0.00316054352451462,-0.0142642298292579,-0.00187489921316058,0.0106850275440534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,37221,0.0156081334514563,0.00612464186078865,0.00360383540431055,0.0276124314986021,0.010832947044618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39462,-0.021363785024417,0.00839128473331511,-0.0378107031017146,-0.00491686694711938,0.0109080097773469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36880,0.00752151544050031,0.00295861578478948,0.00172262850231294,0.0133204023786877,0.0110264387147149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39462,0.0111351384821042,0.00438215952238245,0.00254610581823456,0.0197241711459738,0.0110630572873548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39289,-0.007985093724937,0.00314522937489977,-0.0141497432997405,-0.00182044415013346,0.011133614563799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36847,0.00733582097675244,0.00288954036488484,0.00167232186157815,0.0129993200919267,0.0111370489836028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,37221,0.017222078402173,0.00678985878723136,0.00391395517919951,0.0305302016251464,0.011210359699139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39104,0.0110349302562852,0.00435863448639347,0.00249200666295404,0.0195778538496164,0.0113601659351212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36847,0.00916868546534263,0.00362173374209496,0.00207008733083651,0.0162672835998488,0.0113674507508486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39636,0.0132172578050074,0.00522405477702402,0.00297811044204027,0.0234564051679744,0.0114137913676625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36861,-0.0158051475473197,0.00626526517879806,-0.0280850672977639,-0.0035252277968755,0.0116594195822258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39455,-0.0103399281938022,0.00410146675522236,-0.018378803034038,-0.00230105335356634,0.0117114041931068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39541,0.00609977285385742,0.00241996038139915,0.0013566505063151,0.0108428952013997,0.0117254342022531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39455,-0.00575412574635493,0.0022839026841381,-0.0102305750072656,-0.00127767648544426,0.0117649070111866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37162,-0.00979480289539361,0.00388991900268631,-0.0174190441406588,-0.00217056165012845,0.0118146299967377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39123,-0.00756213145534146,0.00300347241457063,-0.0134489373878999,-0.00167532552278303,0.0118197213349434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37164,-0.0187254949233853,0.0074376262128142,-0.0333032423005012,-0.00414774754626949,0.0118255534246534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39312,0.0149184431472155,0.00592577311410877,0.00330392784356228,0.0265329584508687,0.0118277736918563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37203,0.0235207049364283,0.00936822811437403,0.00515897783225525,0.0418824320406014,0.0120618615166367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36847,-0.0122829144924473,0.00489409404026483,-0.0218753388113664,-0.00269049017352822,0.0120945745035614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36955,0.0239654360251512,0.00956746063819197,0.00521321317429497,0.0427176588760075,0.012261569714469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36861,0.00810053415603578,0.00323456056390407,0.0017607954507838,0.0144402728612878,0.0122797170012113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39194,0.00931486144341968,0.00373133323710579,0.00200144829869232,0.016628274588147,0.0125573041077395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36847,0.0084245268600248,0.00337594149922923,0.00180768152153551,0.0150413721985141,0.0125922952281635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,39104,0.00842822251599559,0.00337858285018215,0.00180620012963857,0.0150502449023526,0.012620742493998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39043,0.0127928284835223,0.00513669169038281,0.00272491277037201,0.0228607441966726,0.012768098761679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39445,-0.00540505076339724,0.00217317968530703,-0.00966448294659901,-0.00114561858019546,0.0128874499921934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39654,0.0065195637478064,0.00262358300327386,0.00137734106138964,0.0116617864342232,0.0129663714873494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,37162,-0.0143466516129017,0.00577863799531626,-0.0256727820837215,-0.00302052114208179,0.013051719856277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,39099,-0.0269077990232338,0.0108509828293954,-0.0481757253688488,-0.00563987267761873,0.0131583581422911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39608,-0.0100134132549729,0.00405030818926323,-0.0179520173059288,-0.00207480920401695,0.0134370935993839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39589,-0.0104150787454282,0.00421823771777538,-0.018682824672268,-0.00214733281858848,0.0135578363362696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,37162,-0.008846878741259,0.00358343721332778,-0.0158704156793814,-0.00182334180313656,0.0135688096023132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36847,0.00803043744481462,0.00327112995708844,0.00161902272892128,0.014441852160708,0.014104334646764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37143,-0.00907327801357069,0.00369891797439965,-0.016323157243394,-0.00182339878374738,0.0141821779203239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36955,-0.0147405431271687,0.00601316816348675,-0.0265263527276027,-0.00295473352673466,0.0142446621558556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39583,-0.0209029789176575,0.00852781379976103,-0.0376174939651892,-0.00418846387012594,0.0142511597067756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36823,0.00968906604406372,0.00395378255928942,0.00193965222785646,0.017438479860271,0.0142763174834968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39455,0.00425757848895281,0.00174087348846093,0.000845466451569388,0.00766969052633623,0.0144702798250931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36880,-0.00771243906283764,0.00315660705679578,-0.0138993888941574,-0.00152548923151791,0.014568716458735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39531,0.00667974526866109,0.00273906153897966,0.00131118465226095,0.0120483058850612,0.014751718717565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35538,-0.0226695738491975,0.0093072127494249,-0.0409117108380703,-0.00442743686032466,0.0148786721356944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39485,0.00584905440095174,0.0024017870609423,0.00114155176150484,0.0105565570403986,0.0148912945279302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37203,-0.00992491254574157,0.00407576275542085,-0.0179134075463664,-0.00193641754511671,0.0149010608411684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36763,0.0206456980916685,0.00847978294940635,0.00402532351083209,0.037266072672505,0.0149183930704481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37247,-0.0156602618663361,0.00644128044609664,-0.0282851715406855,-0.00303535219198668,0.015061118465424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39482,0.00824118797865558,0.00340409692792525,0.0015691579999221,0.0149132179573891,0.0154912784098086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36823,0.0118682423133159,0.00490554307024901,0.00225337789562786,0.021483106731004,0.0155624523252727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36916,-0.0150005832198759,0.00620537553508041,-0.0271631192686335,-0.00283804717111824,0.0156481029049221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39428,0.0203414571780888,0.00841646725408333,0.00384518136008548,0.0368377329960921,0.0156667345799103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39397,0.00746312114751129,0.00308911274805386,0.00140846016132573,0.0135177821336969,0.0157064172074322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39531,-0.00526602514292443,0.00218226549278991,-0.00954326550879266,-0.000988784777056204,0.0158293218960861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39470,0.0106732433282055,0.00442565985152043,0.00199895001922541,0.0193475366371855,0.0158914450392754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37164,0.0148108741557911,0.00614305664470939,0.00277048313216067,0.0268512651794215,0.0159231930299457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39582,-0.00715216754625771,0.00298179899967486,-0.0129964935856204,-0.00130784150689498,0.0164695429411999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39462,-0.0194735198736449,0.00812657281876842,-0.035401602598431,-0.00354543714885879,0.0165747282565257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39485,0.0111512034189801,0.00466176293798309,0.00201414806053321,0.0202882587774269,0.0167664410124077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37190,-0.023080694277176,0.00965112458986535,-0.0419968984733121,-0.00416449008103996,0.0167939608598523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39187,-0.0187764558412398,0.00785268696489094,-0.0341677222924261,-0.0033851893900536,0.0168110530253959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36880,-0.00649659758598767,0.00271827172714262,-0.0118244101711872,-0.00116878500078814,0.0168643916112047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37203,0.00754751324732339,0.00315858627359152,0.00135668415108402,0.0137383423435628,0.016884725842193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37269,-0.00630567318593622,0.00263929420538779,-0.0114786898284963,-0.00113265654337615,0.0169017178628618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,37247,-0.0158818825139218,0.00665247562560765,-0.0289207347401128,-0.0028430302877308,0.0169840971906108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36992,0.0135563420982964,0.00568186551645403,0.00241988568604653,0.0246927985105463,0.0170523024384733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,37164,-0.00747774185894645,0.00314012760002252,-0.0136323919549906,-0.00132309176290232,0.017263961903686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39485,-0.0154360533485397,0.00648253557984734,-0.0281418230850404,-0.00273028361203888,0.0172698751432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36975,0.00476372550313314,0.00200273983265649,0.000838355431126427,0.00868909557513985,0.0173932260646171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39428,-0.0126665206414065,0.00533231344690682,-0.0231178549973439,-0.00221518628546912,0.0175411776245531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39589,0.00462094685720178,0.00194559531380529,0.000807580042143405,0.00843431367226016,0.0175574742733044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39455,-0.0063522783773843,0.00267602979999106,-0.0115972967853668,-0.00110725996940183,0.0176200455483564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36763,0.0301034847595154,0.0126960744059336,0.00521917892388558,0.0549877905951451,0.0177512049193015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39498,-0.00382240203215164,0.00161271926265389,-0.00698333178695328,-0.000661472277350011,0.0177929437333838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39037,-0.00391408411139,0.00165618987044827,-0.00716021625746861,-0.000667951965311383,0.0181257285034999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39428,-0.0239489789049018,0.0101431709963054,-0.0438295940576604,-0.00406836375214326,0.0182338520731521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36916,0.0135573285752292,0.00574297262298476,0.00230110223417902,0.0248135549162793,0.0182567042991495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36861,0.0113854721137916,0.00482404002683901,0.00193035366118711,0.020840590566396,0.0182827904817374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37243,0.0151823593951533,0.00643393321104486,0.0025718503015054,0.0277928684888012,0.0183030664749249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,37247,0.0136137142757668,0.00577009059041532,0.00230433671855277,0.0249230918329808,0.0183214808868993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39123,-0.0120809468658677,0.00512241314061665,-0.0221208766214763,-0.00204101711025901,0.0183645541532904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37203,-0.00560005502855707,0.00238251226289811,-0.0102697790638374,-0.000930330993276781,0.0187642048974958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36847,0.00821806995640474,0.00349834415478444,0.00136131541302724,0.0150748244997822,0.0188328780505704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36847,-0.0131729159924913,0.00560799823762412,-0.0241645925382346,-0.00218123944674807,0.0188419722118975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36880,-0.0176175095250234,0.00750230479078087,-0.0323220269149539,-0.00291299213509286,0.0188759414898367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36823,0.0166224007798599,0.0070797138038564,0.00274616172430131,0.0304986398354184,0.0188956782143389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39487,0.0103916726878522,0.0044278617971024,0.00171306356553151,0.0190702818101729,0.0189441129907451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36457,-0.0231946059406349,0.00988933451466683,-0.0425777015893819,-0.00381151029188795,0.0190220378398014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39526,0.00713071462399734,0.00304668079186447,0.00115922027194298,0.0131022089760517,0.0192716152214154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36992,0.010970249889265,0.00468784596141715,0.00178207180488738,0.0201584279736426,0.0192917348378367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36861,0.0102697891887344,0.00439375290080411,0.00165803350315834,0.0188815448743104,0.0194362056061556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37162,-0.0100170969449898,0.00428651496605557,-0.0184186662784587,-0.0016155276115209,0.0194605591718312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37164,-0.0082539298518098,0.00353408401745563,-0.0151807345260228,-0.00132712517759677,0.0195316553678364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39654,-0.00617480827724116,0.00264471323511102,-0.0113584462180588,-0.000991170336423558,0.0195681666686823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39462,0.0169079409095338,0.0072424250609857,0.0027127877900018,0.0311030940290657,0.0195790652583583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39104,0.00632180839625722,0.00270972500807076,0.00101074738043853,0.0116328694120759,0.01966122098675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36880,0.012543283096851,0.00538015043664218,0.00199818824103228,0.0230883779526696,0.0197481755125169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,39355,0.00885142592447267,0.00380246703784633,0.00139859053029385,0.0163042613186515,0.0199354396987549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39355,-0.00788941698359318,0.0033909334940751,-0.0145356466319804,-0.00124318733520598,0.0199987824016499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39355,-0.0145102738128407,0.00624474747893894,-0.0267499788715611,-0.00227056875412042,0.0201605088477724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,39187,0.0079102069943029,0.0034066727184433,0.00123312846615402,0.0145872855224518,0.0202478722290358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36916,-0.0153643665072719,0.00662932456678616,-0.0283578426581727,-0.00237089035637097,0.0204851815909543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39104,-0.0112153479894945,0.00485372775633894,-0.0207286543919189,-0.00170204158707019,0.020865078636516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36880,-0.0171165326406937,0.00741507599755708,-0.0316500815959056,-0.00258298368548181,0.0209964457409663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39568,0.00643028868001174,0.00278623244489311,0.000969273088021243,0.0118913042720022,0.0210192763660491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37164,0.0183520818267878,0.00795558877609951,0.00275912782563273,0.0339450358279428,0.0210810595785627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37203,-0.0141601927936428,0.00614710959089643,-0.0262085275917998,-0.0021118579954858,0.0212637549691603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37162,0.0118061992515065,0.0051306952166976,0.00175003662677921,0.0218623618762338,0.0214025619313406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39541,0.00728325961971013,0.00316718056796043,0.00107558570650768,0.0134909335329126,0.0214842789071141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39104,-0.0174748970627918,0.00760191633062413,-0.0323746530708151,-0.00257514105476846,0.0215332059772563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36847,0.0135144203145222,0.00588160476941358,0.00198647496647162,0.0250423656625728,0.0215929560528877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39319,0.00638315298875836,0.00278551943507815,0.000923534896005191,0.0118427710815115,0.0219456237539499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39462,-0.0203651652800614,0.00889117917182614,-0.0377918764568406,-0.00293845410328215,0.0220066731131795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39589,0.0147776076475419,0.0064572792531864,0.00212134031129658,0.0274338749837873,0.0221210164024962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39428,0.0152460265793229,0.00667562810586076,0.00216179549183579,0.02833025766681,0.0223952213967536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36847,-0.0163530533385092,0.00716217038430851,-0.0303909072917539,-0.0023151993852645,0.0224322644330322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39462,0.011260537707563,0.0049323522924042,0.0015931272144508,0.0209279482006753,0.0224445533311482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37164,0.0198281154165648,0.00868548637566556,0.00280456212026028,0.0368516687128693,0.022452566392295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37243,0.00526736902176136,0.00231005059272469,0.000739669860020967,0.00979506818350175,0.0226124237461029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39462,-0.00872796769277519,0.00383016243070239,-0.0162350860569519,-0.0012208493285985,0.0226961437131853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39601,-0.0109764501039441,0.00481800099383513,-0.020419732051861,-0.00153316815602728,0.0227275332517757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39355,-0.0123653196982813,0.00542939976407693,-0.0230069432358721,-0.00172369616069054,0.0227720047583528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39194,0.00732287895456915,0.00321758181856463,0.00101641859018247,0.0136293393189558,0.0228665639272949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39428,-0.0155118902755037,0.00681931264823039,-0.0288777430660353,-0.00214603748497214,0.0229380095529155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,39123,0.034439279950862,0.015144764138459,0.00475554223948235,0.0641230176622417,0.0229800227525996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39428,-0.00897783116679134,0.00394951663306039,-0.0167188837675897,-0.00123677856599297,0.0230314331395812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36992,0.00834663509261354,0.00367184567482613,0.00114981756995433,0.0155434526152727,0.023034323626248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37164,0.0102514636167713,0.00451940649751175,0.0013934268816483,0.0191095003518944,0.0233263613960404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37055,0.0124475331660585,0.00549182737968694,0.00168355150187207,0.0232115148302449,0.0234342503331657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39485,0.0154689676280243,0.00682774372898039,0.00208658991922275,0.0288513453368259,0.0234897647191235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,37247,0.010544561863689,0.00466114751710878,0.0014087127301558,0.0196804109972222,0.0237002397268044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37083,-0.00622100447301585,0.00275238522792682,-0.0116156795197524,-0.000826329426279272,0.0238243658938218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39485,0.00909619245448201,0.00403487550368764,0.00118783646725424,0.0170045484417098,0.0241858302073338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39355,0.0210504756129547,0.00936151119414288,0.00270191367243462,0.0393990375534747,0.0245512696423127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39636,0.0138545612617895,0.00616359260126767,0.00177391976330488,0.0259352027602741,0.0246028456697461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39103,-0.00567209527756224,0.00252367798846327,-0.0106185041349503,-0.000725686420174226,0.0246196428217771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37221,0.00948955391174434,0.00422505177415639,0.00120845243439781,0.0177706553890909,0.0247197059433964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36861,-0.0146113949478218,0.00650658703757985,-0.0273643055414783,-0.00185848435416526,0.0247451671003013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,37162,0.00674408889338201,0.0030043197893058,0.00085562210634265,0.0126325556804214,0.0247982770498237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36880,-0.0114733484805238,0.00511815308252376,-0.0215049285222704,-0.00144176843877723,0.0249985346216826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38915,-0.0131158843718777,0.00585123494962977,-0.0245843048731521,-0.00164746387060337,0.0250050353580475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36880,-0.0108374791729659,0.00484120751241426,-0.0203262458972979,-0.00134871244863394,0.0252002304373078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39455,-0.00919222499724001,0.0041080238548927,-0.0172439517528297,-0.00114049824165032,0.025260010259476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36916,-0.0125038915022083,0.00559987209454437,-0.0234796408075153,-0.00152814219690135,0.0255739653176467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,37269,-0.0040803641999884,0.00182951319477396,-0.00766621006174537,-0.000494518338231437,0.025744743719417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36823,0.0149965607529293,0.00673603445812952,0.00179393321499547,0.0281991882908632,0.0260107683820037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39589,-0.0130747840523635,0.00587791842113585,-0.0245955041577898,-0.00155406394693726,0.0261368936059395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,39355,0.025995894112873,0.0116903328842314,0.00308284165977955,0.0489089465659665,0.0261829854436138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37164,-0.00778484117155725,0.0035069287201921,-0.0146584214631338,-0.000911260879980742,0.026446807417646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39601,-0.00887371192658681,0.00401098372409116,-0.0167352400258055,-0.00101218382736814,0.0269571421958087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37135,0.00532134494414713,0.00240769767811176,0.000602257495048089,0.0100404323932462,0.0271133513342745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39455,0.00834478117839434,0.0037757820266581,0.000944248406144459,0.0157453139506442,0.0271146336717184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37164,-0.016653252541204,0.00753903790441093,-0.0314297668338494,-0.00187673824855853,0.0271968592716335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39654,-0.00534524878418269,0.00242512116584807,-0.0100984862692449,-0.00059201129912047,0.0275311055023964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36847,0.012238275638904,0.00556107275239451,0.00133857304421073,0.0231379782335972,0.0277753522445512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36992,0.00688476571831011,0.00313033086287017,0.000749317227084574,0.0130202142095356,0.0278695844467797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39453,0.0191129928391769,0.0086937487080642,0.00207324537137106,0.0361527403069827,0.0279304599380808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36861,-0.0120022482522544,0.00546492991595182,-0.0227135108875199,-0.00129098561698882,0.0280938517180958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36861,0.00764291000338583,0.00348095048270331,0.000820247057287335,0.0144655729494843,0.0281362512303625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39485,-0.00342690324068615,0.00156165455426677,-0.00648774616704903,-0.000366060314323277,0.0282215198903086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39499,-0.00956749681312189,0.00436137394328141,-0.0181157897419535,-0.00101920388429032,0.0282730363453731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36823,-0.0107739225656518,0.0049161350266909,-0.020409547217966,-0.00113829791333767,0.0284310800602828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39355,0.00679261863657297,0.00310282228412582,0.000711086959686372,0.0128741503134596,0.0285996340535451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36954,-0.00409837079724139,0.00187216406723281,-0.0077678123690177,-0.00042892922546508,0.0286073606760042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39497,0.00525190413147692,0.00239925153380381,0.000549371125221462,0.00995443713773238,0.0286138946503043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39194,-0.00821490098992975,0.00375434730597902,-0.0155734217096486,-0.000856380270210871,0.0286776956309202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,39180,-0.00835228648119418,0.00381916766665806,-0.015837855107844,-0.000866717854544389,0.028762656026288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37235,0.00476309179372981,0.0021782968732618,0.000493629922136684,0.00903255366532294,0.0287888681312292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36847,0.0173031843617029,0.00791483742008424,0.00179010301833781,0.032816265705068,0.028821769543092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36763,-0.011077842382031,0.00507325857938802,-0.0210214291976316,-0.00113425556643052,0.0290122794383872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36992,-0.0108301665498551,0.0049618610917785,-0.020555414289741,-0.00110491880996927,0.0290776971175794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39541,0.00921874775011178,0.00422742232128979,0.000933000000383792,0.0175044954998398,0.0292208666477831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,37164,-0.00657402126852957,0.0030184474443888,-0.0124901782595316,-0.000657864277527531,0.0294282344932626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36880,-0.0189365025137933,0.00871429841599132,-0.0360165274091363,-0.00185647761845031,0.029796274943176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39592,-0.00451873388675223,0.00208350918822908,-0.00860241189568123,-0.000435055877823226,0.0301126880889641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,39123,0.0157651687422984,0.00726946436069719,0.00151701859533195,0.0300133188892649,0.0301227202203136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37255,0.00500348291674531,0.00230858367092001,0.000478658921742087,0.00952830691174853,0.0302274046867019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39526,0.0193931120836974,0.00896277839915167,0.00182606642136017,0.0369601577460347,0.0305000532991355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36880,-0.00861921820617751,0.00398991026971789,-0.0164394423348246,-0.000798994077530453,0.0307720932726042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39410,0.0138664083630981,0.00641945681471899,0.00128427300624884,0.0264485437199473,0.0307839013986843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,37255,-0.00535213777343417,0.00247878314015912,-0.010210552728146,-0.000493722818722299,0.0308547572343104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36955,0.00727441715635528,0.00336994650870523,0.000669321999293029,0.0138795123134175,0.0308990150381679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,39104,0.0201587021130709,0.00934650290115783,0.00183955642680156,0.0384778477993402,0.0310360914010674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39194,0.00730684870868182,0.00339725308315664,0.000648232665694809,0.0139654647516688,0.0315073385996212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,37221,-0.0126469285656301,0.00588021500968648,-0.0241721499846156,-0.00112170714664462,0.0315138928329243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36916,0.00499466456306205,0.00232238915728424,0.000442781814784948,0.00954654731133916,0.0315223813071942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39123,-0.0111116740500514,0.00517099229053889,-0.0212468189395076,-0.000976529160595157,0.0316627998360576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,39312,-0.0127261938299656,0.00593324977667984,-0.0243553633922581,-0.0010970242676731,0.0319774594071545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37221,0.013788427024555,0.00643315570502426,0.00117944184270745,0.0263974122064026,0.0321048050824566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36847,0.00925535778651117,0.00431862543264797,0.000790851938521141,0.0177198636345012,0.0321224034544512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36861,-0.00884862664066425,0.00412954322589082,-0.0169425313634103,-0.000754721917918245,0.0321516398086693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36955,-0.0158495258545204,0.00739699816723487,-0.0303476422623007,-0.00135140944674003,0.0321566843890279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37247,-0.00586028100773718,0.00274055568294471,-0.0112317701463088,-0.000488791869165554,0.03250682360151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37221,0.0238014176542004,0.0111428426502673,0.00196144605967647,0.0456413892487244,0.032696139089172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39485,0.0164354905123496,0.00769606141319311,0.00135121014249111,0.0315197708822081,0.0327304574124173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39509,0.00741157491441431,0.00347289584868978,0.000604699050982342,0.0142184507778463,0.0328491040497383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39654,0.00523512891782069,0.00245513464283545,0.000423065017863215,0.0100471928177782,0.0329966555434939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36916,-0.00732465948106502,0.00344114337552059,-0.0140693004970854,-0.000580018465044657,0.0333107341924945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,39194,-0.00786051453795503,0.00370100285504091,-0.0151144801338352,-0.000606548942074846,0.0336961354299449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36992,0.00785707932913059,0.00370805900932547,0.000589283670852666,0.0151248749874085,0.0341168560990445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39531,0.00475902373929147,0.00224749474172607,0.000353934045508365,0.00916411343307457,0.034235507654352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39531,-0.00535856397673691,0.00253231864287436,-0.0103219085167707,-0.000395219436703154,0.0343551818517053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39531,-0.00502304513490334,0.00237426996597664,-0.00967661426821756,-0.000369476001589119,0.0343937717593511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39428,-0.00783616971305529,0.00370961551087059,-0.0151070161143616,-0.000565323311748946,0.0346691733547049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36823,0.0108330000003273,0.00513399578648807,0.000770368258810675,0.0208956317418439,0.0348738696274783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,37269,-0.00375209559830714,0.00178105738390624,-0.00724296807076337,-0.00026122312585092,0.0351658007303891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39589,0.00488985652161769,0.0023242765602187,0.000334274463589045,0.00944543857964634,0.0354107169553147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37117,0.0054270280233754,0.00258205323000942,0.000366203692556932,0.0104878523541939,0.0355881709091233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,39104,-0.00822608486627482,0.00391616438586564,-0.0159017670625715,-0.000550402669978161,0.0356978516411726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39187,0.0174463451289137,0.00830901743915973,0.00116067094816059,0.0337320193096667,0.0357732476130021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36823,0.015210263667289,0.00725294455968233,0.000994492330311644,0.0294260350042664,0.0360035842669979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36763,0.00566540205526281,0.00270359037973874,0.000366364910974882,0.0109644391995507,0.0361460081933945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39654,0.00775626957323325,0.00371030272050029,0.000484076241052682,0.0150284629054138,0.0365923370050241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39187,-0.0172006330874699,0.00825267837298954,-0.0333758826985294,-0.00102538347641035,0.0371547446448315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37247,-0.0142940268108162,0.00686600859769587,-0.0277514036623001,-0.000836649959332306,0.037375642219671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39589,0.0238225446313874,0.0114501794314992,0.00138019294564906,0.0462648963171258,0.0374929006283725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,37081,0.0184834096440845,0.00889912240192432,0.00104112973631285,0.0359256895518562,0.0378224267127746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39589,-0.00894735866869517,0.00431494936206005,-0.0174046594183329,-0.000490057919057468,0.0381359391186755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36955,0.00779123267058266,0.00375837952404721,0.000424808803450118,0.0151576565377152,0.0381899436774061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36823,0.00790814864920737,0.00381767356770295,0.000425508456509592,0.0153907888419051,0.038336739237096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39187,-0.0156349947044829,0.00755227566257227,-0.0304374550031246,-0.000832534405841278,0.0384476067273079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39541,0.01611948816808,0.00778801045964526,0.000854987667175264,0.0313839886689847,0.0384896892131345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36847,0.0133765285054639,0.00646429812381218,0.000706504182792025,0.0260465528281358,0.0385392517075074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39123,0.0235172518123367,0.0113732639970339,0.00122565437815028,0.045808849246523,0.0386794949422288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39389,-0.00550124625500383,0.0026627441488764,-0.0107202247868016,-0.00028226772320608,0.0388450842286986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36847,0.0075105830039015,0.003639148237406,0.000377852458585736,0.0146433135492173,0.0390546113294907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36880,-0.00897305103375853,0.00434794964032843,-0.0174950323288023,-0.00045106973871481,0.0390627934555266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,37162,0.00966174371788347,0.00468845608139451,0.000472369798350233,0.0188511176374167,0.0393470376528189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38989,-0.0108404073539876,0.00526697662315349,-0.0211636815353684,-0.000517133172606708,0.0395902527978918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36823,0.0130888178891898,0.00635974670610615,0.000623714345221793,0.0255539214331579,0.0396041042625129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36916,-0.00931373596346334,0.00453154417764678,-0.018195562551651,-0.000431909375275645,0.0398696937622102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39104,-0.0112438495672606,0.00547074722328514,-0.0219665141248994,-0.000521185009621674,0.0398708499031852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39589,-0.00480256394384138,0.00233741896148431,-0.00938390510835063,-0.000221222779332144,0.0399305259280918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39526,-0.00499289855194895,0.00243128543282943,-0.00975821800029463,-0.000227579103603276,0.0400312054358786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39466,-0.0104055816762872,0.00507352565901519,-0.020349691967957,-0.000461471384617478,0.0402884766335955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39499,0.00615157967112761,0.00299978331305184,0.000272004377546002,0.0120311549647092,0.0403159220394223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,37269,0.00269237924778414,0.00131354944172571,0.000117822342001757,0.00526693615356652,0.0404142470339819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37269,0.00348558538574604,0.00170060584201933,0.00015239793538816,0.00681877283610393,0.0404224292698085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39104,0.00506194564164017,0.00247226375288367,0.00021630868598817,0.00990758259729217,0.0406273807407802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36855,-0.00896250207499326,0.00438626736168075,-0.0175595861038875,-0.000365418046098997,0.0410428898110423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,39319,-0.00626058759940854,0.00306999176863744,-0.0122777714659379,-0.000243403732879161,0.041439256049506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39434,0.0124903511763663,0.00612736662899641,0.000480712583533292,0.0244999897691992,0.0415221346722693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39531,-0.0104843993888971,0.00514443911690859,-0.020567500058038,-0.000401298719756292,0.0415667163376329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37221,0.0206419135095736,0.0101311327459942,0.000784893327425012,0.0404989336917222,0.0416231981454185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,37091,-0.00807050807081676,0.00396588908804803,-0.0158436506833909,-0.000297365458242624,0.0418736311113224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39579,-0.0106482251920152,0.00523416401037312,-0.0209071866523466,-0.000389263731683924,0.0419317314032843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,37164,-0.0108995854341005,0.00536277552660022,-0.021410625466237,-0.000388545401964086,0.0421286323243164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,39104,-0.0113341777839148,0.00557820880253043,-0.0222674670368745,-0.000400888530955176,0.042185138111059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39194,-0.0102204174624682,0.00503270748739003,-0.0200845241377526,-0.000356310787183714,0.0422932953346467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39516,0.00940755799372415,0.00463288863357529,0.000327096271916591,0.0184880197155317,0.0423128027610415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39428,-0.00815490017716998,0.00402203330165491,-0.0160380854484136,-0.000271714905926352,0.0426231940911849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38992,0.0219337472551645,0.0108199085833457,0.000726726431806924,0.043140768078522,0.0426636798439699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36847,0.0128820744140686,0.0063565026822288,0.000423329156900144,0.025340819671237,0.042724928009705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36861,0.00579417665107143,0.00285946288834633,0.000189629389912619,0.0113987239122302,0.0427537155529005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39654,0.0129828321437891,0.00641569051191593,0.000408078740433835,0.0255575855471443,0.043028130004387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39068,0.0085131514251202,0.00420750718535455,0.000266437341825286,0.0167598655084151,0.0430578897525419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,37164,-0.018664493767592,0.0092444614823636,-0.0367836382730246,-0.000545349262159312,0.0435090021175727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36955,-0.00585939124501405,0.00290251710611635,-0.0115483247730021,-0.000170457717026014,0.0435368502738426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39601,0.00615857586989997,0.00305666284735939,0.00016751668907557,0.0121496350507244,0.043942846450107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36823,0.00602573559339691,0.00299171972709756,0.000161964928285685,0.0118895062585081,0.0440166791083157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39642,-0.00992145036409189,0.0049266379909693,-0.0195776608263917,-0.000265239901792055,0.0440441525604073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,39194,0.0261533427641586,0.0130050420516242,0.000663460342975167,0.0516432251853421,0.0443419766550156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37164,-0.0183323405967605,0.0091487208283936,-0.0362638334204119,-0.000400847773109,0.0451111017623458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36955,-0.010449536472577,0.00521896231433299,-0.0206787026086697,-0.000220370336484366,0.0452821035835147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39423,-0.0114194838311808,0.00570718665670682,-0.0226055696783262,-0.000233397984035415,0.0454216788035623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38875,0.00569193810707397,0.00284657279143228,0.000112655435866706,0.0112712207782812,0.0455648108732772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",37269,-0.00290687739438933,0.00145519336794832,-0.00575905639556805,-5.46983932106135e-05,0.0457824001906991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37162,0.00795357598983942,0.00398255299172328,0.000147772126061792,0.015759379853617,0.0458350749115819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39589,-0.00930154298952697,0.00466093231784968,-0.0184369703325123,-0.000166115646541601,0.0459910107703696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36880,-0.0155581574070081,0.00780127572820737,-0.0308486578342945,-0.000267656979721602,0.0461400626351924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39485,-0.00621023087255032,0.00312316899601913,-0.0123316421047478,-8.88196403528241e-05,0.046781267011628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37221,-0.0103916705627059,0.00522713275687427,-0.0206368507661795,-0.000146490359232337,0.0468302437393701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39123,0.0135988222838277,0.00685097469543791,0.000170911880769391,0.027026732686886,0.0471689513932192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36909,-0.0116755276198388,0.00588261847664648,-0.0232054598340659,-0.000145595405611687,0.0471941820505514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36847,-0.00827977335889463,0.00417873795251652,-0.016470099745827,-8.94469719622433e-05,0.0475679041245361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36916,0.0152547753799253,0.00769913331366017,0.000164474085151385,0.0303450766746992,0.0475725546006631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39589,0.0111000489737944,0.00561893361995285,8.69390786868256e-05,0.022113158868902,0.0482326851067619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39456,0.00791105426173876,0.0040183153084473,3.5156257182041e-05,0.0157869522662955,0.0490002981530074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,39085,-0.012126430447242,0.00617737983184655,-0.0242340949176612,-1.87659768227794e-05,0.0496606888384729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39589,-0.0102151488675026,0.00520813049127761,-0.0204230846304068,-7.21310459851632e-06,0.049852434761762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39187,0.0193363150859028,0.00986609637554143,-1.23381015845053e-06,0.038673863981964,0.0500292291858407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36847,0.00861914260819024,0.00441654650385641,-3.72885393683312e-05,0.0172755737557488,0.0510133045869504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36861,0.0114000530908905,0.00584159551670629,-4.94741218537847e-05,0.0228495803036349,0.0510164125010975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39455,0.00654363673968544,0.00335806012541535,-3.81611061286511e-05,0.0131254345854995,0.0513575294933999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39123,0.00826791649209283,0.0042430803618269,-4.85210170878894e-05,0.0165843540012735,0.0513664724825528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39601,0.00620206550533859,0.0031833971896365,-3.73929863489442e-05,0.0124415239970261,0.0514030492560941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36823,0.00485732052321125,0.00249526452940249,-3.33979544176223e-05,0.00974803900084012,0.0516034579717244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36955,0.0204800993151447,0.0105268937835272,-0.000152612500568621,0.0411128111308581,0.0517368977245628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37243,0.00489219289536047,0.00251559680908482,-3.83768504457717e-05,0.00982276264116671,0.0518276325838618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39428,0.00391093908179739,0.00201154834606055,-3.16956764812842e-05,0.00785357384007607,0.0518848374265811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,39104,0.0125375681887838,0.00646432362493946,-0.000132506116097574,0.0252076424936651,0.0524594182778576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39104,-0.0103827369742349,0.00535956233425109,-0.0208874791493671,0.000122005200897201,0.0527357000685326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,39330,0.00539484192857487,0.00278695175402157,-6.75835093074065e-05,0.0108572673664571,0.0529172454165349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39214,0.00592030486605737,0.00305870364515678,-7.47542784499079e-05,0.0119153640105647,0.0529406678240979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37019,0.00959224003898323,0.00495897885212889,-0.000127358511189403,0.0193118385891559,0.0530965114492649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36847,0.00631451276750118,0.00327712644100191,-0.000108655056862554,0.0127376805918649,0.0540218554784216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39123,0.00828969200775353,0.00430245278670915,-0.0001431154541964,0.0167224994697035,0.0540317918535198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39531,-0.00996253935793298,0.00517446543340897,-0.0201044916074146,0.000179412891548594,0.0542072144354468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39526,-0.00723721505287263,0.00375989010695604,-0.0146065996625065,0.00013216955676122,0.0542672368583867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,39187,-0.0201996876584558,0.0104944294465737,-0.0407687693737403,0.000369394056828586,0.0542734960886846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36957,-0.0113038035927362,0.00587577641295938,-0.0228203253621366,0.000212718176664213,0.0544026513368217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36757,-0.0106261846215466,0.00553294084886936,-0.0214707486853305,0.000218379442237378,0.054813941458979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39636,0.0045106187236746,0.00235100276765243,-9.73467009241545e-05,0.00911858414827335,0.0550545223078583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39258,0.0299110898002644,0.0156323992382097,-0.000728412706626665,0.0605505923071554,0.0557156611608219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36847,0.00900542714714932,0.00471100373886695,-0.000228140181029905,0.0182389944753285,0.0559540313381412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39495,0.0157649399368681,0.0082641192438211,-0.000432733781021308,0.0319626136547574,0.0564571672741092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,37269,0.00518599699070121,0.00271860399175119,-0.000142466833131127,0.0105144608145335,0.0564658320363919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37203,-0.00951870779862446,0.00499457556115458,-0.0193080758984874,0.000270660301238509,0.056697436244807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39589,0.0038183287641417,0.00200503723630967,-0.000111544219025251,0.00774820174730866,0.0568812117405177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,37164,0.0129976828065085,0.00683173903977314,-0.000392525711446845,0.0263878913244639,0.0571226719398881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36993,0.00649894746759337,0.00341731073640962,-0.000198981575769491,0.0131968765109562,0.057223799454105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36916,-0.0130830807669833,0.00688362881556879,-0.0265749932454982,0.000408831711531483,0.0573764105246387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39485,-0.0112299002535783,0.00593739916971405,-0.0228672026262179,0.000407402119061227,0.0585923428868997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39485,-0.00594041572796745,0.00314256144491991,-0.0120998361600105,0.000219004704075567,0.0587357115519361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,39123,0.0127507480648279,0.00674999486939534,-0.00047924187918698,0.0259807380088427,0.0589113791973793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36992,-0.0111639936462598,0.00591738048798201,-0.0227620594027046,0.000434072110184895,0.059231232359397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39531,-0.00533395427409187,0.00282766480435136,-0.0108761772906205,0.00020826874243679,0.0592675387502917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39477,0.00471525358845396,0.00250016266613349,-0.000185065237167672,0.00961557241407559,0.0593170931959364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36823,-0.0145479369169389,0.00771640931006026,-0.0296720991646571,0.000576225330779159,0.059409429520294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37269,-0.00545765441917391,0.0028973198585147,-0.0111364013418627,0.000221092503514907,0.0596294458025848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36847,0.0113203866784471,0.00601863222609613,-0.000476132484701368,0.0231169058415955,0.0600102721464693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,37203,0.00614420045760191,0.00327293857986596,-0.000270759158935378,0.0125591600741392,0.060503446448374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39104,-0.0107492570172072,0.00572623417266611,-0.0219726759956328,0.000474161961218323,0.0605112521962456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36847,0.00537276821031756,0.00286361679943964,-0.000239920716584134,0.0109854571372193,0.0606488867476442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39355,0.0102175027396913,0.00545248602633379,-0.000469369871922977,0.0209043753513055,0.060961505635731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36825,-0.00688196971861874,0.00367629523870226,-0.0140875083864752,0.00032356894923768,0.0612322437596545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39561,0.00619968805311012,0.00332317134545302,-0.000313727783977803,0.012713103890198,0.0621175746161521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39541,0.00721258790344972,0.00387310570022992,-0.000378699269000932,0.0148038750759004,0.0625910363857687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,37114,0.0153890702315585,0.00827088401945874,-0.000821862446580623,0.0316000029096976,0.0628193480398616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37181,-0.00985927551682069,0.00530239268720317,-0.0202519651837389,0.000533414150097521,0.0629933428045742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36916,0.0101665716916687,0.00547100012590826,-0.000556588555111537,0.0208897319384489,0.0631548562839952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36823,0.0120679790800749,0.00649962212309538,-0.000671280281192078,0.0248072384413418,0.0633747395654744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39455,0.0122709356469841,0.00661494993128616,-0.000694366218336739,0.025236237512305,0.0636114359281937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,37203,-0.0123659403733732,0.00666814803508128,-0.0254355105221325,0.000703629775386138,0.0636937356405197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36861,0.00656047022556128,0.00353843830440485,-0.000374868851072211,0.0134958093021948,0.0637545590215472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,39194,0.0141385153280148,0.00762859250720116,-0.000813525986099434,0.0290905566421291,0.0638509843047777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36861,-0.00734098726010385,0.00396523262728989,-0.015112843209592,0.00043086868938433,0.0641446336294748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39427,-0.0114171667946502,0.00616754041345741,-0.0235055460050267,0.000671212415726359,0.0641647524217578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,37164,-0.0115780147074384,0.00625552767904982,-0.0238388489583761,0.000682819543499242,0.0642149777791643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39123,0.00964612771802225,0.00523172627738796,-0.000608055785658153,0.0199003112217027,0.0652360461170184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36916,-0.00852641132525534,0.0046302477703693,-0.0176016969551792,0.000548874304668486,0.0655780739618154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,39187,0.00545938534305806,0.00296539656415205,-0.000352791922679951,0.0112715626087961,0.0656371890003551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36847,0.00663464390363459,0.00360721679367914,-0.00043550101197652,0.0137047888192457,0.0658994569603447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37164,-0.00744171684786974,0.00404604064437211,-0.0153719565108391,0.000488522815099603,0.0659004012004227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36847,0.0180834781445315,0.00984290707555303,-0.00120861972355244,0.0373755760126154,0.0662029630238045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36823,0.00817984816747412,0.00445281751815265,-0.000547674168105063,0.0169073705030533,0.0662331274813487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36916,-0.0138916388595956,0.00757619364926467,-0.0287409784121543,0.000957700692963198,0.0667385931385611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39418,0.0070626663556359,0.00386743354796211,-0.000517503398369828,0.0146428361096416,0.0678416422118578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39455,0.00610251050594354,0.00334227687955257,-0.000448352177979504,0.0126533731898666,0.0678920828577847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39104,-0.00530517132277124,0.0029068031657598,-0.0110025055276604,0.000392162882117963,0.0680081131319896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36847,-0.00704746134697826,0.00387122222324232,-0.0146350569045332,0.0005401342105767,0.0687108783784567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36916,0.018846216119898,0.0103636341897484,-0.00146650689200898,0.0391589391318049,0.0690125118049232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39433,0.0143704045901881,0.00790270026051244,-0.00111888792041626,0.0298596971007925,0.0690203796243867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36847,0.00846701094938442,0.00466139823624717,-0.000669329593660031,0.0176033514924289,0.0693316273615509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36861,-0.0070127198361049,0.00386923545810962,-0.0145964213339997,0.000570981661789954,0.0699438813614468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39608,-0.0079068898887743,0.00436800316625561,-0.0164681760946353,0.000654396317086702,0.070287039018998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39589,0.0211709886875235,0.0117072618274146,-0.00177524449420908,0.0441172218692561,0.0705697319496063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37164,-0.0104532418867108,0.00578882414401835,-0.0217993372089868,0.000892853435565145,0.0709790820737661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39343,-0.0151932639867386,0.00842582828376237,-0.0317078874229129,0.00132135944943561,0.0713805492823348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36861,0.00502894997595676,0.00279034671566538,-0.000440129586747384,0.0104980295386609,0.0715276551766428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37255,0.00970184828982225,0.00539254815281073,-0.000867546089686781,0.0202712426693313,0.0720230334559877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39477,0.00373786392858993,0.00207945763215132,-0.00033787303042665,0.00781360088760652,0.0722733872327974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,37269,0.00361538399400346,0.00201312780043833,-0.000330346494855655,0.00756111448286258,0.0725333516904985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37162,-0.00533758952678254,0.00297214399314442,-0.0111629917533456,0.000487812699780522,0.0725386535583493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36880,0.0121220716975072,0.00675589032514369,-0.0011194733397744,0.0253636167347889,0.0727901207968982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39462,0.00540044264097056,0.00301092822904099,-0.000500976687949775,0.0113018619698909,0.0728949425090264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36861,-0.00835003517064221,0.00466376241926475,-0.0174910095124011,0.000790939171116705,0.0734127962946114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37164,0.0185539168116363,0.0103668069764454,-0.00176502486219673,0.0388728584854693,0.0735190835906372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39319,-0.0118111890748242,0.00659976308196433,-0.0247467247154743,0.00112434656582586,0.0735324162606997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,39092,0.0138711438240844,0.00776878353079701,-0.00135567189627772,0.0290979595444466,0.074201345091789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37203,0.00844099354268234,0.00473566062124501,-0.000840901274957872,0.0177228883603226,0.074702580025398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39463,0.00823451145661308,0.00462231437054661,-0.000825224709658267,0.0172942476228844,0.0748560173488628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36823,-0.0124366369692506,0.00699377858653178,-0.0261444429988529,0.00127116906035171,0.0753885279970787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39455,0.00420643731462856,0.00237057173648766,-0.000439883288887256,0.00885275791814438,0.0760106728361655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37164,-0.0203882995937219,0.011490393606217,-0.0429094710619073,0.0021328718744635,0.0760246047226981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37162,0.00649826506545005,0.00366445810671564,-0.000684072823712602,0.0136806029546127,0.0761992673625685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36847,0.00797113192437421,0.00449653950350178,-0.000842085502489291,0.0167843493512377,0.0762986968568859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39526,0.00526698364664126,0.0029795151660607,-0.000572866078837712,0.0111068333721202,0.0771259810901389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39617,0.00471300508787393,0.00266795155872574,-0.000516179967228519,0.00994219014297638,0.0773278015025196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,37164,-0.00927055995425752,0.00525018814722424,-0.019560928722817,0.001019808814302,0.0774605151846005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39187,0.00521202481557713,0.00296067308480428,-0.000590894430639255,0.0110149440617935,0.0783575526609228
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39104,-0.0123883039579479,0.00703748069129814,-0.0261817661128922,0.0014051581969965,0.0783723568368263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36880,0.00426248424836537,0.00242265761270149,-0.000485924672529544,0.00901089316926029,0.0785299592455617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39187,-0.00783762652947872,0.00445499103831802,-0.016569408964582,0.0008941559056246,0.0785488115924713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39485,-0.00499242654769174,0.00283801953584075,-0.0105549448379396,0.000570091742556118,0.0785768936639343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,39231,-0.00658546255460109,0.00374403317675514,-0.0139237675810412,0.000752842471838992,0.0786114391849427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36955,-0.00571731350469712,0.00325219274404974,-0.0120916112830346,0.000656984273640376,0.0787741381871622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39499,-0.00380308387219487,0.00216340220446503,-0.00804335219294632,0.000437184448556582,0.0787817772538729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36916,-0.0410438926888339,0.0233606668315163,-0.0868307996786059,0.00474301430093817,0.0789481895682014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39654,-0.00641919594902197,0.00366321791952326,-0.0135991030712876,0.000760711173243628,0.0797358654354556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,39354,0.00448576032623979,0.0025618161336778,-0.000535399295768697,0.00950691994824828,0.0799651205116716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,37143,-0.00797191691137166,0.00455627749048369,-0.0169022207927197,0.000958386969976369,0.0802019096131623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39636,0.00135206729561941,0.000774414719704974,-0.000165785555002336,0.00286992014624116,0.0808448204240117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36899,-0.00875320036367333,0.00502397050867284,-0.0186001825606721,0.00109378183332544,0.0814828711295286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37099,-0.00908451123517109,0.00521617265905529,-0.0193082096469195,0.00113918717657728,0.0816019376465034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36847,0.00796206259989003,0.00457433909788476,-0.00100364203196411,0.0169277672317442,0.0817797611874555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,39123,0.00879192209208125,0.00505502913187498,-0.00111593500639371,0.0186997791905562,0.0820130702084079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,37162,0.0168014191997941,0.0096601392189427,-0.00213245366933361,0.0357352920689218,0.0820146063559847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39428,0.0127708218953478,0.00734609387716228,-0.0016275221038903,0.0271691658945858,0.0821519849702319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,39079,-0.00558098774034222,0.00321055058822659,-0.0118736668932663,0.000711691412581882,0.0821742011716093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39477,0.00610621456727707,0.00351478953681759,-0.000782772924885413,0.0129952020594395,0.0823561936950832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39463,0.00929567082899558,0.0053509719483328,-0.0011922341897367,0.0197835758477279,0.0823736275363074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37221,0.0123639487558458,0.00712566101790553,-0.00160234683924901,0.0263302443509407,0.0827418954232159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39571,0.005375818528813,0.00310009769243586,-0.000700372948361282,0.0114520100059873,0.0829242089517831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36992,0.00478813380732726,0.00276377514664977,-0.000628865480106293,0.0102051330947608,0.0832160282064706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39457,0.00339385223860225,0.0019599559926328,-0.000447661506958033,0.00723536598416252,0.0833660465350659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,37203,0.00707702122190783,0.00409439692769606,-0.000947996756376434,0.0151020392001921,0.0839291234489767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36823,0.00906860785638116,0.00525133170065504,-0.00122400227690271,0.019361217989665,0.0842077430708192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39601,-0.00503715602376878,0.00291859714335524,-0.0107576064247451,0.000683294377207493,0.0843889266436325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39435,0.0102826793296716,0.00598825468763844,-0.00145429985809976,0.0220196585174429,0.0859740268444286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39344,-0.00739586881844713,0.00430960382964034,-0.0158426923245422,0.00105095468764794,0.0861578433287563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,39332,0.00786615088819363,0.0045858528321976,-0.00112212066291367,0.0168544224393009,0.0863095580202466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36992,0.0112844657236688,0.00658080932727967,-0.00161392055779938,0.0241828520051369,0.0864151404321732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39654,0.00464481049256774,0.00271417615660061,-0.000674974774369457,0.00996459575950494,0.0870433694314599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36847,0.00603368709568523,0.00352797730540697,-0.000881148422912419,0.0129485226142829,0.0872465697301974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39485,0.00521729257488277,0.00305215467508456,-0.000764930588282964,0.0111995157380485,0.0874011963896805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36992,-0.0117203086783086,0.00685736630289788,-0.0251607466319884,0.00172012927537127,0.0874468018328662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37221,-0.0119423232417883,0.0069898456890899,-0.0256424207924045,0.00175777430882794,0.0875633506264246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39420,-0.00668167758573291,0.00391467880893656,-0.0143544480512486,0.000991092879782753,0.0878750440849294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36847,-0.00706438493943855,0.00414073512923019,-0.0151802257927297,0.00105145591385262,0.0880200559340657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39066,0.0115572865559122,0.00677559859837492,-0.00172288669690264,0.024837459808727,0.0880811296674188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39485,-0.00434144964132683,0.00254723221823335,-0.0093340247890642,0.000651125506410531,0.088330929133532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37247,0.0148183975645066,0.00869606600016115,-0.00222589179580921,0.0318626869248225,0.0883988993474099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37203,-0.00429002223819295,0.00251759997594445,-0.00922451819104408,0.000644473714658177,0.0884030861463602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36880,-0.00595673915138686,0.00350380318024802,-0.012824193384673,0.000910715081899246,0.0891412522177662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,39330,-0.00445923363932304,0.00263474318950317,-0.00962333029074926,0.000704863012103168,0.0905766223781586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39438,0.00706525052959661,0.00417730694083778,-0.00112227107444543,0.0152527721336387,0.0907924846364087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39104,-0.00577415448014112,0.00341452152300824,-0.0124666166652373,0.000918307704955022,0.0908469630928157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,37255,-0.00654797239188468,0.00387682043397866,-0.0141465404424829,0.00105059565871349,0.091242659122997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36861,-0.00748329784805216,0.00443342495664483,-0.016172810763076,0.00120621506697169,0.091450365271373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39068,-0.00996154110111954,0.00590683901257138,-0.0215389455657594,0.00161586336352036,0.0917320489566508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,37050,-0.0163293197099514,0.00972406365187057,-0.0353884844676177,0.00272984504771494,0.0931244060709891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36992,0.0113670671577267,0.00677122568713194,-0.00190453518905193,0.0246386695045053,0.0932293766837289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,39123,-0.014504620600315,0.0086518991612032,-0.0314623429562733,0.00245310175564328,0.0936681247366482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39485,0.00732418313888083,0.00436907639719794,-0.00123920659962713,0.0158875728773888,0.0936867792734745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,37221,0.0045530975915021,0.00271635018197401,-0.000770948765166958,0.00987714394817116,0.0937270072510066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37203,-0.00577253950422646,0.00344474262669334,-0.0125242350525454,0.000979156044092495,0.0938110037311701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36992,0.00678396762322434,0.00405441354703525,-0.00116268292896475,0.0147306181754134,0.0943069086710551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36916,0.0141665384337775,0.00847429955982692,-0.00244308870348329,0.0307761655710382,0.0946073887124746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37221,-0.0112662680839522,0.00674153728574883,-0.02447968116402,0.00194714499611547,0.0947122217115796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39123,-0.00526728746032811,0.00315206677629077,-0.011445338341858,0.000910763421201799,0.0947314843262543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36880,0.0138937874444238,0.00831972572515406,-0.00241287497687816,0.0302004498657258,0.0949482211051589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39588,-0.00394604562035016,0.00236320097661885,-0.0085779195345231,0.000685828293822774,0.0949819108515739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39104,0.016718794206046,0.0100207914027813,-0.00292195694340533,0.0363595453554974,0.09525561997049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36880,-0.00788285208918463,0.00472876724957219,-0.0171512358983461,0.00138553171997687,0.095539724435041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39559,-0.00631909171353968,0.0037913837698683,-0.0137502039024816,0.0011120204754022,0.0955952023598525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36847,0.00728019787942794,0.00437393319587494,-0.00129271118448694,0.0158531069433428,0.0960475931135738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39455,-0.00589314299678772,0.00354097372158618,-0.0128334514910966,0.0010471654975212,0.0960789917671376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38905,-0.013862894808117,0.00833256168618392,-0.0301947157130375,0.00246892609680349,0.0961937896703395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36823,0.00858242892106136,0.00516438341447284,-0.00153976257130541,0.0187046204134281,0.0965682549874802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36823,0.00700723927876583,0.004216643200535,-0.00125738139428277,0.0152718599518144,0.0965771912351725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,39123,-0.00878762661295534,0.00529411591500265,-0.0191640938063605,0.00158884058044985,0.096958846824649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36847,0.00971004166211628,0.00585260279676856,-0.0017610598195501,0.0211811431437827,0.0971213435954862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39623,0.00755254234413745,0.00455477598784853,-0.00137481859204567,0.0164799032803206,0.0973060715741682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39636,-0.0147328794503111,0.00890145455760414,-0.0321797303832152,0.00271397148259301,0.0979230128895901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,37247,0.0105322265229008,0.00637339900902056,-0.00195963553477952,0.0230240885805811,0.0984512993318872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39485,0.00466270408600715,0.00282190209743513,-0.000868224024965707,0.01019363219698,0.0984888596456901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36823,0.00911090949509519,0.00553251315634953,-0.00173281629134989,0.0199546352815403,0.0996257935171565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39507,0.00449105910452699,0.00272733436432614,-0.000854516249552247,0.00983663445860623,0.099643792337516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36763,0.0141623553920127,0.00860126773491615,-0.0026961293684229,0.0310208401524484,0.0996775816242691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39485,-0.0037909284094361,0.00230254945136774,-0.00830392533411688,0.000722068515244678,0.0997013538190517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37247,0.0131935184858455,0.00802100206999266,-0.00252764557134008,0.0289146825430312,0.100020858116623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,37122,0.0104893238589363,0.00638442576553469,-0.00202415064151172,0.0230027983593843,0.100417070452978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,39355,-0.00179691797680203,0.00109438457546697,-0.0039419117447173,0.000348075791113236,0.10062274923179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37221,0.0166748752131122,0.0101674835174825,-0.00325339248115352,0.0366031429073779,0.101025663335296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36992,0.0092352459298832,0.00564035814938786,-0.00181985604291701,0.0202903479026834,0.101582246294756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36955,0.0123877844777785,0.00757804160954909,-0.00246517707693774,0.0272407460324947,0.102138238041589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39589,0.00868468975979325,0.00532448301639729,-0.00175129695234543,0.0191206764719319,0.102892975835843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36823,-0.00779961402052776,0.00478680978168686,-0.017181761192634,0.00158253315157848,0.103254440831607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36861,0.011594572661698,0.00711700189352879,-0.00235475104961845,0.0255438963730144,0.10330935734191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39433,0.00974164247999273,0.00598349801455986,-0.00198601362854459,0.0214692985885301,0.103527923177063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36763,-0.00732544347107147,0.00449979209345848,-0.0161450359742501,0.00149414903210716,0.103560750557984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37221,0.0054937356855994,0.00337660070337829,-0.00112440169302204,0.0121118730642208,0.10376137303232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39477,0.00371617832092398,0.00228695565304857,-0.00076625475905121,0.00819861140089916,0.104195144219802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,37164,-0.0154782344507148,0.00952640852395586,-0.0341499951576683,0.00319352625623869,0.104236105673994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39568,-0.00851922022457744,0.00524403710667155,-0.0187975329536537,0.00175909250449879,0.104278524658033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36992,0.00431215948403098,0.00265461219651381,-0.000890880421136092,0.00951519938919805,0.104315002352847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39123,0.00717184326440529,0.00442642221840671,-0.00150394428367185,0.0158476308124824,0.105203343140851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36808,-0.0138433141114818,0.00855364578436038,-0.0306084598488282,0.00292183162586451,0.105599584548065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39428,0.0167581840106159,0.0103631908431071,-0.00355367004187398,0.0370700380631058,0.105880505192395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36831,-0.00583455986821298,0.00360857800083732,-0.0129073727498541,0.00123825301342817,0.105934317303411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37221,-0.0097796960195507,0.00605972804962247,-0.0216567629968107,0.00209737095770935,0.106577375371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39123,-0.00642362259210499,0.00398154819976102,-0.0142274570636366,0.00138021187942661,0.106690443656416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36823,0.00492180322605291,0.00305150376741962,-0.00105914415808955,0.0109027506101954,0.106789406551644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,39194,-0.00464210833468854,0.0028784737015711,-0.0102839167897679,0.00099970012039082,0.106831574069696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39623,0.00547292770870895,0.00339375487186232,-0.00117883184014119,0.0121246872575591,0.106842079004105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36763,-0.00381820003349231,0.00237135418425485,-0.00846605423463182,0.000829654167647199,0.107394056618405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39423,-0.00409338576201401,0.00254387899587887,-0.0090793885939366,0.000892617069908579,0.10761297776195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37164,-0.00385027559473967,0.00239977410110101,-0.00855383283289765,0.000853281643418313,0.108643590555757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36992,0.0105664501953076,0.00658957601516398,-0.00234911879441385,0.023482019185029,0.108847315625045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36955,0.0134561665374551,0.00839251316996796,-0.00299315927568215,0.0299054923505923,0.108881859408325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39462,0.00480686936735091,0.00300200924666751,-0.00107706875611741,0.0106908074908192,0.109349825662779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37164,0.00698297551400656,0.00436483761474325,-0.00157210621089021,0.0155380572389033,0.109662303772585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,37243,-0.00370229539520781,0.00231682663839827,-0.00824327560646842,0.000838684816052807,0.110067060383531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39516,-0.0124306019679669,0.00779496674738047,-0.0277087367928326,0.00284753285689881,0.11080122076298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37203,0.00928362194738817,0.00582539707862993,-0.0021341563267265,0.0207014002215028,0.111040085006883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39462,0.0066983076458741,0.00420379929981944,-0.001541138981772,0.0149377542735202,0.111092936561766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,37255,0.00435760448485088,0.00273780737054581,-0.0010084979614189,0.00972370693112067,0.111490242551297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36880,0.00939650580616903,0.00591860439587221,-0.0022039588097405,0.0209969704220786,0.112397307828434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,37162,-0.00824171271149649,0.00519235928780745,-0.0184187369155991,0.00193531149260611,0.112474786787403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36847,-0.00882894904256865,0.00556513683549991,-0.0197366172401485,0.00207871915501118,0.112657165078126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37210,-0.0027971604065742,0.00176360651678789,-0.00625382917947847,0.000659508366330075,0.112753742533713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,37269,-0.0058863535057609,0.00371268595764022,-0.0131632179827357,0.00139051097121394,0.112884178177545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39123,-0.005093579695781,0.0032137321463823,-0.0113924947026903,0.0012053353111283,0.113001020406277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,37040,0.00461750526965456,0.00291415326770322,-0.00109423513504376,0.0103292456743529,0.113102806234688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,39341,-0.00958481195666275,0.00606965477035263,-0.0214813353065539,0.00231171139322841,0.114326048469549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39355,0.00823154962495611,0.00522352488371608,-0.0020065591471274,0.0184696583970396,0.115079045385216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37221,-0.00921062053849253,0.00584803642962372,-0.020672771940555,0.00225153086356996,0.115282672505764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39591,-0.0115079919638,0.00730700409152405,-0.0258297199831871,0.00281373605558718,0.115294383025969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37164,0.0144183665213469,0.00915811895066654,-0.00353154662195952,0.0323682796646533,0.115424328437424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39552,0.00839844762923658,0.00533650876756357,-0.00206110955518803,0.0188580048136612,0.115561139321639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37126,-0.00749127330440307,0.0047631369735157,-0.0168270217724938,0.0018444751636877,0.115799265221155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36955,-0.00968559934338837,0.00615969764884121,-0.0217586067351172,0.0023874080483404,0.115879702446742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36763,0.00673695594375371,0.00428632334648947,-0.00166423781536564,0.0151381497028731,0.116038178917647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,37162,-0.0113656149187845,0.00723243385822969,-0.0255411852809147,0.00280995544334565,0.116096416829621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36847,0.0101815243537226,0.00648224676682335,-0.00252367930925117,0.0228867280166964,0.116282916266979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39082,-0.00812479696094079,0.00517634950543864,-0.0182704419916005,0.00202084806971895,0.116529879696735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39462,-0.00669871196846205,0.00426799927109245,-0.0150639905398032,0.00166656660287914,0.116547806120939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36992,0.0100119466185622,0.00637969790609686,-0.00249226127738766,0.022516154514512,0.116592817128276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36880,0.0149394174621055,0.00956011453462054,-0.00379840702575076,0.0336772419499617,0.118152907133846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39601,0.0153159292100959,0.00984631278617596,-0.00398284385080899,0.0346147022710008,0.119848173760147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36955,0.00739128043050896,0.00475559831965679,-0.00192969227601836,0.0167122531370363,0.12015553345872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,39123,0.0199205343662211,0.0128214628055138,-0.00520953273258594,0.0450506014650282,0.120280772072264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36880,0.00615213668156706,0.00396101363185451,-0.00161145003686777,0.0139157234000019,0.120407438445028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39516,0.0105817453944213,0.00682213123671775,-0.00278963182954546,0.0239531226183881,0.120900919026087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37162,-0.00402046799500355,0.00259522318090085,-0.00910710542956921,0.00106616943956211,0.121363339937192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36823,0.010393622459099,0.00671243350027403,-0.00276274720143812,0.0235499921196361,0.1215483596425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37247,0.00973996684290992,0.00630495422824246,-0.0026177434444453,0.0220976771302651,0.122416555875326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39440,0.0150843976021528,0.00977557506989267,-0.00407572953483682,0.0342445247391424,0.1228348803804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39420,0.00401324103024818,0.00260150502950366,-0.00108570882757899,0.00911219088807535,0.122934125726581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39524,0.00555933252133781,0.00361205714700176,-0.00152029948678565,0.0126389645294613,0.123799839200073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36741,0.00706158528893215,0.00458983497117614,-0.00193449125457308,0.0160576618324374,0.12394554436057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,37164,-0.00932510569602675,0.00606735557729681,-0.0212171226275285,0.002566911235475,0.124335143135164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36847,0.0056100112597022,0.00365232050420443,-0.0015485369285385,0.0127685594479429,0.124560750795922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39330,-0.0054561462000658,0.00355263333480354,-0.0124193075362807,0.00150701513614914,0.124607880644908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36955,0.0119092984166122,0.00777514244816285,-0.00332998078178703,0.0271485776150113,0.125618203139487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36763,0.00875571392918275,0.00571699860325884,-0.00244960333320458,0.0199610311915701,0.125665920874658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39531,0.00976270538090154,0.00638726837890221,-0.0027563406417468,0.0222817514035499,0.126418521257409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39404,-0.00668830311172384,0.00437600899234942,-0.0152652807367287,0.00188867451328102,0.12643378642197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37221,-0.00839586067785035,0.00549560921575402,-0.0191672547407282,0.00237553338502753,0.126601934501565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39485,0.0048726265034265,0.0031937007646729,-0.00138702699533239,0.0111322800021854,0.127105846304282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37203,0.00542562494449986,0.00355690167944827,-0.00154590234721875,0.0123971522362185,0.127189267632697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36916,-0.0068233599077784,0.00447430278784755,-0.0155929933719596,0.0019462735564028,0.127281785275036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37247,-0.00459385297631593,0.00301484114037109,-0.0105029416114433,0.0013152356588114,0.127596817572422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39589,0.00913752256121022,0.00599822634225501,-0.0026190010696096,0.02089404619203,0.127686865737678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37247,0.00834761812523527,0.00548848556077077,-0.00240981357387543,0.019105049824346,0.128301393519346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37162,0.00667127654747828,0.00438676388656357,-0.00192678067018631,0.0152693337651429,0.128341431957623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36533,0.0145470646448563,0.00957142184586448,-0.00421292217303811,0.0333070514627507,0.128576446847856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39428,-0.025424427641635,0.0167572515521865,-0.0582686406839206,0.00741978540065063,0.129232399785068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39123,-0.0106299410725044,0.00701823605824839,-0.0243856837466713,0.00312580160166239,0.12989091561885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39455,-0.0123102414800973,0.00812891498291556,-0.0282429148466118,0.00362243188641724,0.129951327550586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39564,0.00377624628990541,0.00249382326515893,-0.0011116473098061,0.00866413988961691,0.129985959704977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36789,-0.00465359273901422,0.00307601041128633,-0.0106825731451354,0.00137538766710699,0.13033921825692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36992,0.00464105936548303,0.00306944851238613,-0.00137505971879379,0.0106571784497599,0.130554651252038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39104,0.00694634076179563,0.00459541590865288,-0.00206067441916402,0.0159533559427553,0.130662199127857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37162,0.00608314745863867,0.00402513229881623,-0.00180611184704115,0.0139724067643185,0.130739108196955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39636,-0.0051600571688907,0.00341597344556082,-0.0118553651221899,0.0015352507844085,0.130919585577017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36916,0.00673980993331466,0.00446315028141803,-0.00200796461826468,0.015487584484894,0.131042876187154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36882,-0.00520549616012682,0.00345013861093198,-0.0119677678375535,0.00155677551729986,0.131380723950988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,37162,-0.00680456792170233,0.00451466101181252,-0.0156533035048549,0.0020441676614502,0.131780232535499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39169,-0.00568970982015222,0.00377740517840279,-0.0130934239698217,0.00171400432951724,0.132024927868898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,37136,-0.00340960167032794,0.00226398795167784,-0.00784701805561651,0.00102781471496062,0.132088014559706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36861,0.00800869286914758,0.00531858057829495,-0.00241572506431052,0.0184331108026057,0.132145220599526
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37221,0.011251340360605,0.00747404395149739,-0.00339778578432991,0.0259004665055399,0.132248939977995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39516,0.0115941195396555,0.00770654703133038,-0.00351071264175207,0.026698951721063,0.132486341062915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37243,0.00342702506262747,0.00227868130587271,-0.00103919029688305,0.00789324042213799,0.132618669456627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36823,0.0145852572058543,0.0097128586253744,-0.00445194569987953,0.0336224601115881,0.133214560775184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37255,0.00395003664336114,0.00263494636116702,-0.00121445822452621,0.00911453151124849,0.133873474244202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37162,0.0114199275816783,0.00762502924588885,-0.00352512974026379,0.0263649849036205,0.13423872835024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39589,-0.00308775885094868,0.00206266462023373,-0.00713058150660679,0.000955063804709441,0.134420426419346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39370,0.0092559718074193,0.00618798243606093,-0.00287247376726011,0.0213844173820987,0.134727454091411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39415,-0.0240159903021097,0.0160652426940337,-0.0555038659824157,0.00747188537819631,0.134960671969226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,37243,-0.00911344110244327,0.00610261933534961,-0.0210745749997285,0.00284769279484196,0.135366207102054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39355,-0.0103843536621672,0.00696060514968419,-0.0240271397555482,0.00325843243121379,0.135753052141517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37162,0.0126001249807344,0.00846102152967829,-0.00398347721743503,0.0291837271789039,0.136460402478588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39541,0.00344317905538495,0.00231229008693847,-0.00108890951501445,0.00797526762578435,0.136487871374693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36823,0.010507967526241,0.00706112221873278,-0.00333183202247523,0.0243477670749572,0.136738378353073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39104,0.00653057542950904,0.00439915009262028,-0.0020917587520267,0.0151529096110448,0.137695598371832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36847,0.00515462926142887,0.0034808815588462,-0.00166789859390967,0.0119771571167674,0.138674585502142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,37243,0.0119116067158537,0.00805231305203729,-0.00387092686613939,0.0276941402978468,0.139090750322394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39104,0.00737312753491343,0.00498706595893001,-0.00240152174458938,0.0171477768144162,0.139308873985513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37164,0.00727402416803015,0.00492096078251633,-0.00237105896570185,0.0169191073017621,0.139386645792714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36847,0.00694498492273451,0.00470064970423246,-0.0022682884975611,0.0161582583430301,0.139579887956601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36992,0.00383404685416886,0.00259747243223034,-0.00125699911300261,0.00892509282134034,0.139950652492915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39599,-0.00288205083503146,0.00195267017533243,-0.00670928437868301,0.000945182708620104,0.139977100119264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,37177,-0.00383763930110651,0.00260150250918182,-0.00893658421910287,0.00126130561688986,0.140193564707461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37203,0.0313179191543037,0.0212304209429728,-0.010293705893923,0.0729295442025305,0.1401986364583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39319,-0.0146896328916617,0.00996897013706257,-0.0342288143603043,0.00484954857698095,0.140627830090561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37241,0.00244013027139052,0.00165652390186294,-0.000806656576260844,0.00568691711904189,0.140764160065259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39104,-0.0110138065307266,0.00748588989610218,-0.0256861507270868,0.00365853766563372,0.14123809729507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,37255,0.00324487918709833,0.00220629637990191,-0.00107946171750941,0.00756922009170608,0.141387141708368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36955,-0.00410415665341992,0.00279428375961919,-0.00958095282227353,0.0013726395154337,0.141920682009826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36741,-0.0116940699729047,0.00796630579524478,-0.0273080293315845,0.00391988938577504,0.142145738137367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,39194,0.00778277937462386,0.00531294711787327,-0.00263059697640776,0.0181961557256555,0.142977584194837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37247,0.0130596762257438,0.00892186050356683,-0.00442717036124721,0.0305465228127348,0.143277554602212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39462,0.0131263542648506,0.00897198714935149,-0.00445874054787833,0.0307114490775795,0.143478037788225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37221,0.009620340444222,0.00658629394561252,-0.00328879568917853,0.0225294765776225,0.14413319516286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39428,-0.0111187793666671,0.00762956025327925,-0.0260727174630944,0.00383515872976023,0.145046554342091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36861,-0.00385192760362187,0.00264370528261535,-0.00903358995754797,0.00132973475030422,0.14513656658596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36847,0.0050098853121853,0.00343979193812029,-0.00173210688653047,0.0117518775109011,0.145293563975575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36823,0.0118756779424576,0.00815876279481841,-0.00411549713538652,0.0278668530203016,0.145535966158961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39455,0.00373453530902222,0.00257065510177839,-0.00130394869046342,0.00877301930850786,0.146312351987958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36763,0.00423853312183219,0.00291977865936274,-0.00148423305051878,0.00996129929418316,0.146620959337488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37162,-0.00458203421035436,0.00315674936876013,-0.0107692629731242,0.0016051945524155,0.146664261558103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,37221,0.00486714615153588,0.00335529109959688,-0.001709224403674,0.0114435167067458,0.146919086963029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39510,-0.00362067865345892,0.0025021010211814,-0.00852479665497446,0.00128343934805662,0.147902240245627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,39123,0.0040110896013055,0.00277681955234243,-0.00143147672128565,0.00945365592389665,0.148622391818638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36880,0.00337638209232992,0.00234029360657665,-0.0012105933765603,0.00796335756122015,0.149125323075242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36880,-0.00411156524828777,0.00285459369260125,-0.00970656888578622,0.00148343838921068,0.149798424175742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36847,0.00527545165476536,0.00366295152140467,-0.00190393332718779,0.0124548366367185,0.149830761884131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39123,0.0103478661732832,0.00719612525983902,-0.00375653933600126,0.0244522716825677,0.150461769104744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39149,-0.00394474918885253,0.00275060045213499,-0.00933592607503711,0.00144642769733204,0.15155327346602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,39187,0.0108501896677724,0.00757355332846478,-0.00399397485601853,0.0256943541915634,0.151981421339565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39458,-0.00369246904812647,0.00258338014617699,-0.00875589413463336,0.00137095603838042,0.152933971180791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37247,-0.0093493045918192,0.00654140330915746,-0.0221704550777678,0.00347184589412942,0.152956632931696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37247,-0.00320261615716066,0.00224734575262723,-0.00760741383231004,0.00120218151798872,0.154162497986982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39123,-0.00834245796200804,0.00587154735221896,-0.0198506907723572,0.00316577484834111,0.155388066855504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37203,0.0125738675008507,0.0088665190951855,-0.00480450992571287,0.0299522449274143,0.156177555636582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39455,0.00449707901384855,0.00317298082200671,-0.0017219633972846,0.0107161214249817,0.156414776518732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39520,-0.00903383697558675,0.00637849032848,-0.0215356780194076,0.00346800406823406,0.156709225410766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39568,0.00837866236316625,0.00592334431728224,-0.00323109249870694,0.0199884172250394,0.15723119615148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39495,-0.00855609235760738,0.0060489402734982,-0.0204120152936639,0.0032998305784491,0.157242327690728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39636,-0.00409889632241341,0.00290736602993113,-0.00979733374107842,0.0015995410962516,0.158609913712998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36763,-0.00710701574674672,0.00504515632177496,-0.0169955221374256,0.0027814906439322,0.158954776466677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36847,-0.00353064332781237,0.00250895937290777,-0.0084482036987116,0.00138691704308685,0.159388948288702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37203,-0.0076136472656638,0.00541105423544593,-0.0182193135671378,0.00299201903581022,0.159435653969809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39578,0.00509094326591545,0.00362693928417661,-0.00201785773107072,0.0121997442629016,0.160444453644598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39477,0.00631788878137609,0.00450790694972897,-0.00251760884009269,0.0151533864028449,0.161081472104782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37247,-0.00312550816155225,0.00223071006710309,-0.00749769989307432,0.00124668356996981,0.161200344480355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36861,0.0128158951182216,0.00914734097236275,-0.00511289318760942,0.0307446834240525,0.161223702451207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,37195,0.0120981719877648,0.00864335278214776,-0.00484279946524485,0.0290391434407744,0.161625052770423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39104,0.00620241609599299,0.00443960457881411,-0.00249920887848266,0.0149040410704686,0.162415187583269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37162,0.011697404165487,0.00838454650310164,-0.00473630698059223,0.0281311153115662,0.163005627685361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39485,0.00386267412626415,0.0027758801445724,-0.00157805095709775,0.00930339920962606,0.164090420750109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39104,0.0100699934115692,0.00724540999197106,-0.00413101017269405,0.0242709969958325,0.164597209586477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,39079,0.0110807083707021,0.007990858182677,-0.00458137366734486,0.026742790408749,0.165562588707671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37162,-0.00433946019240987,0.00313010586805116,-0.0104744676937902,0.00179554730897041,0.165660676418246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36861,-0.00848810532906511,0.00613256402830779,-0.0205079308245484,0.00353172016641816,0.166351557551462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,39321,0.00582953893304103,0.00421189863844114,-0.00242578239830361,0.0140848602643857,0.166359511798106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36823,0.0142107377251097,0.0102837866395436,-0.00594548408839578,0.0343669595386151,0.167040112067904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39123,-0.00967053113735674,0.00700449414578194,-0.0233993396630893,0.00405827738837586,0.167417459176232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36847,0.00456875623773903,0.00331213089292744,-0.00192302031239876,0.0110605327878768,0.167796076555309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39355,0.00507703067056676,0.00368343007576624,-0.00214249227793507,0.0122965536190686,0.168118053122443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37164,-0.00672621105316992,0.00488738492629432,-0.0163054855087068,0.00285306340236694,0.168771810632168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37201,-0.00272305907971935,0.00198101696529803,-0.0066058523317035,0.0011597341722648,0.169286982860305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36968,0.00624003266828704,0.00454685404898593,-0.00267180126772538,0.0151518666042995,0.169968321284725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38907,-0.00377660594689162,0.00275660553759024,-0.0091795528005685,0.00162634090678526,0.17070179785261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37221,-0.00832068538223491,0.00607495934312502,-0.02022760569476,0.00358623493029013,0.170814237748359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36880,-0.00332318680283108,0.00242807885395502,-0.00808222135658292,0.00143584775092076,0.171133872518414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37162,0.00854046485147141,0.00624407784729658,-0.00369792772922989,0.0207788574321727,0.171408138484715
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39455,0.00333997159433383,0.00244378367165998,-0.00144984440211972,0.00812978759078739,0.171733107743972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39601,-0.0035924727875574,0.00263129640619258,-0.00874981374369486,0.00156486816858006,0.172183373978129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36847,0.00452388761728999,0.00331372365391054,-0.00197101074437467,0.0110187859789546,0.172215725763761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39287,0.00462018745230054,0.00338694384027975,-0.00201822247464778,0.0112585973792489,0.172551459984706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39541,0.003448660224759,0.00252922968566011,-0.00150862995913482,0.00840595040865282,0.172738409839172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37221,0.00842943090405137,0.00618898601757107,-0.00370098169038792,0.0205598434984907,0.173220282359686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36763,0.00898557638764429,0.0065981137183138,-0.00394672650025076,0.0219178792755393,0.173273246256952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36992,-0.00541143293675261,0.00397850342588465,-0.0132092996514865,0.00238643377798131,0.17380122562019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,39123,-0.00523034092853442,0.00385288941235414,-0.0127820041767485,0.00232132231967969,0.174639684835074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37255,0.0030247834978955,0.00222889359527388,-0.0013438479488413,0.00739341494463231,0.17478020390469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,37269,0.0025044916798548,0.00184690678153121,-0.00111544561194638,0.00612442897165598,0.175108227627395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37164,-0.00526180036548902,0.00388101639171716,-0.0128685924932547,0.00234499176227661,0.17519359201493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39439,0.0024599265447583,0.00181669212738812,-0.00110079002492242,0.00602064311443902,0.175734772546995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36992,-0.00522368840805109,0.00385787115843327,-0.0127851158785803,0.00233773906247812,0.175749956372901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39460,-0.0074064288726013,0.00547362816183662,-0.0181347400698011,0.00332188232459847,0.176040413464117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,39187,-0.00284844193163894,0.00210936873949089,-0.00698280466104109,0.00128592079776321,0.176915991000757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39432,0.00228535588316431,0.0016924453884056,-0.00103183707811066,0.00560254884443929,0.176931291799438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37247,-0.00568241889052684,0.00420969617377169,-0.0139334233911193,0.00256858561006566,0.177090991800581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36847,-0.00801854918801096,0.00595380254986041,-0.0196880021857374,0.00365090380971544,0.178071014641368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39187,-0.00668758438625732,0.00496805104837431,-0.016424964441071,0.00304979566855633,0.178285079172311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39418,0.00344201847377487,0.00255929775446126,-0.00157420512496919,0.00845824207251894,0.178675522187635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39636,0.00318456730285696,0.00237248104878526,-0.00146549555276215,0.00783463015847606,0.179520725889059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37203,0.00572686103875779,0.00426755695029454,-0.00263755058381951,0.0140912726613351,0.179635116117265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39601,0.00733448444071371,0.0054721822594318,-0.00339099278777263,0.0180599616692,0.180160891352669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39636,-0.00417972360548114,0.0031221751291477,-0.0102991868586106,0.00193973964764835,0.180681330858575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37255,0.00742432989975037,0.00554648510888147,-0.00344678091365732,0.018295440713158,0.180736150311097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39554,0.0033506716906972,0.00250400885605553,-0.00155718566717165,0.00825852904856604,0.180876511035942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37145,-0.00495363609257887,0.0037028832823469,-0.0122112873259788,0.00230401514082106,0.180992756555829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39617,0.00568972113697473,0.00425582925274989,-0.00265170419841505,0.0140311464723645,0.181267433608195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37221,0.00796697024019491,0.00596560273447439,-0.0037256111193749,0.0196595515997647,0.181741615594757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39608,0.00249229932304102,0.00186651225766941,-0.00116606470199102,0.00615066334807305,0.181807784560294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37024,0.0016095470791768,0.0012064923191896,-0.000755177866434811,0.00397427202478842,0.182204573282204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39355,-0.00653485323767148,0.00489930210833037,-0.016137485369999,0.00306777889465604,0.182278815585234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36916,-0.00854616860091578,0.00641417266170522,-0.021117947017858,0.00402560981602645,0.182756983932167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39516,0.00349635209445905,0.00262647622631431,-0.001651541309117,0.0086442454980351,0.183144992353519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36538,0.00822758606150263,0.00618319705333059,-0.00389148016302532,0.0203466522860306,0.183333836764485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36861,-0.00966293187242475,0.00726570885763271,-0.0239037212333849,0.00457785748853536,0.183563616993194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37221,-0.00616314526386433,0.00463925940985424,-0.0152560937071786,0.00292980317944997,0.184044614285493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36916,-0.00632756015757143,0.00476346264345385,-0.015663946938741,0.00300882662359812,0.184085821365082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39437,0.0136210686220614,0.0102635274409922,-0.00649544516228334,0.0337375824064061,0.184484825223652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,37162,-0.00438308049071568,0.00330703356692344,-0.0108648662818856,0.00209870530045427,0.185068534877495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36948,-0.0037269106081438,0.00281436822077192,-0.00924307232085677,0.00178925110456917,0.185446197813684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37162,-0.0101930149207819,0.00771367038881507,-0.0253118088828594,0.00492577904129568,0.18638442992295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39654,0.00229245029682611,0.0017363004392869,-0.00111069856417621,0.00569559915782842,0.186752288103363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36823,0.00840413737021992,0.0063652922228558,-0.00407183538657745,0.0208801101270173,0.186757097753974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39462,-0.00530298326925788,0.00402434052757861,-0.013190690703312,0.00258472416479619,0.187615072698331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39589,0.00416550807891643,0.00316897993864382,-0.00204569260082546,0.0103767087586583,0.18871023019094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36861,0.00585436477280092,0.00445963545577362,-0.00288652072051537,0.0145952502661172,0.189293118609115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,37162,-0.003749081790799,0.00285636160287255,-0.0093475505324292,0.00184938695083119,0.189362533524492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39541,0.0073165624888025,0.00559337161584192,-0.00364644587824767,0.0182795708558527,0.190867015640811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36847,0.0113770581703432,0.00870399426939334,-0.00568277059766774,0.0284368869383541,0.191200374667155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39496,0.00331933788796545,0.00254032527035686,-0.00165969964193398,0.00829837541786489,0.191348655639873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36763,-0.0042972547737387,0.00328970167449418,-0.0107450700557473,0.00215056050826989,0.191483488997654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39194,-0.0064026632558952,0.00490238545710433,-0.0160113387518197,0.00320601224002929,0.191562679729662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36847,-0.0139513921539086,0.0107226567514643,-0.0349677993867786,0.00706501507896143,0.193243834309837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36928,-0.00988623324070542,0.00760155193680857,-0.0247852750368502,0.00501280855543938,0.193434982497789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39531,0.00844220128383094,0.00649758170208778,-0.00429305885226111,0.021177461419923,0.193866488332828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,37243,-0.00295083548804066,0.00227516190682985,-0.00741015282542716,0.00150848184934584,0.194662067800597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36880,-0.00434272273844645,0.00335040798144182,-0.0109095223820724,0.00222407690517953,0.194938480615762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36880,0.0136798090409946,0.010563976334176,-0.00702558457399043,0.0343852026559796,0.195361929855874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,39104,0.00777899197340185,0.00601361280241172,-0.00400768911932512,0.0195656730661288,0.195836516839147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36763,-0.00853714173614421,0.00664675188128225,-0.0215647754234574,0.004490491951169,0.199023380260646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36916,0.00527350503593854,0.00410953017745295,-0.00278117411186925,0.0133281841837463,0.19943258673002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36482,-0.00557355699208451,0.00435016264156192,-0.0140998757695459,0.00295276178537685,0.200137740526234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36847,0.00641651901293531,0.00500813242512464,-0.00339942054030897,0.0162324585661796,0.200140401077532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36847,0.00967787595911286,0.00755585369061037,-0.00513159727448347,0.0244873491927092,0.200272147171941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37162,-0.00887960589547107,0.00694372844276555,-0.0224893136432916,0.00473010185234941,0.200992568809288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39462,-0.0171444645523052,0.0134201001825158,-0.0434478609100362,0.00915893180542578,0.201438005179893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36763,-0.00737653850656436,0.00577827978361097,-0.0187019668824419,0.00394888986931314,0.20176840480058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39526,0.00348925436114365,0.00273374375237177,-0.00186888339350501,0.00884739211579232,0.2018462490438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39355,-0.0107839472873933,0.00844938732022153,-0.0273447464350275,0.00577685186024089,0.20186961959703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36880,0.00708512559863285,0.00555338436057063,-0.00379950774808558,0.0179697589453513,0.20204256952575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37221,-0.00703657246252399,0.00552162644435426,-0.0178589602934583,0.00378581536841037,0.202556962147182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,37203,-0.0107113967676783,0.00841834232497963,-0.0272113477246384,0.00578855418928175,0.203258539015131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39187,-0.00829995265726996,0.00652601858466669,-0.0210909490832167,0.00449104376867676,0.203455427236147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37221,0.00445262355493162,0.0035010992231546,-0.0024095309224514,0.0113147780323146,0.203474907378643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39462,-0.00818078547597187,0.00643551362933616,-0.0207943921894707,0.00443282123752701,0.203679385388619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,39309,0.0078712834636118,0.00619625908160705,-0.00427338433633803,0.0200159512635616,0.2039875931793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36864,0.00778380288247899,0.00613028139812257,-0.00423154865784124,0.0197991544227992,0.204204587645189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37247,-0.00454443284179092,0.00358080430946002,-0.0115628092883326,0.00247394360475073,0.204425090061906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39124,-0.00886355536921399,0.00698611244922218,-0.0225563357696895,0.00482922503126149,0.204554191417928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36992,0.00968675869829808,0.00764782469341099,-0.00530297770078746,0.0246764950973836,0.205320757896082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36955,-0.00281418498086774,0.00222553856178729,-0.00717624056197082,0.00154787060023535,0.206075565876214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36847,0.00546803859420834,0.00433120560513052,-0.00302112439184748,0.0139572015802642,0.20680168494168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37243,-0.00443255434815515,0.00351649465186733,-0.0113248838658151,0.00245977516950482,0.207510724921706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37247,-0.00723411355182995,0.00574280220365286,-0.0184900058709896,0.00402177876732965,0.207806513165601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39623,-0.00424922212796014,0.00337729391001856,-0.0108687181915965,0.00237027393567623,0.208348333898998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,39194,-0.00496446644051693,0.00394907385390386,-0.0127046511941685,0.00277571831313464,0.208729486224214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39428,-0.0098950378196737,0.00787270123132958,-0.0253255322330797,0.00553545659373228,0.208816827691414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36861,0.00777846386757855,0.00619046805192572,-0.00435485351419585,0.019911781249353,0.208950160262452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39428,0.0021427848668974,0.00170763136293456,-0.00120417260445434,0.00548974233824915,0.209560528262106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39636,-0.00986148776211897,0.00789732973709826,-0.0253402540468316,0.00561727852259362,0.211789804779764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39194,0.00514652320574808,0.00412465251496465,-0.00293779572358264,0.0132308421350788,0.212143506477652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39526,0.0122795009044968,0.00986050692619357,-0.00704709267084256,0.0316060944798362,0.21303296699752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39455,0.0032126448223965,0.00258828149233762,-0.00186038690258524,0.00828567654737824,0.214541316607793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39455,-0.00254323503971475,0.00204993584286663,-0.00656110929173334,0.00147463921230384,0.214757693311914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39355,0.00877792818508653,0.00708280939067372,-0.00510437822063397,0.022660234590807,0.215243350879591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,39194,0.00372273525390374,0.00301265242069546,-0.00218206349065936,0.00962753399846684,0.216589706685228
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,39123,-0.0067722942995389,0.00548371833145088,-0.0175203822291826,0.00397579363010483,0.216856922171455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39462,-0.00932764738607865,0.00755749418601369,-0.0241403359906655,0.00548504121850817,0.217138440269942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37221,0.00404518196460709,0.00327906800014174,-0.00238179131567073,0.0104721552448849,0.217360638329473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36857,-0.00392886710655297,0.00318517608168031,-0.0101718122266464,0.00231407801354044,0.217418218757569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39462,0.00516288973697251,0.00419093400456206,-0.00305134091196912,0.0133771203859141,0.217998774285642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36861,0.00961259165888139,0.00780983695844705,-0.00569468877967482,0.0249198720974376,0.218409300930519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39296,0.00354885218107428,0.00288662944869296,-0.00210894153836393,0.00920664590051249,0.218937470412547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36880,0.00554540813004319,0.00451367772500127,-0.0033014002109593,0.0143922164710457,0.219253084424025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36287,-0.0055196045594354,0.00449712883072324,-0.014333977067653,0.00329476794878215,0.219711014550972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39477,0.00416356176217586,0.00339602282317142,-0.00249264297124012,0.0108197664955918,0.220213703352181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36955,0.00736581196490996,0.00600843986147946,-0.00441073016358977,0.0191423540934097,0.220255292849489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39104,-0.00536011132002511,0.00437309302436419,-0.0139313736477789,0.0032111510077287,0.220330326581207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36861,0.00551008249393462,0.00449576323629175,-0.0033016134491972,0.0143217784370664,0.220366211288828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37243,-0.00281993809791796,0.00230118964112844,-0.00733026979452971,0.00169039359869379,0.220437240214376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36861,-0.00592575862379521,0.00483877118889113,-0.0154097501540218,0.00355823290643141,0.220733679508667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37221,0.00927614866698663,0.00758067350260194,-0.00558197139811317,0.0241342687320864,0.221104003901717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36880,-0.00356282877432597,0.00291382677625899,-0.00927392925579358,0.00214827170714164,0.221454183396162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36847,0.00521999110179242,0.00427220426061379,-0.00315352924901061,0.0135935114525954,0.221787740947103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,37146,0.00961277205016632,0.00787598424235772,-0.00582415706485482,0.0250497011651875,0.222291649903863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39485,0.0107521003601203,0.00881221280080858,-0.00651983672946453,0.0280240374497051,0.222432365146548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36880,-0.00625131656418548,0.00512670442633909,-0.0162996572398101,0.00379702411143914,0.222729375240401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39516,0.00565110022525881,0.00463978727913081,-0.00344288284183758,0.0147450832923552,0.223256209596537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,37164,-0.00493748311817273,0.00405895908790633,-0.0128930429304691,0.00301807669412367,0.223839665530391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36847,0.00368485376605108,0.00304718939695732,-0.00228763745198528,0.00965734498408743,0.226584838543774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39187,0.00367895636140763,0.00304389204811781,-0.00228707205290328,0.00964498477571855,0.226822259134227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39455,0.00340609214767343,0.00282810702570699,-0.00213699762271227,0.00894918191805912,0.228464933342691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39531,0.00599862712102022,0.00498184114444098,-0.0037657815220841,0.0157630357641245,0.228570435465944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36916,-0.00662570768325761,0.00550448734722073,-0.0174145028838102,0.00416308751729501,0.228731484450697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36742,0.0052534286853869,0.00438865629720514,-0.00334833765713517,0.013855195027909,0.231311251137346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39636,0.00805181888146838,0.0067281259078591,-0.00513530789793545,0.0212389456608722,0.231426509835032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39541,0.00282114826336911,0.00235797726897149,-0.00180048718381501,0.00744278371055322,0.23154867071647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36880,0.00444579299673888,0.00372631106831496,-0.00285777669715844,0.0117493626906362,0.232860211164329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,39194,-0.00846895220703464,0.00709894551726812,-0.0223828854208802,0.00544498100681087,0.23289352672709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37247,0.00288153889137109,0.00241602343873551,-0.00185386704855051,0.0076169448312927,0.233017477827541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,39104,-0.00715246827269164,0.00600265362709961,-0.0189176693818069,0.0046127328364236,0.233456625867857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36880,0.00511372065798073,0.00429232515159974,-0.00329923663915475,0.0135266779551162,0.233533562148239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39531,0.00729542162924928,0.00613650918777366,-0.00473213637878708,0.0193229796372857,0.234515324030497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39531,-0.00968282515763878,0.00814579406289116,-0.0256485815209055,0.00628293120562788,0.23458033815178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39390,0.00899452144956472,0.00759094210860927,-0.00588372508330944,0.0238727679824389,0.236075101036205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,39123,-0.0103350775238387,0.00873515135585074,-0.0274559741813061,0.00678581913362878,0.236765102748527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37221,-0.0113128041544889,0.00957375320510201,-0.0300773604364888,0.00745175212751104,0.23736749534123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39123,-0.00670938204005487,0.00567861435427049,-0.017839466174425,0.00442070209431529,0.237416370759347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36861,0.00454961221909736,0.00385220760113641,-0.00300071467913001,0.0120999391173247,0.23760937047361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39428,0.00943265142304778,0.00798721125654286,-0.00622228263977623,0.0250875854858718,0.237633667279887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37221,0.00727043694283678,0.0061622116538241,-0.00480749789865845,0.019348371784332,0.238084988605394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36823,0.00473865355959903,0.00403004886426371,-0.00316024221435784,0.0126375493335559,0.239685323693451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37247,-0.0111842561611623,0.0095226776417428,-0.0298487043389781,0.00748019201665363,0.24022208154547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37125,-0.0113159874285922,0.00964167807350688,-0.0302136764526657,0.0075817015954813,0.240555973296821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,39187,-0.003184150827695,0.00271438518360981,-0.00850434578757022,0.00213604413218021,0.240788618550505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,37203,-0.00561798130453563,0.0047907300287354,-0.015007812160857,0.00377184955178576,0.240947065433237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39601,0.00590698522252542,0.00504005092263594,-0.00397151458584103,0.0157854850308919,0.241211859588017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36880,-0.00398058330678379,0.00339725221213101,-0.0106391976425606,0.00267803102899298,0.2413372788872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39428,0.00596164414941522,0.00509127693709412,-0.00401725864728925,0.0159405469461197,0.241636446901574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,39050,0.00445630372465714,0.00380841810349844,-0.0030081957581998,0.0119208032075141,0.241972044222594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36861,0.0044991728263212,0.00384573632039327,-0.00303847036164961,0.012036816014292,0.242058878971925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36861,-0.00699395145734294,0.00598726021394875,-0.0187289814766825,0.00474107856199661,0.24277319077648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39654,0.00917760325144673,0.00786019490868201,-0.00622837876957,0.0245835852724635,0.242984425749749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36763,-0.00376033709515897,0.00322192047012759,-0.010075301216609,0.0025546270262911,0.24318836783897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39440,0.00256361548643979,0.00219812098435444,-0.00174470164289491,0.00687193261577448,0.243521479040942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39123,-0.0126709010862337,0.010864985205572,-0.0339662720891548,0.00862446991668732,0.243546770912058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36928,0.0105998654543533,0.00910107976614113,-0.00723825088728332,0.0284379817959899,0.244169932908053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36823,0.0102712369994486,0.00883935024293195,-0.00705388947669807,0.0275963634755952,0.24526192520913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39123,0.00346825479491692,0.00298485656820856,-0.00238206407877186,0.0093185736686057,0.24527458174409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39589,0.00465181770007747,0.00400429663045591,-0.00319660369561611,0.0125002390957711,0.245372993789605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36992,0.00901262565197442,0.00776056720405669,-0.00619808606797668,0.0242233373719255,0.245527412002133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37247,0.00517459132133366,0.00445763738929336,-0.00356237796168132,0.0139115606043486,0.245729767334619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39428,0.00403318835834142,0.00347561664113642,-0.00277902025828596,0.0108453969749688,0.24589478895871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39636,-0.00703470165285839,0.00606675089272574,-0.0189255334026008,0.00485613009688405,0.246250257665135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39187,-0.00833320029808076,0.00718678005265083,-0.0224192892012764,0.00575288860511487,0.24626392277304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,39104,-0.00473480869956774,0.00408516892681781,-0.0127417397961306,0.00327212239699517,0.246465304086552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37247,0.00925908375692944,0.00800329948586197,-0.00642738323536003,0.0249455507492189,0.247331417624007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39330,0.00250242450101526,0.00216652703845864,-0.00174396849436367,0.0067488174963942,0.24809276487382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39428,-0.00285389331483414,0.00247344055471144,-0.00770183680206856,0.00199405017240027,0.248594352982266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,37255,0.00482432792479111,0.00418548856328399,-0.00337922965924551,0.0130278855088277,0.249082995688966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37164,0.0089565102876618,0.00778536841645209,-0.0063028118085843,0.0242158323839079,0.249989037198979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,37269,0.00321321770032463,0.00279467649661487,-0.00226434823304052,0.00869078363368978,0.250262646578404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39530,0.00249220057493476,0.00216794230382434,-0.00175696634056095,0.00674136749043048,0.250339417174964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36992,-0.0037664530661353,0.00327816863603284,-0.0101916635927597,0.00265875746048906,0.25059836033122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36916,-0.00845389987698226,0.00736495177322656,-0.0228892053525063,0.0059814055985418,0.251050281229095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,39194,0.00814103806487725,0.00709668375194971,-0.00576846208894418,0.0220505382186987,0.251333748407946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39474,0.00791781323213245,0.00692242624417495,-0.00565014220645045,0.0214857686707154,0.252728285753355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39485,-0.0121072792304495,0.0105955802255961,-0.0328746164726179,0.00866005801171895,0.253192747066421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39194,-0.00654712890994451,0.00573254153395817,-0.0177829103165025,0.0046886524966135,0.253431496169963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36916,-0.0062078546927986,0.00545101932006733,-0.0168918525601306,0.00447614317453337,0.254790569401167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36823,0.00354715614736128,0.00311905412052688,-0.0025661899288714,0.00966050222359397,0.255454229202209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36861,0.0038050526859891,0.00335217914129643,-0.00276521843095191,0.0103753238029301,0.256356077887649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39485,-0.0109239033192895,0.00963373548850406,-0.0298060248767574,0.0079582182381785,0.256845405994016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36823,0.00464097575411942,0.00412079673572926,-0.00343578584790993,0.0127177373561488,0.260088911094026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,39208,0.00538087865994783,0.0047910993684372,-0.00400967610218908,0.0147714334220847,0.261413745120873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36992,0.00732492065632773,0.00652351346687853,-0.00546116573875419,0.0201110070514097,0.261523122198444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37164,0.0042074630114819,0.00374891288821271,-0.00314040624941502,0.0115553322723788,0.261749519158147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36847,0.00513472947881275,0.00458021158222995,-0.00384248522235795,0.0141119441799835,0.262280559383294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37203,0.002594532492645,0.0023144743598096,-0.00194183725258182,0.00713090223787181,0.262307735236658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39589,0.00280882133047717,0.00251116589222272,-0.00211306381827935,0.0077307064792337,0.263357270794048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36916,-0.00299879067659571,0.0026836712323998,-0.00825878629209932,0.00226120493890789,0.263835885157458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39462,-0.00821627386830865,0.00735883600594642,-0.0226395924399636,0.00620704470334633,0.264218283640893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36955,-0.00504427177940805,0.00451964238828362,-0.0139027708604439,0.00381422730162784,0.264410354166904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39455,-0.00315061338065082,0.00282299642357512,-0.00868368637085806,0.00238245960955641,0.264417360632903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39485,0.00676929954713901,0.00607628872531303,-0.00514022635447452,0.0186788254487525,0.265274835658504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39480,0.00572345349343379,0.00514977426366402,-0.00437010406334769,0.0158170110502153,0.266414462358395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36763,0.00885231352963393,0.0079892306503775,-0.00680657854510598,0.0245112056043738,0.267870166593171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39635,-0.00235697183136445,0.00212902228571435,-0.00652985551136457,0.00181591184863567,0.268282192709696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39636,0.00435719378876491,0.00393683298357078,-0.00335899885903383,0.0120733864365636,0.268408153064694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39414,0.00867521658869854,0.00785595881165349,-0.0067224626821423,0.0240728958595394,0.269487335174643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36955,-0.00725424393290478,0.00657106704280837,-0.0201335353368092,0.00562504747099963,0.269628516364658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,39045,0.00463291008515234,0.00419715809181726,-0.0035935197748095,0.0128593399451142,0.269689113929909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37143,0.00691266294098881,0.00626354368233788,-0.00536388267639343,0.019189208558371,0.269772641887515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39485,-0.00669265801359727,0.00607208159622514,-0.0185939379421985,0.00520862191500401,0.270391684584457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36763,-0.00458923327730098,0.00416675484725885,-0.0127560727779283,0.00357760622332637,0.270747323809763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39482,-0.00511938371925286,0.004653920186628,-0.0142410672850437,0.00400229984653802,0.271343044706169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39281,0.0113990595121409,0.0103652585966946,-0.00891684733738049,0.0317149663616622,0.271464534432815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37162,-0.00394454831519427,0.00358842366452864,-0.0109778586976704,0.00308876206728186,0.271683063654284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37162,-0.00376486025077674,0.00345046469746044,-0.0105277710577992,0.00299805055624573,0.275242142859164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,39104,-0.00378970617345206,0.00347458413510074,-0.0105998910782495,0.0030204787313454,0.275425727656913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39601,-0.00369805576888715,0.00339107591533964,-0.0103445645629528,0.00294845302517855,0.275498940709189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36847,0.00582351040573844,0.0053410452051155,-0.00464493819628795,0.0162919590077648,0.275588292239522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39194,0.005594923728974,0.00513216138487671,-0.00446411258538435,0.0156539600433324,0.275656483369115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39485,0.00269922716550256,0.00247880760730612,-0.00215923574481743,0.00755769007582255,0.276205912502615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,37247,0.00622106585770868,0.00571829527747067,-0.00498679288613384,0.0174289246015512,0.276649523823431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39589,0.00746527839331928,0.00687866784166044,-0.00601691057633519,0.0209474673629737,0.277815089155603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37247,-0.00317613162735503,0.00292960069575435,-0.00891814899103355,0.0025658857363235,0.27831796303967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39462,0.00376075258025277,0.00347103841895608,-0.00304248272090116,0.0105639878814067,0.278618978001604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,37203,0.00264280249683756,0.00244047674278568,-0.00214053191902238,0.0074261369126975,0.278871427830616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39187,0.00312324293049674,0.00289065511899904,-0.00254244110274137,0.00878892696373486,0.279954195792401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36861,0.00809509932649283,0.00749726148318339,-0.00659953318054662,0.0227897318335323,0.280278592728708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36847,-0.0093100885317222,0.0086323466048668,-0.0262294878772611,0.00760931081381673,0.280826361888119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,37162,-0.00430097655477909,0.00398824969102913,-0.0121179459491962,0.00351599283963802,0.280870374148664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36880,-0.00418975672769606,0.00388675685026361,-0.0118078001542127,0.00342828669882062,0.281073871106775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37255,-0.00564478629713451,0.00523806706355342,-0.0159113977416992,0.00462182514743019,0.281211704671159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39485,-0.00270564484514609,0.00251075667942694,-0.00762672793682289,0.00221543824653071,0.281220089958244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36763,0.00361476674849905,0.00335733213765015,-0.00296560424129525,0.0101951377382934,0.28164509599912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39485,-0.00233136322271236,0.00216543425481239,-0.00657561436214464,0.00191288791671992,0.281664577796053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39485,0.00554071980635733,0.00514996309723749,-0.00455320786422814,0.0156346474769428,0.282000147006792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37243,0.00230992770311651,0.00214755709822439,-0.0018992842094033,0.00651913961563631,0.282123289938728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36992,-0.00389410997770099,0.00362309825147675,-0.0109953825505954,0.00320716259519345,0.282484468449904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36823,0.00489072152651576,0.00455490050659045,-0.00403688346640152,0.013818326519433,0.282965815151426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,39355,-0.00357660790900285,0.00333299191680114,-0.0101092720659331,0.00295605624792739,0.283247087847401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39462,0.00641413664594284,0.00597754317153591,-0.00530184797026753,0.0181301212621532,0.283270891405553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,39104,0.00678700642020994,0.00633600902729172,-0.00563157127328183,0.0192055841137017,0.284106127320068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36971,-0.00535544910346415,0.00500883587446546,-0.0151727674174164,0.00446186921048814,0.285000012926031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36992,0.00697553062040269,0.00653063110462428,-0.0058245063446609,0.0197755675854663,0.285484672601432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36880,0.00658911206839876,0.00618007093582296,-0.00552382696581424,0.0187020511026118,0.286359772349288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,39187,-0.0045106405938971,0.00424105484065129,-0.0128231080815736,0.00380182689377942,0.287542902382017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36880,-0.0040368719296746,0.00379565581882152,-0.0114763573345648,0.00340261347521558,0.287553006540798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36955,0.0118225054328673,0.0111230380446414,-0.00997864913462988,0.0336236600003644,0.287854832485741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36916,0.00718096051753313,0.00677173584087763,-0.00609164173058704,0.0204535627656533,0.288968985215567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39123,0.00381898407387704,0.00360545826363286,-0.00324771412284338,0.0108856822705975,0.289515701995366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36709,-0.00415180619492749,0.0039202380581167,-0.0118354727888362,0.00353186039898125,0.289588809165627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39428,-0.00306151540629494,0.00289335821940545,-0.00873249751632963,0.00260946670373975,0.290018559106254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39355,-0.00278577436880774,0.00263334137440474,-0.00794712346264102,0.00237557472502555,0.290124669877278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39123,-0.0103065657840657,0.00974833130030554,-0.0294132951326646,0.00880016356453312,0.290408243785255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39123,-0.00339872267855191,0.00321683600111878,-0.00970372124074471,0.0029062758836409,0.290738012233979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39123,0.00797571045204216,0.00755294171723017,-0.00682805531372896,0.0227794762178133,0.290997459181033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39123,-0.00498402309708751,0.00472047224879314,-0.0142361487047221,0.00426810251054705,0.291062609308391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36992,-0.00481319030082289,0.00456077302631631,-0.0137523054324029,0.00412592483075707,0.291287769585651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36880,0.00547420290979377,0.00518966799584588,-0.00469754636206414,0.0156459521816517,0.291524872203797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36763,0.00397830918759512,0.00377399498156975,-0.00341872097628159,0.0113753393514718,0.291840711423084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36847,-0.00384597297338144,0.00365063565723708,-0.0110012188615661,0.00330927291480325,0.292128878049744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36763,-0.00421345625213287,0.00400251673955865,-0.0120583890616678,0.00363147655740208,0.292498381617546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39355,0.0109752936939713,0.0104317201362838,-0.00947087777314491,0.0314214651610874,0.29276717133538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,37162,-0.00258156759366858,0.00245628124286463,-0.00739587882968325,0.00223274364234609,0.293275578775986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36847,0.0109551213196036,0.0104241931985237,-0.00947629734950275,0.03138653998871,0.293310173398635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39472,0.00260293051088048,0.00247802669150821,-0.00225400180447562,0.00745986282623657,0.293549054576572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38483,0.00452873263387551,0.00431197318647841,-0.00392273481162218,0.0129802000793732,0.293612449957616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39654,0.0057005850902699,0.00543957615042216,-0.00496098416455753,0.0163621543450973,0.294662951518384
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37164,0.00598886616256416,0.00571798446558999,-0.00521838338999222,0.0171961157151205,0.294947201116531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36880,0.00977432936753927,0.00934172498569035,-0.00853545160441382,0.0280841103394923,0.295438817437108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37162,-0.00474594745253147,0.00454482947272226,-0.0136538132190671,0.00416191831400415,0.296388655465085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,37255,0.00372014780390163,0.00356253732717717,-0.00326242535736562,0.0107027209651689,0.296393583778932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36916,-0.00300678765323925,0.00288424929163362,-0.00865991626484115,0.00264634095836265,0.297206930197889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36992,-0.00658372373343543,0.00631670283160168,-0.0189644612833747,0.00579701381650387,0.297305592082308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36847,-0.00345132448479777,0.00331306577070427,-0.00994493339537814,0.0030422844257826,0.297556566957864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39194,-0.00617667938904218,0.00592933107824312,-0.0177981683023987,0.00544480952431434,0.297560425504548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36861,-0.01107255984619,0.010630420851753,-0.0319081847156258,0.00976306502324588,0.297621235819332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39485,-0.00806857260140863,0.00775097367893302,-0.0232604810121174,0.0071233358093001,0.29790372591026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36823,0.00318879670792064,0.00306850790156632,-0.00282547877914935,0.00920307219499064,0.298731540979474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36880,-0.00291640424287792,0.00280956751408533,-0.00842315657048517,0.00259034808472933,0.299278126666571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39123,0.00334504353539752,0.00322266088959134,-0.00297137180820151,0.00966145887899655,0.299298497756392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39428,-0.00556496348500715,0.00537016175377995,-0.0160904805224158,0.00496055355240155,0.30009067475216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36992,0.00389599317958137,0.00376213453850748,-0.00347779051589329,0.011269776875056,0.300417860770066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37162,-0.00363899184931188,0.00351503764089355,-0.0105284656254632,0.00325048192683948,0.300565344179203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36861,-0.00329485404609086,0.00318344286375675,-0.00953440205905409,0.00294469396687236,0.300690447265983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39123,0.00458245630449306,0.00444106538205045,-0.00412203184432583,0.013286944453312,0.30216541584557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39187,-0.00582054742676224,0.00565962157597089,-0.0169134057156652,0.0052723108621407,0.303762589018493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39564,0.00641066811591918,0.00623835910693833,-0.00581651573367994,0.0186378519655183,0.304144642854324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,39104,-0.00655032659238467,0.00637579010469479,-0.0190468751975865,0.00594622201281712,0.304260935241762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36847,-0.00772702898439298,0.00752397858962207,-0.0224740270200522,0.00701996905126628,0.304446577134673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,39130,-0.0082388187384231,0.00803493751037199,-0.0239872962587522,0.00750965878190601,0.305203489210754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36823,-0.00507772391675989,0.00495230420357383,-0.0147842401557646,0.00462879232224482,0.305229662900208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,39194,0.0044431843612963,0.0043415532018472,-0.00406625991432422,0.0129526286369168,0.306131327099321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,37164,0.00933834305438501,0.00912689603404846,-0.00855037317234997,0.02722705928112,0.306248144420476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,39308,0.00641585242275454,0.00627615960431899,-0.00588542040171069,0.0187171252472198,0.306675598272887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36916,0.00807631882775493,0.00792840035818851,-0.00746334587429456,0.0236159835298044,0.308385706918907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38827,0.0020634284115128,0.00202600549625027,-0.00190754236113774,0.00603439918416333,0.308471183046147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,39187,-0.00207088144603316,0.002038214550432,-0.00606578196487987,0.00192401907281356,0.3096331109025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36648,0.00426332361562286,0.00419785091945337,-0.00396446418650575,0.0124911114177515,0.309841615221508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39608,0.00290925909747054,0.00286860953313024,-0.00271321558746473,0.00853173378240581,0.310517603229164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36823,0.00451900427006346,0.00446213362083107,-0.00422677762676543,0.0132647861668924,0.311201703364188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39559,-0.00734733210385949,0.00725607643544706,-0.0215692419173357,0.00687457770961676,0.311278731159373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39455,-0.00529217852558551,0.00522788069831197,-0.015538824694277,0.00495446764310595,0.311411426655716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37221,-0.00814760360323592,0.00805352363750348,-0.0239325099327427,0.00763730272627091,0.311709371224622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,37255,0.00400914042110111,0.00397713225778316,-0.00378603880415388,0.0118043196463561,0.313450445583334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37164,-0.00482428791674435,0.00481826363321125,-0.0142680846378384,0.00461950880434971,0.316724871512458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,37167,-0.00857437418556161,0.00856369207635465,-0.0253592106552167,0.00821046228409351,0.316726283053674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36847,0.00303781644452025,0.00303929947288204,-0.00291921052232855,0.00899484341136905,0.317566216771352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39541,-0.00254709939148963,0.00255074008882143,-0.00754654996557964,0.00245235118260037,0.318017748435918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39589,-0.00512459098706861,0.00513940874177545,-0.0151978321209485,0.00494865014681127,0.318723740466683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36932,-0.00328316047773778,0.00329277935821676,-0.00973700801984263,0.00317068706436707,0.318745596006595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36847,0.00342718352410266,0.00344110875722166,-0.00331738964005178,0.0101717566882571,0.319292292146343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,39194,-0.00622128564447255,0.00626033574114704,-0.0184915436971207,0.00604897240817565,0.320354914947702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39428,0.00378911017881584,0.00382025263437957,-0.00369858498456811,0.0112768053421998,0.321287672140068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,37241,-0.00241655779128817,0.00243674643629186,-0.00719258080642021,0.00235946522384386,0.321355374410083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39485,-0.00564443135387816,0.00569840674202909,-0.0168133085682552,0.00552444586049886,0.321932059609743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39654,-0.00304332575913065,0.00307537469171441,-0.0090710601548909,0.00298440863662959,0.322395760643382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39194,0.00315187141967767,0.00318644163953841,-0.00309355419381761,0.00939729703317294,0.322605581618378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39194,-0.0048474360779962,0.00490437442822505,-0.0144600099573173,0.0047651378013249,0.322977761439869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36823,0.00517078460268602,0.00524050712787548,-0.00510060936794991,0.015442178573322,0.323811252507809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39541,0.0038915905874116,0.0039532883537868,-0.00385685458601053,0.0116400357608337,0.324937952494179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,39187,0.00638415928956603,0.00648706574782216,-0.0063304895761654,0.0190988081552975,0.325064477202549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39462,0.00298949568666321,0.00304475129947738,-0.00297821686031246,0.00895720823363887,0.326188504776076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36823,0.00585769450738335,0.00596593683102821,-0.00583554168143194,0.0175509306961986,0.326189696001655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,37221,-0.00417332266818325,0.00425849565348091,-0.0125199741490058,0.00417332881263933,0.327105041568302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36992,0.00504041869833488,0.00515113035051284,-0.00505579678867028,0.01513663418534,0.327842354598096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36763,0.0053479749210271,0.00546550506281621,-0.00536441500209268,0.0160603648441469,0.327848288943448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36823,0.00440920661095758,0.00451057195332619,-0.00443151441756175,0.0132499276394769,0.328327351056117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39462,0.00533736606673493,0.00547234018938649,-0.0053884207044626,0.0160631528379324,0.329409728539966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39485,0.011046695115788,0.0113380207138465,-0.0111758254833512,0.0332692157149271,0.329920587719042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36992,0.00303033650329539,0.00311080266218409,-0.00306683671458543,0.00912750972117621,0.330009141014526
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36763,-0.00534872617376551,0.00550324335571504,-0.016135083150967,0.00543763080343597,0.331108188436839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36847,0.00581890995222025,0.00598869432153304,-0.0059189309179845,0.017556750822425,0.331244065290627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39104,0.00737590908658272,0.00759699882586382,-0.00751420861211037,0.0222660267852758,0.331615224342696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37221,-0.00660795283696548,0.00683408316760513,-0.0200027558454715,0.00678685017154058,0.333606646087588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39123,0.00267766377410107,0.00277033789248679,-0.00275219849517303,0.00810752604337518,0.333786112672621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36823,0.00547232587700844,0.00566262576889731,-0.00562642063003029,0.0165710723840472,0.33386610584049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,37247,-0.00462786770176391,0.0047891200566158,-0.0140145430127309,0.00475880760920306,0.333897623167985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36847,-0.00447035451871335,0.00466104161534595,-0.0136059960847914,0.00466528704736471,0.337532534633937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39386,0.00228518785381155,0.00238296520229132,-0.00238542394267944,0.00695579965030253,0.337590289425162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36880,0.00398222813670924,0.00415500757016962,-0.00416158670082321,0.0121260429742417,0.33787138292505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36861,-0.00417057038562294,0.0043552187633932,-0.0127067991618736,0.00436565839062773,0.338281661265724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36823,-0.00748488464120473,0.00781966000681619,-0.0228114182545645,0.007841648972155,0.338491082923564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,39104,-0.00447924135567772,0.00467994856371181,-0.0136519405405529,0.00469345782919743,0.338525826100217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36847,0.00340511952321674,0.00355998543082511,-0.00357245192120046,0.0103826909676339,0.338839266908898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,37221,-0.00323316329653059,0.00338477072463712,-0.00986731391681935,0.00340098732375816,0.339490122529523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39462,0.00577690519307528,0.0060534578364171,-0.00608787216630223,0.0176416825524528,0.339939620877244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36847,0.0053773411832702,0.0056381548772528,-0.00567344237614528,0.0164281247426857,0.340233205834917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39522,0.0127313972065636,0.0133852500086509,-0.0135036928103923,0.0389664872235194,0.341542858188331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36847,0.00388086715970925,0.00408350585907613,-0.00412280432407996,0.0118845386434985,0.341939615743682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36847,0.00360163332614045,0.00379153813014768,-0.003829781408949,0.0110330480612299,0.342174717850835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36955,-0.00452481191828647,0.00476569461981146,-0.0138655733731169,0.00481594953654399,0.34240767123661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39104,0.00336751487514921,0.00355147187156235,-0.00359336999311301,0.0103283997434114,0.343041960216591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,37197,0.00708232301271097,0.00747862936208454,-0.00757579053697473,0.0217404365623967,0.343652576532909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,37203,-0.00195815964677255,0.00206794284656512,-0.00601132762604017,0.00209500833249508,0.343701628208147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37269,-0.00165099051304112,0.00174538591264285,-0.00507194690182111,0.00176996587573886,0.34420866420603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39568,0.00436600096789146,0.00461591586701391,-0.0046811941314558,0.0134131960672387,0.344236134932398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,39123,0.00790221943684112,0.00835846590388876,-0.00848037373478085,0.0242848126084631,0.344462592944029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36861,0.0036517010789362,0.00386416118693084,-0.00392205484744824,0.0112254570053206,0.344668191749857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39455,-0.00440913782932866,0.00467209362940984,-0.0135664413429719,0.00474816568431462,0.345329082116462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36763,-0.00697858212092364,0.0074052499991356,-0.0214928721192294,0.00753570787738213,0.346015051176381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,39355,0.0028090585119906,0.00298121422059164,-0.00303412136036901,0.00865223838435022,0.346078317909753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,37162,0.00650940580334587,0.00691115827865156,-0.00703646442281119,0.0200552760295029,0.346277609390182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37164,0.00644477280488322,0.00684571645753369,-0.00697283145188282,0.0198623770616493,0.346501690051024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39462,0.00335018786556556,0.00357524905133863,-0.00365730027505815,0.0103576760061893,0.348747808690386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37247,-0.00395669210795507,0.00423297254194648,-0.0122533182901702,0.00433993407426004,0.349944409991775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39485,-0.00355575632823771,0.00380479165394749,-0.0110131479699748,0.00390163531349938,0.350036854692823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39415,-0.00908586811050914,0.00972685360314584,-0.028150501172675,0.00997876495165671,0.350266634463344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36763,0.00266071733215153,0.00284903638081355,-0.00292339397424303,0.00824482863854608,0.350373386517942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37162,-0.00448155507438337,0.00479911385450992,-0.0138878182292228,0.00492470808045606,0.350409483854358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36823,0.00304377157090475,0.00326945577257963,-0.00336436174335132,0.00945190488516083,0.35188624791499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36955,0.00921815008254326,0.00991367464596549,-0.0102126522235491,0.0286489523886356,0.352470899576476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37173,0.00474957613150215,0.0051092981479417,-0.00526464823846358,0.0147638005014679,0.352598646979294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39506,0.00994465037257607,0.0107036388190645,-0.0110344817127904,0.0309237824579425,0.352857024739595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36847,-0.00395929442273551,0.00426454235017291,-0.0123177974290744,0.00439920858360339,0.353206852357758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36847,0.00516184252999095,0.00555994822214314,-0.00573565598540959,0.0160593410453915,0.353219446459028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39428,0.00272732496203023,0.00293925666704327,-0.00303361810537458,0.00848826802943504,0.353476392795377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,37221,-0.0029576371411986,0.00319251721354774,-0.00921497087975216,0.00329969659735496,0.354241139475857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39531,0.00729913309961691,0.007880223555271,-0.00814610506871425,0.0227443712679481,0.354325884703525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36847,0.00357405013060413,0.00385937727147032,-0.0039903293214777,0.011138429582686,0.354428088352753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39428,0.00266067447573918,0.0028802099300436,-0.00298453698714628,0.00830588593862464,0.355616811857338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36763,-0.0054993393329327,0.00595654934772342,-0.0171741760544706,0.00617549738860521,0.355898954853396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36916,-0.00233813987558168,0.00253434499735964,-0.00730545607040657,0.00262917631924321,0.35624318470549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39654,0.00188208121127525,0.00204816424766466,-0.00213232071414749,0.00589648313669799,0.358156563770939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37243,-0.00220717894814617,0.00240353934573934,-0.00691811606579528,0.00250375816950295,0.358477233496244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39589,0.00539972379685269,0.00588361535546622,-0.0061321622998611,0.0169316098935665,0.358761200080008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39462,-0.00330441891523017,0.00360169430537048,-0.0103637397537563,0.00375490192329597,0.358915155279195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36861,0.00492167047404476,0.00537801420132192,-0.0056192373605462,0.0154625783086357,0.36013254782047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,39319,0.00412117916016851,0.00453781523052805,-0.00477293869166647,0.0130152970120035,0.363794808868175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36847,-0.00312122333645618,0.00344160829197542,-0.00986677558872801,0.00362432891581565,0.364472889180015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36763,0.00461669149235092,0.00509464438191937,-0.00536881149621104,0.0146021944809129,0.364855554215949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36880,0.00471970115204756,0.00521144838809553,-0.00549473768861968,0.0149341399927148,0.365143474928077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,39374,0.00411563220975602,0.00455279681459661,-0.00480784954685334,0.0130391139663654,0.36602118860295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39549,-0.00499217015723182,0.00553239042622567,-0.0158356553926341,0.00585131507817048,0.366883674042688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39194,0.0049548324060656,0.00549883609160808,-0.00582288633348624,0.0157325511456174,0.367566192865099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36823,0.00255788387611883,0.00283926304274467,-0.00300707168766072,0.00812283943989837,0.367660564290709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39601,-0.00327753402765133,0.00363886997178383,-0.0104097191723476,0.00385465111704497,0.367761605057915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36823,0.0039775032696974,0.00444067140056016,-0.00472621267540052,0.0126812192147953,0.370431172351779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36690,0.00629310735796735,0.00706150260876025,-0.00754743775520275,0.0201336524711374,0.372847286788749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36880,0.00275239242971286,0.00309181576571267,-0.00330756647108397,0.00881235133050968,0.373365659676921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39455,0.0032361829675698,0.00364728984622966,-0.00391250513104034,0.0103848710661799,0.374940086662714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37221,-0.00732434032700925,0.00826222258396923,-0.0235182965915889,0.00886961593757044,0.375372671799445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39194,-0.00234593903314204,0.00265127048003882,-0.00754242917401813,0.00285055110773406,0.376259629732515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39541,-0.00328684954098458,0.00371838165646348,-0.010574877587653,0.00400117850568384,0.376739309817462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36823,0.00282981242961647,0.00320268667062669,-0.00344745344481185,0.00910707830404478,0.376943093351268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36861,0.00329529392183971,0.00373474484502279,-0.00402480597440496,0.0106153938180844,0.377613080157752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36955,-0.0022493357694882,0.00255001725918912,-0.00724736959749886,0.00274869805852247,0.377746995880954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36880,-0.0022013939731142,0.00249675787544194,-0.00709503940898039,0.002692251462752,0.377955559293439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36926,0.00651120294224259,0.00740638486396335,-0.00800531139112558,0.0210277172756108,0.379345691577777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39187,0.00441592046988668,0.00502735009994146,-0.00543768572599857,0.0142695266657719,0.379752214066129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39455,0.0019104517923105,0.00217871859607591,-0.00235983665599828,0.00618074024061928,0.380571587609736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39428,-0.010744138591976,0.0122959388959375,-0.0348441788280136,0.0133559016440615,0.382243531133959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36688,-0.00268388589913737,0.00307505329566051,-0.00871099035863197,0.00334321856035723,0.382792881576165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36823,-0.00600259062163254,0.00688410803099909,-0.0194954423623908,0.00749026111912568,0.383253161426308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36992,0.00333712188642251,0.00382764029664954,-0.00416505309501059,0.0108392968678556,0.383307804152197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39516,0.00643805224472836,0.00741009484069996,-0.00808573364304356,0.0209618381325003,0.384958426407887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39485,0.00650261917543239,0.00750160888936387,-0.0082005342477208,0.0212057725985856,0.386049030615543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36880,0.00324671805883465,0.00374647174680579,-0.00409636656490469,0.010589802682574,0.386174192225698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36916,-0.00713726257948913,0.00823665031622358,-0.0232810971992874,0.00900657204030909,0.386219058498069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39428,-0.00791674295777221,0.00915178875344637,-0.0258542489145271,0.0100207629989827,0.387025916189427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36763,0.00316613342932493,0.00366520908897355,-0.00401767638506322,0.0103499432437131,0.387695736716654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39462,-0.00290431492405723,0.00336418632593046,-0.00949812012288093,0.00368949027476646,0.387984235456119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36763,0.00202892089653138,0.00235488143375772,-0.00258664671363376,0.00664448850669651,0.38893495857789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37164,0.0112755896614653,0.0130871186543869,-0.0143751629011331,0.0369263422240637,0.388935353836676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36847,0.00510222722256131,0.00593284500126367,-0.00652614897991548,0.0167306034250381,0.389807485271469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39541,-0.00802664666921338,0.00933478721850189,-0.0263228296174771,0.0102695362790503,0.389877723752436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39455,0.00593796221337653,0.00692902158603649,-0.00764292009525498,0.019518844522008,0.391475265370461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39462,0.0037312240186996,0.00435913961019339,-0.00481268961727943,0.0122751376546786,0.392036756433389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,37203,-0.00812892631878796,0.00950747563827844,-0.0267635785698137,0.0105057259322378,0.392565194474216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37164,0.00447865713658319,0.00523918055323214,-0.00579013674775181,0.0147474510209182,0.392656259955883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37203,0.00413404252180358,0.00483682821291281,-0.00534614077550553,0.0136142258191127,0.392732684696696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38760,-0.00211878685550546,0.00249409134497308,-0.00700720589165269,0.00276963218064178,0.395604798098139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39462,0.00404663657185329,0.00476651994485006,-0.00529574252005283,0.0133890156637594,0.395911042367571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36992,0.00300986333073448,0.00355862417625143,-0.00396504005471833,0.00998476671618729,0.39768375592555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39541,-0.00289975581198271,0.00342909118115707,-0.00962077452705057,0.00382126290308515,0.397770406964456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39104,0.00491993486240327,0.00583786938122018,-0.0065222891247883,0.0163621588495948,0.399375283908316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37203,-0.00266898189248983,0.00318140219869674,-0.00890453020193544,0.00356656641695579,0.401522881939918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36861,0.00281465146663501,0.00335871290750224,-0.00376842583206938,0.00939772876533939,0.402038474989056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37247,-0.00242500837585985,0.0028939699845295,-0.00809718954553767,0.00324717279381797,0.402073229336948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39123,-0.0045254325624754,0.00540084620699191,-0.0151110911281796,0.00606022600322875,0.402093912449026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39513,0.00294610812448439,0.0035313225664122,-0.00397528410568353,0.0098675003546523,0.404137036176089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37164,-0.00244079164755185,0.00292616891211358,-0.00817608271529448,0.00329449942019077,0.404226029161117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36847,0.00320986693190551,0.00384923781641149,-0.00433463918826102,0.010754373052072,0.404355234499858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39436,0.00256703060000491,0.00308117757880119,-0.00347207745444541,0.00860613865445523,0.404783025346741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36763,-0.00371576179945572,0.00446432972088731,-0.0124658480523948,0.00503432445348339,0.405243113393309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36847,0.00446982413350683,0.00537194412612873,-0.00605918635370549,0.0149988346207191,0.405386453388936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36847,0.00356492638832779,0.00429036956956484,-0.00484419796801929,0.0119740507446749,0.406038449831217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37221,-0.00585210939701608,0.00704531798720918,-0.0196609326519461,0.00795671385791391,0.406193646862568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36992,-0.00825173661704063,0.00995995125394465,-0.0277732410747721,0.0112697678406909,0.407407880134142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39606,0.00247010175126251,0.00298424795871042,-0.00337902424780991,0.00831922775033493,0.407845914570601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39526,-0.0034373836157132,0.00415547675785395,-0.0115821180611069,0.00470735082968055,0.408140454947741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39123,-0.00684910921077444,0.00828771877938878,-0.0230930380183764,0.00939481959682757,0.40858119239723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,37221,-0.00157341965678855,0.0019076831591741,-0.00531247864876979,0.00216563933519268,0.409511689680318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,37255,0.00665860587150156,0.00809686199888847,-0.00921124364631983,0.022528455389323,0.410882403245158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36880,0.00650985341411646,0.00791638808599573,-0.00900626723443517,0.0220259740626681,0.410907039673819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36763,0.00460400170275652,0.00561836319358613,-0.00640799015667229,0.0156159935621853,0.412542131554547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36880,0.00400199039272771,0.00488433261319339,-0.00557130152913134,0.0135752823145868,0.412601009277495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37255,0.0101344470130986,0.0123712467121048,-0.0141131965426269,0.0343820905688241,0.412691173397715
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,37241,0.00163311079227682,0.00199420121729483,-0.00227552359362105,0.00554174517817468,0.412841729450215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36992,0.00436254382970103,0.00533078253553934,-0.00608578993995608,0.0148108775993581,0.413162425733204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39541,-0.00913680215676698,0.0111717406245939,-0.031033413780971,0.0127598094674371,0.413456060049535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36861,0.00493335912619857,0.00603708094623021,-0.00689931952841264,0.0167660377808098,0.413843405551823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36992,0.00397945766252793,0.00487229886243561,-0.00557024810784587,0.0135291634329017,0.414085939071505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39123,0.00560996930408806,0.00688835312928038,-0.00789120282930149,0.0191111414374776,0.415421199677235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39206,-0.00217745966378993,0.00267443432792165,-0.00741935094651636,0.0030644316189365,0.415557396640221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39194,0.00277684224370917,0.003419904119999,-0.00392616983148887,0.00947985431890721,0.416824859747355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39194,-0.00485447719065194,0.00598035479019326,-0.0165759725794307,0.00686701819812686,0.416955479198229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,39355,0.00313095911826082,0.00386038007704166,-0.00443538583274084,0.0106973040692625,0.417350228640808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37203,-0.00238511127076001,0.00295416895527036,-0.00817528242308992,0.0034050598815699,0.419467648852192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37221,0.00325459468372821,0.00403494535413033,-0.00465389821036723,0.0111630875778237,0.419910887689731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36823,-0.00327883146598421,0.00407043264019892,-0.0112568794407741,0.00469921650880567,0.420532804517054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39453,0.00648728916794938,0.00808159565997797,-0.00935263832560744,0.0223272166615062,0.422147111630879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36861,-0.00518340073245436,0.00646051513603732,-0.0178460103990875,0.00747920893417879,0.42238322061099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39428,0.00189651491443226,0.00236784572245339,-0.00274446270157639,0.0065374925304409,0.423176016928805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36992,-0.00385222032911169,0.00481748238011762,-0.0132944857941422,0.00559004513591884,0.42393831466198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36763,0.00579813711018578,0.00726456846025605,-0.00844041707191608,0.0200366912922876,0.424805090635554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39428,-0.00521048381806368,0.00653359657087537,-0.0180163330969794,0.00759536546085204,0.425178628933353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36880,-0.00399127938855221,0.00500558399073936,-0.0138022240104014,0.00581966523329694,0.425254091995403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,39029,0.00499204564475209,0.00626789475037511,-0.00729302806598312,0.0172771193554873,0.425785270129317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39526,0.00196933859491218,0.00247326013566617,-0.00287825127099351,0.00681692846081788,0.425898055836851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39636,0.00259223175266667,0.00325865419837491,-0.00379473047614814,0.00897919398148148,0.426340081949193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39187,-0.00687785399299391,0.00864848724306642,-0.0238288889894041,0.0100731810034163,0.426471183923859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39462,0.00264565690614551,0.00332723317128529,-0.00387572010957367,0.00916703392186468,0.426537523356201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37162,0.00408686236238531,0.0051486218568592,-0.00600443647705873,0.0141781612018293,0.427339546215242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,37196,-0.00222844624184914,0.00281041629601411,-0.00773686218203679,0.00327996969833851,0.427836924559626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36880,0.00364582070359991,0.00459810347800547,-0.00536646211329082,0.0126581035204906,0.427853192971786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,39194,0.00376751943104486,0.0047525153584597,-0.00554741067153615,0.0130824495336259,0.427940801564388
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39194,0.00206251535584584,0.00261409222919622,-0.00306110541337875,0.00718613612507043,0.4301254579776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36763,0.00453777499010657,0.00575690080831993,-0.0067457505942005,0.0158213005744136,0.430576033814775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36916,0.00143256511061352,0.00182049264486206,-0.00213560047331612,0.00500073069454316,0.431349115166752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36861,0.00511505157121716,0.00651679303139939,-0.00765786277032564,0.01788796591276,0.432525321905189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38999,0.00466407545937835,0.00594659509628226,-0.00699125092933488,0.0163194018480916,0.43286099555226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36861,0.00315479929862493,0.00403236198137319,-0.00474863018486652,0.0110582287821164,0.434012050841704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,39194,-0.00348798165131885,0.00446149509392889,-0.0122325120354195,0.00525654873278178,0.434346681016161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37255,-0.00229008826038744,0.00293386673566197,-0.00804046706228489,0.00346029054151002,0.435069892752749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38842,0.00329031610435006,0.00421681935405875,-0.00497464982960509,0.0115552820383052,0.43523664202749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,39123,0.00283706155970189,0.00364791707931896,-0.00431285591576328,0.00998697903516706,0.436746076019034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36861,0.00207652153584098,0.00267432726454615,-0.00316515990266948,0.00731820297435144,0.437489274493585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39541,-0.00290714932428078,0.00374436904171981,-0.0102461126460516,0.00443181399749005,0.437521672518473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36880,-0.00265580674303128,0.00342779674562529,-0.00937428836445685,0.00406267487839428,0.438481240315914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37127,-0.0029877899978041,0.00386064881473064,-0.0105546616746762,0.00457908167906796,0.438999173648303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36847,0.00331938102035266,0.00429020357991144,-0.00508941799627375,0.0117281800369791,0.439116011870023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36916,-0.00476746754339941,0.00617586981056845,-0.0168721723721136,0.00733723728531475,0.440158213053904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36955,-0.00461207910333501,0.00597631521067668,-0.0163256569162613,0.00710149870959128,0.440291187312545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36992,-0.0053509728687509,0.00694461952601067,-0.0189624271397318,0.00826048140223001,0.441005616414498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,37164,0.00490067976463453,0.00636134671684763,-0.00756755980038682,0.0173689193296559,0.441086454922474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37162,0.00252534112084387,0.00328962349115501,-0.00392232092181994,0.00897300316350769,0.442698273057105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39566,-0.00332425264930234,0.00433797102537572,-0.0118266758590387,0.00517817056043408,0.443500810836998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39441,0.00875951558011005,0.0114401440417013,-0.0136631667416245,0.0311821979018446,0.443877429346851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,39187,0.00878688244280952,0.0114843738950767,-0.0137224903915408,0.0312962552771599,0.444214507903006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39123,0.00317055811405792,0.0041511477478554,-0.00496569147173866,0.0113068076998545,0.445011431284644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37119,-0.00326398558453766,0.00427864610238369,-0.0116501319452097,0.00512216077613437,0.445564219353361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,37164,-0.00236426920522,0.00309925928650686,-0.00843881740677346,0.00371027899633345,0.44556715618444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36916,0.00191167901251622,0.00250787627152115,-0.00300375847966524,0.00682711650469768,0.445913259722206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36847,0.00290292057746626,0.00381119900164767,-0.00456702946576317,0.0103728706206957,0.446264485049896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38959,-0.00241133420432704,0.00316654258129826,-0.00861775766367162,0.00379508925501754,0.44636858948758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37162,-0.00539605256069193,0.0070896312906741,-0.0192917298904132,0.00849962476902931,0.446600157061544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,39123,0.00576818652931499,0.0075790980890259,-0.00908684572517576,0.0206232187838057,0.446630457396019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,37162,-0.00556409111718587,0.00731988958108952,-0.0199110746961213,0.0087828924617496,0.447189066587852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39433,0.00184590757888013,0.00242875997502457,-0.00291446197216803,0.00660627712992829,0.447254239999005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36880,-0.00323982420906835,0.00426704242132943,-0.011603227354874,0.00512357893673734,0.447707294743644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37203,-0.00400953232127661,0.00528954976904919,-0.014377049868613,0.00635798522605981,0.448458925685365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39068,0.00324537677087976,0.00428275917353114,-0.00514883120924129,0.0116395847510008,0.448596658452224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39581,0.00231858190626156,0.00306459328818168,-0.00368802093857453,0.00832518475109765,0.449318800114646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36861,0.00262670562912285,0.00349115529700745,-0.00421595875301176,0.00946937001125746,0.451831640232018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36861,0.00344088684638933,0.00457379296687315,-0.00552374736868204,0.0124055210614607,0.451881993361001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39477,-0.00241535737578774,0.00321477643951927,-0.0087163191972455,0.00388560444567002,0.452465959866806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37162,0.00338439123035255,0.00451335181884998,-0.00546177833459342,0.0122305607952985,0.453351674540515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39123,0.00276871198182466,0.00370578799103943,-0.00449463248061261,0.0100320564442619,0.454995991502387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39578,-0.00426559895759581,0.00570967098935006,-0.0154565540967219,0.0069253561815303,0.455024986419342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39654,0.00475202949240081,0.00637864333305496,-0.00775011144038691,0.0172541704251885,0.456288903500775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36823,0.00659842535967366,0.00889283582219843,-0.0108315328518353,0.0240283835711826,0.458105429637031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39455,0.00156799163706899,0.00212585101499332,-0.00259867635231792,0.0057346596264559,0.46077940490399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,39055,-0.00749940420267088,0.0101819495404367,-0.0274560253019267,0.012457216896585,0.461414498219314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36861,0.00230532419561781,0.00313037262118805,-0.00383020614191077,0.0084408545331464,0.461478332315082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39601,-0.00221920663755338,0.00301838912108308,-0.00813524931487622,0.00369683603976946,0.462211538537646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39654,0.00461814216264299,0.00628453335882393,-0.00769954322065192,0.0169358275459379,0.462446759622094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36916,0.00275728195640536,0.00375882650172391,-0.00461001798697351,0.0101245818997842,0.463237688048254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39485,-0.00449260250838827,0.00614792424308572,-0.0165425340248363,0.00755732900805974,0.464942575062698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37162,0.00444943245341939,0.00609192081787664,-0.00749073234961883,0.0163895972564576,0.465169864632002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,37203,0.00599429023491055,0.00822514586351098,-0.010126995657571,0.0221155761273921,0.466151979975391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36880,-0.00401960719597788,0.00551797646208158,-0.0148348410616578,0.00679562666970202,0.466347760566912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39579,0.00280665802616748,0.00385546268135132,-0.00475004882928111,0.0103633648816161,0.466643717434674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36880,-0.00581796417803844,0.0079947307282584,-0.0214876364054249,0.00985170804934803,0.466795747818958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39496,0.00369514737119502,0.00509424905693033,-0.00628958078038843,0.0136798755227785,0.468244549907106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36819,0.00571416577469513,0.00788381895275726,-0.00973811937270909,0.0211664509220994,0.468590487465282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,39314,0.00219079299316935,0.00302400847845274,-0.00373626362459801,0.00811784961093671,0.468790759520654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36823,0.00269825845095206,0.00372804399344691,-0.00460870777620388,0.010005224678108,0.469218650848802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36992,0.00243680227521217,0.0033687080972565,-0.00416586559541056,0.0090394701458349,0.469469754397926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39641,0.00219281002823584,0.00303356263757669,-0.00375297274141447,0.00813859279788616,0.469783321522624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37221,-0.00189242546075865,0.00261819755563692,-0.00702409266980701,0.00323924174828972,0.469817820182355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36992,-0.00350003514490658,0.00485394549896115,-0.0130137683228704,0.00601369803305728,0.47087980592174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36763,-0.0045798373756199,0.00635254936100191,-0.0170308341231836,0.00787115937194384,0.470957172500493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39355,0.00648091338761713,0.00899146104312759,-0.0111423502569129,0.0241041770321472,0.471052896628063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36955,-0.00493360939939796,0.00685252412295301,-0.0183645566803859,0.00849733788158994,0.471557140098621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39068,-0.00281274873554699,0.00390840555833465,-0.0104732236298829,0.00484772615878893,0.471741834538615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39304,-0.00181366610062723,0.00252081908917528,-0.00675447151541078,0.00312713931415631,0.471859673264914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39531,0.00453064593696689,0.0063011057357103,-0.0078195213050253,0.0168808131789591,0.472137305032495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36847,-0.00403918546318061,0.00561842941571277,-0.0150513071179776,0.00697293619161641,0.472205499287842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,37145,-0.00294199718096566,0.00409272956439945,-0.0109637471271886,0.00507975276525726,0.472255833545229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36976,0.00633983096153215,0.00882766207841632,-0.0109623867121638,0.0236420486352281,0.472661058924713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36861,0.00334939581460918,0.00466404505569237,-0.00579213249454786,0.0124909241237662,0.472689974603289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36861,0.00254720984331318,0.00354951671795257,-0.00440984292387386,0.00950426261050022,0.473004148283182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39194,0.00426677271807701,0.00595861155121831,-0.00741210592231089,0.0159456513584649,0.473960531754518
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36992,-0.0035075822726965,0.00490253789070432,-0.013116556538477,0.00610139199308397,0.47433659301717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37221,0.00196903530538307,0.00275537863645516,-0.00343150682206905,0.00736957743283519,0.474859947206513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36847,-0.00333485946937105,0.00468550021325517,-0.0125184398873512,0.00584872094860909,0.476638983440545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36847,-0.00392196410310757,0.00551990580564872,-0.0147409794821791,0.00689705127596393,0.477399522229603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36916,0.00352433334399335,0.00496136699634339,-0.00619994596883971,0.0132486126568264,0.477497125246428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39104,-0.00252999869898669,0.00359274811632495,-0.0095717850069836,0.00451178760901022,0.481321939861697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36880,-0.00391595488320203,0.00556981223116775,-0.0148327868562908,0.00700087708988675,0.482026751183919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,39256,0.00423314222307434,0.00602239488052141,-0.00757075174274762,0.0160370361888963,0.48212903484502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36880,0.00362884440602352,0.00516329418656046,-0.00649121219963499,0.013748901011682,0.482183753115489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36861,0.00484085718583864,0.00689585282540075,-0.00867501435194683,0.0183567287236241,0.482695178220025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36880,0.00178339342766832,0.00254082278616624,-0.00319661923321751,0.00676340608855415,0.482757148604434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39458,0.00242099436289738,0.00345019361448838,-0.00434138512149984,0.0091833738472946,0.482878329806048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36823,0.00749564843248096,0.0107043626979061,-0.013484902455415,0.028476199320377,0.483789116072055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39204,0.00265945186890987,0.00380099599120395,-0.00479050027384989,0.0101094040116696,0.484142968535261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37221,-0.00306970866194261,0.00438871851155715,-0.0116715969445946,0.00553217962070941,0.484280815136899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39428,0.00183245150815839,0.00262050985487626,-0.00330374780739907,0.00696865082371586,0.484392363934516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39589,-0.00401699005893741,0.00574914043866369,-0.0152853053187182,0.00725132520084343,0.4847431323863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39551,-0.00160375381294478,0.00229764210499194,-0.00610713233872898,0.00289962471283943,0.485188045232214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36861,-0.00328153751159891,0.00470870170551864,-0.0125105928544154,0.00594751783121763,0.485872678386414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36763,0.00263666319886519,0.00378474543836814,-0.00478143786033637,0.0100547642580668,0.486031654339644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39462,0.00597657428897668,0.00859120679148725,-0.0108621910223383,0.0228153396002917,0.486651430613189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39187,-0.0046558572457677,0.00669685484071309,-0.0177816927335654,0.00846997824202997,0.486921870573807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36880,-0.00258894560773641,0.00372523227564643,-0.00989040086800342,0.0047125096525306,0.487083573555199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37203,0.00594231510629589,0.00858447290561259,-0.0108832517887048,0.0227678820012966,0.488813886826964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,39042,0.00189178510625748,0.00273297157320168,-0.00346483917721782,0.00724840938973277,0.488817658013794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39396,0.00141939449086343,0.00205488840777954,-0.00260818678838448,0.00544697577011133,0.489739408936673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36775,0.00336322404789136,0.00487061934322391,-0.00618318986482751,0.0129096379606102,0.489884891383697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39104,-0.00397426603072753,0.00576315559548643,-0.0152700509978809,0.00732151893642587,0.490457350712958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36763,-0.00446004544942497,0.00647064791162335,-0.0171425153562067,0.0082224244573568,0.490664228046811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39355,0.0022167673627171,0.00321818536950812,-0.00409087596151881,0.00852441068695301,0.490943962750513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39123,0.00332710869362665,0.00485076773588998,-0.00618039606871771,0.012834613455971,0.492791285401203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36955,0.0013198104629666,0.00192818869895943,-0.00245943938699388,0.00509906031292708,0.49368353703173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36955,0.00178808165655048,0.00262725207530708,-0.00336133241105139,0.00693749572415236,0.496143518866673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36880,-0.00158410009492644,0.00233611102023974,-0.00616287769459634,0.00299467750474346,0.497725471279094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37164,-0.0104905551656074,0.0154791475264357,-0.0408296843174214,0.0198485739862065,0.497960458877398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36880,0.00122439829292589,0.00181261720898464,-0.002328331436684,0.00477712802253578,0.499379349737356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36861,0.0036849215205234,0.00547515498676185,-0.00704638225352983,0.0144162252945766,0.500943299559168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,39104,-0.00336963029054071,0.00501144626334358,-0.0131920649666941,0.00645280438561271,0.501348090061539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36880,-0.00176784207874769,0.00263176649458979,-0.00692610440814368,0.0033904202506483,0.501766737130922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36849,-0.00229021634494814,0.00341052385875264,-0.00897484310810332,0.00439441041820704,0.501905315207656
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39187,-0.00316576634327898,0.00472280101853863,-0.0124224563396147,0.00609092365305673,0.50266724506919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36847,0.00528903876414079,0.00789750893827534,-0.0101900787548789,0.0207681562831605,0.503055307930757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39589,0.00322402204153393,0.00481446175887799,-0.00621232300586693,0.0126603670889348,0.50308879918601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36823,0.00391429557290284,0.00584998481988394,-0.00755167467406967,0.0153802658198754,0.503436464106899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,37221,0.00958550354193051,0.0143264325447115,-0.0184943042457041,0.0376653113295651,0.503457698710886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36916,-0.00608695696420873,0.00911057246306089,-0.0239436789918081,0.0117697650633906,0.50406927736722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39589,-0.00139253258658593,0.0020847523008822,-0.00547864709631504,0.00269358192314318,0.504168869171749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36992,0.00220072760826226,0.00330649586258353,-0.00428000428240146,0.00868145949892597,0.505693751107714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37255,-0.00229071262984286,0.00345028367595615,-0.00905326863471691,0.00447184337503119,0.506753416126751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36880,0.00262738859813787,0.00395885004201065,-0.00513195748420301,0.0103867346804788,0.50691084882446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36763,-0.00301579726698517,0.00454596167440935,-0.0119258821488275,0.00589428761485716,0.507085941425608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39654,0.00184076073157658,0.00278374902822852,-0.00361538736375132,0.00729690882690449,0.508460482019913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39485,-0.00260117504923442,0.0039363258483774,-0.0103163737120541,0.00511402361358529,0.508742410623865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39636,-0.00244034625509974,0.00369681750350384,-0.00968610856196727,0.00480541605176779,0.50918630278339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36847,0.00224469459453606,0.00340346499642134,-0.00442609679844978,0.00891548598752189,0.509566359783433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39455,0.00191243323093658,0.00291090683660838,-0.00379294416881586,0.00761781063068901,0.511198186531212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,39032,-0.00496796749695727,0.00758932361407021,-0.0198430417805349,0.00990710678662035,0.51273596737478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39428,0.00164274482972004,0.00252330711936616,-0.00330293712423763,0.00658842678367771,0.515038083120005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39449,-0.00211078142320688,0.00324351091942398,-0.00846806282527789,0.00424649997886412,0.515204575948838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36847,-0.00210569160687818,0.00323782562811627,-0.00845182983798607,0.00424044662422971,0.515483862883021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,37241,0.000849725594358912,0.00130761692283429,-0.00171320357439629,0.00341265476311411,0.515815246459213
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39498,-0.00196092419183416,0.00301816280400476,-0.00787652328768349,0.00395467490401517,0.51589084391588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,37203,0.00482671249563403,0.00743820259987212,-0.00975216460011533,0.0194055895913834,0.516409241522297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37247,0.00429126585454908,0.00661360113509509,-0.0086713923702373,0.0172539240793355,0.51644397470531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,37255,-0.00523007713476754,0.00806306957594359,-0.021033693503617,0.0105735392340819,0.516578904890894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37164,0.00166798640080824,0.00257405767169461,-0.0033771666357132,0.00671313943732968,0.516997400068538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,39194,0.00180452607673193,0.00278858327883281,-0.00366109714978038,0.00727014930324424,0.517569448278421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39654,0.0014254397939889,0.0022044211378672,-0.0028952256362308,0.00574610522420861,0.517882681267894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36916,0.00153228406476752,0.00237075622268582,-0.00311439813169669,0.00617896626123173,0.518079421835479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39462,0.0060051210145293,0.00931144044514873,-0.0122453022579622,0.0242555442870208,0.518989802424931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39123,-0.00273661883847598,0.00424937847108973,-0.0110654006418119,0.0055921629648599,0.519582586344237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37164,0.00519538037637841,0.00807116633182546,-0.0106241056339995,0.0210148663867563,0.519783964183011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39428,0.00309138626966117,0.00480886946033875,-0.00633399787260278,0.0125167704119251,0.5203306652648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37247,-0.00600413783139628,0.00934692706945426,-0.0243241148875266,0.0123158392247341,0.520647796224345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37203,0.00228195376716188,0.00355732690774038,-0.00469040697200926,0.00925431450633302,0.52122245553337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39123,0.00390197985307094,0.00608490661444251,-0.00802443711123639,0.0158283968173783,0.521366711166157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,37162,0.00668512184339134,0.0104791114647102,-0.0138539366274406,0.0272241803142233,0.523519418096753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36916,0.00170633169267133,0.00267669023528469,-0.00353998116848667,0.00695264455382933,0.523825110213015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37221,-0.00382777912075645,0.00600759267371434,-0.0156026607612366,0.00794710251972365,0.524034072096733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39636,0.00259801887266658,0.00407929107725993,-0.00539739163876288,0.0105934293840961,0.524212617083112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36976,0.00573293770582499,0.00900296534324667,-0.0119128743669385,0.0233787497785885,0.524277663925697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36861,-0.00278263571885937,0.00438368982059958,-0.0113746677672345,0.00580939632951581,0.525589996312783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36763,0.00354289308975157,0.00558485192933699,-0.00740341669174892,0.0144892028712521,0.525847599188414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36861,-0.00206375685726585,0.00326384865525451,-0.00846090022156468,0.00433338650703298,0.527197438595294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36823,-0.00341678771387403,0.00540613976981706,-0.0140128216627155,0.00717924623496741,0.527385577671942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36823,0.0041376444524575,0.00655644688767117,-0.00871299144737799,0.016988280352293,0.527999681941985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37162,0.00345268133622356,0.00547234234346696,-0.00727310965697169,0.0141784723294188,0.528095682722309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36763,0.00306186658848096,0.00486745745806667,-0.00647835002932972,0.0126020832062916,0.529329006625057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37247,0.00182898732697477,0.00290900620552394,-0.00387266483585216,0.00753063948980169,0.529535289632793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36992,-0.00300675365410179,0.00478444755915912,-0.0123842708700537,0.00637076356185009,0.529725073901638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39194,-0.00382624696112702,0.00608892401623345,-0.0157605380329446,0.00810804411069053,0.52975520992195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36992,0.00474635856224598,0.00759596872347314,-0.0101417401357614,0.0196344572602533,0.532079367350612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39104,0.00215122430994574,0.0034455639169911,-0.00460208096735683,0.0089045295872483,0.532410051718362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36880,-0.00348389699401873,0.00558112461410189,-0.0144229012376584,0.00745510724962097,0.532488996723414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,39123,-0.00600147779140887,0.00962513355722871,-0.0248667395635772,0.0128637839807594,0.532951566307143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39436,0.00217963642062662,0.0035012697925737,-0.00468285237281783,0.00904212521407107,0.533604598370984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37221,-0.00154371183176869,0.00248074161021168,-0.00640596538778358,0.00331854172424621,0.533769956415373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39194,0.00511708894722173,0.00824481078236747,-0.0110427401862185,0.021276918080662,0.534843748354676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37243,0.00190658739058825,0.00307459149296804,-0.00411961193562912,0.00793278671680561,0.535195889183377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39485,0.00366020473941505,0.00591061143974987,-0.00792459368249469,0.0152450031613248,0.53575453108227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39365,0.00164291947865555,0.00265774538855272,-0.00356626148290778,0.00685210044021888,0.536477432579857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36847,0.00221448332856704,0.00358489572643689,-0.00481191229524927,0.00924087895238335,0.53676731303271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36992,0.00411740828647717,0.00666802025788913,-0.00895191141898554,0.0171867279919399,0.536925511049199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,39187,0.00247406305380645,0.00400696197164586,-0.00537958241061943,0.0103277085182323,0.536953353462901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36955,-0.00390934801112572,0.0063329319009752,-0.0163218945370371,0.00850319851478566,0.537045073051948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36847,-0.00387458330434196,0.0062793239030039,-0.0161820581542296,0.00843289154554569,0.537220801872989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36823,0.00312609861866577,0.00506841240618237,-0.00680798969745167,0.0130601869347832,0.537390777302065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39187,0.00149078122901378,0.00242665757907047,-0.00326546762596434,0.00624703008399191,0.539003315343922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36823,-0.0040350510393322,0.00658223383187548,-0.0169362293498081,0.00886612727114374,0.539873374639687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37203,-0.00494576031727236,0.00807767194380504,-0.0207779973271302,0.0108864766925855,0.540366439846146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,39319,0.00439573055613907,0.00718187245286455,-0.00968073945147544,0.0184722005637536,0.540508001266772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36861,-0.00230315737871758,0.00377537728688411,-0.00970289686101043,0.00509658210357528,0.541841881490273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36880,-0.00221244445018102,0.00362776332894802,-0.00932286057491914,0.0048979716745571,0.54196265080029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36861,0.00360245027238916,0.00590950519736227,-0.00798017991444089,0.0151850804592192,0.542136189887945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36992,-0.00406215214610697,0.00667210779860758,-0.0171394834313778,0.00901517913916389,0.542650861681449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36880,0.00249557245674307,0.00409992664320243,-0.0055402837639337,0.0105314286774198,0.542742984303561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36992,-0.00245211888657864,0.00403490405718284,-0.010360530838657,0.00545629306549972,0.543379763372116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39636,0.00191518244389114,0.00315240951283105,-0.00426354020125772,0.00809390508903999,0.543508515996256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39526,-0.0023116900271952,0.0038069416335101,-0.00977329562887499,0.00514991557448459,0.543707282294931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37255,-0.00192070230386979,0.00317175451237487,-0.00813734114812454,0.00429593654038496,0.54481463883782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36992,0.00377066893779547,0.00623113507445038,-0.00844235580812727,0.0159836936837182,0.545101208603684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,37269,-0.00140553355085276,0.00232902520605227,-0.0059704229547152,0.00315935585300969,0.546196264013763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,39194,0.00240609180749364,0.00398718128061971,-0.00540878350252098,0.0102209671175083,0.546214105163564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37221,-0.00176735679166672,0.00292876624613871,-0.0075077386340986,0.00397302505076515,0.54622172202692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39104,0.00355847063389617,0.00590435296379089,-0.00801406117513397,0.0151310024429263,0.546726950873823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36847,0.00327065566894056,0.00544501223241739,-0.00740156830659753,0.0139428796444786,0.548070766108599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,39330,0.00278115428425081,0.0046479656936306,-0.00632885847526517,0.0118911670437668,0.549609212596245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36861,0.00197272389510879,0.00329726169667832,-0.00448990903038072,0.00843535682059831,0.549656316488366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36861,-0.00224646329672089,0.00376253657990793,-0.00962103499334043,0.00512810839989865,0.550477646918006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36763,-0.00155707889759637,0.00261292415713641,-0.00667841024558374,0.003564252450391,0.551243428020042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39455,-0.00279891022547246,0.00470911519739519,-0.012028776012367,0.00643095556142211,0.552280244977427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36861,0.00417352038636504,0.0070258178030562,-0.0095970825076251,0.0179441232803552,0.552505367204614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38698,-0.00152375379286731,0.00256622009916392,-0.00655354518722859,0.00350603760149396,0.552672964284113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39104,0.00229860281259384,0.00387633660635821,-0.00529901693586825,0.00989622256105593,0.553201491111302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36651,-0.00204844507910297,0.00345779902654247,-0.0088257311711262,0.00472884101292027,0.553585046310085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36847,-0.00247318603848763,0.00418130105513358,-0.0106685361065495,0.00572216402957419,0.554204818178407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36823,0.0026630171560193,0.00450496762220942,-0.00616671938351117,0.0114927536955498,0.554444767943165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39462,-0.00319339241643474,0.00541136209762088,-0.0137996621277717,0.00741287729490219,0.555114201880649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37181,-0.00199839445509937,0.00340052804643663,-0.00866342942611516,0.00466664051591642,0.556763028595375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37221,0.00122577323881972,0.00210360961216722,-0.00289730160102804,0.00534884807866747,0.560105588886186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36823,0.00508338943307229,0.00874281411452761,-0.0120525262314018,0.0222193050975464,0.560957036259013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36880,0.00146686482180293,0.00252456028998154,-0.00348127334656089,0.00641500299016674,0.561225550343314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39485,-0.00197406285145293,0.00339854036466596,-0.00863520196619822,0.00468707626329236,0.561346159178391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39541,-0.0022203070704199,0.00382424748173286,-0.00971583213461631,0.00527521799377651,0.561527735986773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37030,-0.00230937890176993,0.00398237447505737,-0.0101148328728824,0.00549607506934252,0.561992452309447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36823,0.00336391760105653,0.00582978200739036,-0.00806245513342857,0.0147902903355416,0.56393449949263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39462,-0.00175737373209121,0.00304776266957408,-0.00773098856445641,0.00421624110027399,0.564210857442887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,39104,0.00269899897727654,0.00469210689633461,-0.0064975305395393,0.0118955284940924,0.565150594709862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37221,0.00173852112316663,0.00302291594381549,-0.00418639412671174,0.00766343637304499,0.565224368513293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36955,0.00129488220682404,0.00225481056834621,-0.00312454650713452,0.00571431092078261,0.565791794689047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36861,0.00313848652900559,0.00547495283794691,-0.00759242103337035,0.0138693940913815,0.566489554568989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36847,0.00241832144615803,0.00422401561297988,-0.00586074915528253,0.0106973920475986,0.566982043998019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39104,-0.00156805155341369,0.00273952095022801,-0.0069375126158606,0.00380140950903321,0.567072218945374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36823,-0.00206117480276883,0.00360778173927731,-0.00913242701175236,0.0050100774062147,0.567797457584453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39428,0.00321451482573537,0.00564148555353213,-0.0078427968591876,0.0142718265106583,0.568822340428319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36763,0.00227750999864014,0.00401004886898492,-0.00558218578457031,0.0101372057818506,0.570078812630965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36992,-0.00465432084076231,0.00820147992167732,-0.0207292214872499,0.0114205798057252,0.57038626046415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39104,-0.00335668715743301,0.00594356342449859,-0.0150060714694502,0.00829269715458422,0.572245631597086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39194,0.00427154010926202,0.00756720256995865,-0.0105601769278569,0.019103257146381,0.572435592057236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39428,0.0045581455830564,0.00808732293614164,-0.0112930073717812,0.020409298537894,0.573023851986454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36847,-0.00227672864579215,0.00407166213293569,-0.0102571864263461,0.0057037291347618,0.576059607018936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37221,0.00210305454463539,0.00376552195171531,-0.00527736848072662,0.0094834775699974,0.576510887725424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36861,-0.00135971485686328,0.00243862569220525,-0.00613942121358557,0.00341999149985902,0.577145211371277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36847,0.00238711783943324,0.0042845579706559,-0.00601061578305233,0.0107848514619188,0.577438776633796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36992,0.00244918708855443,0.00440489792204273,-0.00618441283864932,0.0110827870157582,0.578210866819954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39359,-0.00127539356359151,0.00229718871017941,-0.00577788343554315,0.00322709630836013,0.578767869438463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36880,-0.00198134994279235,0.0035704815700424,-0.00897949382007547,0.00501679393449076,0.5789558603461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39462,0.00422182931669551,0.00760894831753883,-0.0106917093856806,0.0191353680190716,0.579005141262816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,37269,0.00107997722450276,0.00195103209742453,-0.00274404568644933,0.00490400013545484,0.579902330387205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36847,-0.00187869115289302,0.00340145617482488,-0.00854554525554979,0.00478816294976374,0.580739314947522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36741,-0.00201604670738646,0.00365254867413368,-0.00917504210868848,0.00514294869391557,0.580988433004636
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,39123,-0.00187626003034785,0.00339972969236586,-0.00853973022738494,0.00478721016668925,0.581035509971302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,39136,-0.00235455053848702,0.00428668844190985,-0.0107564598846303,0.00604735880765628,0.582828335987311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36880,0.00180077307168273,0.00328128000633151,-0.00463053574072703,0.00823208188409249,0.58315118776161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39477,-0.00130044205768775,0.00237162517020721,-0.00594882739129388,0.00334794327591838,0.583470922970578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39194,0.00588875892397406,0.0107569030100141,-0.0151947709756535,0.0269722888236016,0.58408477213124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,39187,0.00525050919907135,0.00960051366381257,-0.0135664975820013,0.024067515980144,0.584456556545066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37203,-0.00222774458836595,0.00407358097034419,-0.0102119632902406,0.00575647411350867,0.584473339667662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36763,0.00294264400458012,0.00538292093445109,-0.00760788102694402,0.0134931690361043,0.584620147767001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37221,-0.00234311677790729,0.00429377330829961,-0.0107589124621745,0.00607267890635995,0.585280954653016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36763,0.00277032202932608,0.00507716196831496,-0.00718091542857123,0.0127215594872234,0.585320685599549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36847,-0.00229129867505487,0.0042030854102526,-0.01052934607915,0.00594674872904022,0.585662347423417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37247,0.00165143161832788,0.00303655155235709,-0.00430020942429201,0.00760307266094778,0.586553481519347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,39104,-0.00331506271826004,0.00612293182671057,-0.0153160090986128,0.00868588366209268,0.588228048621123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36861,-0.00274342169308876,0.00510525378420465,-0.0127497191101299,0.00726287572395235,0.591020146051153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36847,0.00228211334280622,0.0042535654352554,-0.00605487491029435,0.0106191015959068,0.591610402913533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36763,-0.00266981834516628,0.0049780038754551,-0.0124267059410583,0.00708706925072571,0.591744976144872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36992,0.00168263743356595,0.00314325603959292,-0.00447814440403617,0.00784341927116808,0.592440376815799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36763,0.00299180998731884,0.00561166864568082,-0.00800706055821558,0.0139906805328533,0.593945682942027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36823,0.00184812284183379,0.00346762599757149,-0.00494842411340633,0.00864466979707392,0.594067471514778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39497,0.00133624071093735,0.00251058310273074,-0.0035845021704149,0.0062569835922896,0.594565446104009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36763,-0.00196912474885883,0.00369996959708462,-0.00922106515914469,0.00528281566142702,0.594596913186043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,39104,-0.00288835358487689,0.00545592078725424,-0.0135819583278952,0.00780525115814141,0.596537401734328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39123,-0.0016688495801404,0.00315362133722509,-0.00784994740110157,0.00451224824082077,0.59668502356568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39428,0.00124337963751725,0.00236967505535843,-0.00340118347098528,0.00588794274601978,0.599796256515255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39455,0.00111251479978092,0.00212086439862313,-0.00304437942152042,0.00526940902108225,0.599898760682073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39404,-0.00119945091265948,0.00229717852200882,-0.00570192081579676,0.0033030189904778,0.601579950695158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39485,0.00131898676613078,0.00252612330178017,-0.00363221490535836,0.00627018843761992,0.601581448237363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39455,0.00129870042661129,0.00249430439625424,-0.00359013619004702,0.00618753704326961,0.60260688626454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36880,-0.00225759060953101,0.00434288871809292,-0.0107696524969931,0.00625447127793111,0.603187030113784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,37255,0.00382919797052882,0.00737376969837616,-0.0106233906382885,0.0182817865793461,0.603560589962219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37243,-0.00273602666619101,0.00529464978720469,-0.0131135402491122,0.00764148691673019,0.60533746078206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36967,-0.00241663390352184,0.00468574381519867,-0.0116006917813112,0.00676742397426756,0.606043873505731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36847,0.00240180099179333,0.0046773681722274,-0.00676584062577238,0.011569442609359,0.607614884650125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37162,0.0020036822346394,0.00391740877039498,-0.00567443895533475,0.00968180342461355,0.609022803182085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36880,-0.00287712870581052,0.00564918268924987,-0.0139495267767403,0.00819526936511922,0.610551004969574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36916,-0.00213770733225273,0.00420110511933531,-0.0103718733661499,0.00609645870164447,0.610870548954768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36992,-0.00776501155368507,0.0152899485553593,-0.0377333107221893,0.0222032876148192,0.6115669612021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39526,0.00138331569845935,0.00272712580235793,-0.0039618508741622,0.0067284822710809,0.611991689851347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,39194,0.00222493466167881,0.00438931843947702,-0.00637812947969614,0.0108279988030538,0.612234302635165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36763,-0.00211333686748094,0.00417041994595981,-0.0102873599615622,0.00606068622660029,0.612343262733296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37247,-0.00244391857948725,0.00482622729502444,-0.0119033240777351,0.00701548691876065,0.612596658925003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36763,0.00190476839106182,0.00376743544260175,-0.00547940507643761,0.00928894185856125,0.613155287020074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39541,-0.00148707956835835,0.00297161571414816,-0.00731144636808875,0.00433728723137205,0.616781073543596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36823,-0.00384085368949397,0.00768732447896669,-0.0189080096682687,0.0112263022892807,0.6173412396252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37247,-0.00326181669839947,0.00653048340575506,-0.0160615641736794,0.00953793077688045,0.617453005378436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39104,0.00303373936577787,0.00607730150569843,-0.00887777158539106,0.0149452503169468,0.617651732267099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36861,0.00105176571481545,0.00210995353947477,-0.0030837432225551,0.00518727465218601,0.618155908510884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39654,-0.00220063527037085,0.00441512579632852,-0.0108542818311748,0.00645301129043306,0.618187549660921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36823,-0.00255806998482932,0.00514005468315592,-0.0126325771638149,0.00751643719415628,0.618722900381563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36992,-0.00293050296359289,0.00590252505737252,-0.014499452076043,0.00863844614885724,0.619562427016113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36763,0.00161619270369551,0.00325878051143116,-0.00477101709870957,0.00800340250610058,0.619938431398334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36992,0.00234479167612325,0.00473806986653831,-0.00694182526229184,0.0116314086145383,0.620691166221618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36823,0.00151103907650441,0.00305363058461588,-0.00447407686934272,0.00749615502235153,0.620726358118879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37128,-0.00137785675131139,0.00278682289146735,-0.0068400296185874,0.00408431611596462,0.621019230148474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39589,-0.00206958606058037,0.00419340197233999,-0.0102886539263668,0.00614948180520601,0.621642547937941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39123,0.0021483428241673,0.00435660319429909,-0.00639059943665891,0.0106872850849935,0.621932803683993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36847,0.00225560071966066,0.00457930054272024,-0.00671982834407101,0.0112310297833923,0.62232908655528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39635,0.00119683505885857,0.00243193867066152,-0.003569764735638,0.00596343485335514,0.622633084083729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36861,-0.00292475549471531,0.00594746135840612,-0.0145817797571913,0.00873226876776069,0.622893923517725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36861,0.00212823074594646,0.00433727011799454,-0.00637281868532284,0.0106292801772158,0.623658364735313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39462,0.00244976921475393,0.0049998551506494,-0.00734994688051888,0.0122494853100267,0.624163677710959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,37221,0.00447513150948448,0.00914915620261725,-0.0134572146476453,0.0224074776666143,0.624757698410427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37221,-0.0015226892155122,0.00312937649407019,-0.00765626714388977,0.00461088871286537,0.626564984736466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36880,-0.000976427941886845,0.00201150254273212,-0.00491897292564179,0.0029661170418681,0.627385461612443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36916,0.00146852248951166,0.00303159481417632,-0.00447340334627393,0.00741044832529726,0.628106326173145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36916,0.00438157064152277,0.0090742251378841,-0.0134039106287301,0.0221670519117756,0.629204385308758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36847,-0.0026380730317455,0.00548829057563391,-0.013395122559988,0.00811897649649696,0.630757415497394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36916,0.00413645257661923,0.00863976971224532,-0.0127974960593816,0.0210704012126201,0.632111480407883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36880,0.00393616790264507,0.00822334908135122,-0.0121815962968033,0.0200539321020935,0.632190709328452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36763,0.00273108627236874,0.0057069822194172,-0.00845459887768898,0.0139167714224265,0.632266056035895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36992,-0.00253258407665527,0.00529331758489883,-0.012907486543057,0.00784231838974643,0.632338795030042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,37165,0.00120571423543015,0.00252196900423071,-0.00373734501286204,0.00614877348372235,0.632598299663703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37164,-0.0021689865133956,0.0045509833850784,-0.0110889139481493,0.00675094092135806,0.633657079579258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36861,0.00224389915938845,0.00471392650381961,-0.00699539678809798,0.0114831951068749,0.6340721571945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37221,-0.00226356331864901,0.00475950243783933,-0.0115921880968141,0.00706506145951608,0.634375901074442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36823,-0.00215150618925918,0.00455993089058911,-0.0110889707348138,0.00678595835629548,0.637057396987643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,37203,-0.00110971767426766,0.002359085465249,-0.0057335251861557,0.00351408983762037,0.638076137639627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36880,-0.00229678842769684,0.00489761373127555,-0.0118961113409969,0.00730253448560324,0.639105944007073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39418,-0.001710705307541,0.00365659096661015,-0.0088776236020969,0.0054562129870149,0.639904693383701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39415,-0.00197356063514821,0.00423251399972576,-0.0102692880746107,0.00632216680431428,0.641017821035073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39541,0.00383907086258693,0.00823461254246157,-0.0123007697206377,0.0199789114458116,0.641070866222273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36763,-0.00255359703606029,0.00549031313738721,-0.0133146107853392,0.00820741671321865,0.64186123858097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37247,-0.00337378766074487,0.00726843776260171,-0.0176199256754442,0.0108723503539545,0.642534155174254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37221,0.00308483871431161,0.0066636690822934,-0.00997595268698346,0.0161456301156067,0.643419593836651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36823,-0.00305134460977738,0.00659819752389054,-0.0159838117566028,0.00988112253704808,0.643765896483089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36992,-0.00121600349910897,0.00263066484536584,-0.00637210659602603,0.00394009959780808,0.643915883276572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39462,0.00412510254425645,0.00896482252327359,-0.0134459496013598,0.0216961546898727,0.645420069272399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36847,0.00499149256752576,0.0109050211410052,-0.0163823488688444,0.0263653340038959,0.647158590403642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36916,-0.00183214023314676,0.0040137882286216,-0.0096991651612451,0.00603488469495158,0.648066025367873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36763,0.00350844545316497,0.00768929127158153,-0.0115625654391348,0.0185794563454648,0.648198971497368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39485,0.00323519760171733,0.00709964997329755,-0.0106801163459459,0.0171505115493805,0.64862373970962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39636,0.00226807070398089,0.00498088105031551,-0.00749445615463751,0.0120305975625993,0.648860141822574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36861,-0.00278595859264622,0.00612261528592005,-0.0147862845530495,0.00921436736775708,0.649097384083412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36880,-0.00191653123113117,0.0042165088576839,-0.0101808885921916,0.00634782612992927,0.649455093745122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39428,-0.00222873471333193,0.00491351990999604,-0.0118592337369242,0.0074017643102603,0.650128881278792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39428,0.00318278475421622,0.00701841654646626,-0.0105733116768576,0.0169388811852901,0.650202201967206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39568,0.000913090256827092,0.00202668634853755,-0.0030592149863065,0.00488539549996069,0.652332208302639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36763,0.00239216954927019,0.00531799279642118,-0.00803109633171532,0.0128154354302557,0.652844083404904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39428,-0.000962000088119726,0.00214540128837714,-0.00516698661333892,0.00324298643709947,0.653870305655257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36847,-0.00182573356043442,0.0040751512821774,-0.00981303007350214,0.00616156295263329,0.654149376355507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36880,0.00249864990606318,0.00561689767738333,-0.00851046954160815,0.0135077693537345,0.656439382364519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,37221,-0.00250739503030186,0.00563731715774647,-0.0135565366594849,0.00854174659888122,0.656482556545282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39123,0.00354011245718309,0.00797882004574041,-0.0120983748324681,0.0191785997468343,0.657274194746374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,37269,0.00102770211452292,0.00232053979203026,-0.00352055587785639,0.00557596010690222,0.657865790311504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36847,0.00125861772271139,0.00284219142236503,-0.00431207746512407,0.00682931291054685,0.657893860679472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36847,-0.00265053009419941,0.00598882807775531,-0.0143886331265998,0.00908757293820099,0.658077933085818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36861,-0.00167856309436468,0.00380430427929761,-0.00913499948178801,0.00577787329305864,0.659056102672019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39355,-0.0013673913472723,0.00310603745115391,-0.00745522475153396,0.00472044205698936,0.659772143269696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39431,0.0015958553893666,0.00363025919596515,-0.0055194526347251,0.00871116341345831,0.660234490217092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36823,0.00225366450259048,0.00513298052373535,-0.00780697732393081,0.0123143063291118,0.660628824786817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36861,0.00166595031849701,0.00380050117961983,-0.00578303199355785,0.00911493263055188,0.661140097053915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36763,0.00101051939299362,0.00231506680037002,-0.00352701153573162,0.00554805032171887,0.662483930420986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,39194,0.00111704803490918,0.00256461920838585,-0.0039096056135271,0.00614370168334545,0.66316166939909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,39194,0.00182092474751139,0.00420439904706182,-0.00641969738472978,0.0100615468797526,0.664948542000666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39104,-0.00268388416792751,0.00620719081459978,-0.0148499781645431,0.00948220982868806,0.665469390261189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37203,-0.00144901891413586,0.00335212155917881,-0.00801917717012633,0.0051211393418546,0.6655530776644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37221,-0.0018271559537649,0.00422742916685247,-0.0101129171207958,0.00645860521326594,0.665592859710929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37221,0.00241491996389558,0.00561886455204332,-0.00859805455810932,0.0134278944859005,0.667357192028028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36763,-0.00115865954445594,0.00270557180285669,-0.00646158027805505,0.00414426118914317,0.668477034157293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36847,0.00157551853153178,0.00370005330940749,-0.0056765859549069,0.00882762301797047,0.670253922954574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39589,-0.00229174359481611,0.0054082284146301,-0.0128918712874911,0.00830838409785888,0.671753249756645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39462,0.00229440334879528,0.00543540400660657,-0.00835898850415359,0.0129477952017442,0.672942051555851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39413,0.00334801096325226,0.00794450013340984,-0.012223209298231,0.0189192312247355,0.673450821745452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,37221,-0.00308829236497392,0.00733564610983409,-0.0174661587402487,0.0112895740103009,0.673763625497354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36880,-0.00341141814122796,0.00812467360150367,-0.0193357784001752,0.0125129421177192,0.674577662701971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39428,-0.00168388679895334,0.00401208649623877,-0.00954757633158133,0.00617980273367466,0.674708078613455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39462,0.00253966887789398,0.006060177824046,-0.00933827965723619,0.0144176174130242,0.675167334947675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,37203,-0.00222596958269553,0.00531982931034286,-0.0126528350309675,0.00820089586557648,0.675640709523114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39654,0.00120442355009034,0.00289318679388303,-0.00446622256592041,0.00687506966610109,0.677198926848998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37221,-0.00128430072286424,0.00309640946643107,-0.00735326327706914,0.00478466183134066,0.678316549259413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36763,-0.00154561878651176,0.00373179883809172,-0.00885994450917153,0.00576870693614801,0.678752968128634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36861,0.0038435052802828,0.00929924381042074,-0.0143830125881419,0.0220700231487075,0.679383903066606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36992,0.0024760786478102,0.00600224528442855,-0.00928832210966976,0.0142404794052902,0.679961418325236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36823,0.00221281566511932,0.00540599538996344,-0.00838293529920903,0.0128085666294477,0.682307361658619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36763,0.00158699626037626,0.00390494684910189,-0.00606669956386345,0.00924069208461597,0.684450918692104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36847,-0.00211448798185567,0.00520920678087245,-0.0123245332723657,0.00809555730865433,0.684813077050273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36847,-0.00242531944372447,0.00598795590739677,-0.0141617130222221,0.0093110741347732,0.685460280981173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36992,0.00461922860280415,0.0114899244749291,-0.0179010233680569,0.0271394805736652,0.687673009949119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36853,0.0009787491380797,0.0024346314974743,-0.00379312859696992,0.00575062687312932,0.687682709429813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,39299,0.00209124274583575,0.00521950924161104,-0.0081389953677219,0.0123214808593934,0.68867705155894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37247,0.000986726329815849,0.00246560594041798,-0.0038458613134034,0.0058193139730351,0.689018634067305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,37221,-0.00130370231214118,0.00327710755762355,-0.00772683312508333,0.00511942850080097,0.690768762843052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36880,-0.0011658660739982,0.00293214739909912,-0.00691287497623246,0.00458114282823607,0.690920758894599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36880,0.000595806140717616,0.0015057043292314,-0.00235537434457593,0.00354698662601117,0.692333668310733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36847,-0.00142100326275638,0.00360769507129173,-0.00849208560248817,0.00565007907697542,0.693675526673944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37203,-0.000931929411483336,0.002369042409358,-0.00557525253382502,0.00371139371085835,0.694046816191465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39428,-0.0010893637277298,0.00277967089293536,-0.0065375186778831,0.0043587912224235,0.695134833853833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36916,-0.00170135350343039,0.00435364984918619,-0.0102345072078353,0.00683180020097454,0.695960729028658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36861,0.00242735943707564,0.0062154824522385,-0.00975498616931182,0.0146097050434631,0.696148159541642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36880,-0.00105199002517771,0.00272422172858403,-0.00639146461320242,0.00428748456284699,0.699383545968936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39455,0.00101514185193247,0.00263126114902621,-0.00414213000015889,0.00617241370402384,0.699649899354014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37243,-0.00160859216938059,0.00419457604857587,-0.0098299612245893,0.00661277688582812,0.701360347298606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36763,0.0015736596986663,0.00410418428200691,-0.00647054149406724,0.00961786089139984,0.701408971262083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36880,-0.00163826041170976,0.00427504911956252,-0.0100173566860523,0.00674083586263278,0.701567351370757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36992,-0.00233652807720892,0.00609883168654185,-0.014290238182831,0.00961718202841311,0.701644131581995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36880,0.00123981027287002,0.00323926665692894,-0.00510915237471069,0.00758877292045074,0.70191604176369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36992,-0.00191425156876892,0.00502560561606413,-0.0117644385762546,0.00793593543871677,0.703284142666156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39123,0.00171670227028517,0.00451297460360243,-0.00712872795277559,0.0105621324933459,0.703659493014171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36955,0.00275924652922014,0.0073247190935081,-0.0115972028940557,0.017115695952496,0.706400434259135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,37031,0.00110352215339863,0.00293606344011437,-0.00465116218922553,0.00685820649602279,0.707034065776353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39104,-0.0018572092721143,0.00495829339775675,-0.0115754643317175,0.00786104578748892,0.707988511789005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36955,-0.00189099800709672,0.00505505355533087,-0.0117989029755452,0.00801690696135178,0.708350615476089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37162,-0.00168257762303915,0.0045210115034251,-0.0105437601697523,0.00717860492367405,0.709773675993395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39654,0.00115516888452521,0.00311715802265708,-0.00495446083988266,0.00726479860893309,0.710952565294231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39531,-0.00211213311298896,0.00569956527686532,-0.013283281055645,0.00905901482966708,0.71095712668064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,39074,0.00224752140767874,0.00607570025104062,-0.00966085108436087,0.0141558938997183,0.711447656307754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36861,-0.00109606565989179,0.00296819621345458,-0.00691373023826277,0.00472159891847918,0.711932824183783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37203,-0.00266358689362266,0.00725839700673386,-0.016890045026821,0.0115628712395757,0.713650265744811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,37196,-0.00246633297445467,0.00672116481906529,-0.0156398160198226,0.0107071500709133,0.713662235582907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39104,-0.0024635195115983,0.00672436420402992,-0.0156432733514969,0.0107162343283003,0.714103812211172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39601,0.000534602643279454,0.00146540671108899,-0.00233759451045497,0.00340679979701387,0.715254450027323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37164,-0.00246100508063433,0.00680580742708503,-0.015800387637721,0.0108783774764523,0.717654216568033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39531,0.000693172827926756,0.00192154476354377,-0.00307305490861904,0.00445940056447255,0.718300907698811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,37269,0.000637615374579184,0.00177280405645915,-0.00283708057608074,0.00411231132523911,0.719103677179332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39355,0.00260522200725337,0.00724431267426075,-0.0115936308342977,0.0168040748488044,0.719134119962687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39194,-0.00112311570115328,0.00313485835867087,-0.00726743808414817,0.00502120668184162,0.720148784063519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39455,0.00137381446419656,0.00385619579500374,-0.00618432929401077,0.00893195822240389,0.721649677314641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36847,0.00172196542554479,0.00483443794015432,-0.00775353293715766,0.0111974637882473,0.721706360007594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37164,-0.00168154360150356,0.00472939915870127,-0.0109511659525581,0.00758807874955094,0.722182585821843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36763,-0.00176589949251754,0.00497486315205406,-0.0115166312705435,0.00798483228550843,0.722622315133802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36823,0.000959663516702701,0.00270486330581018,-0.00434186856268525,0.00626119559609066,0.722751565579868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39531,0.00264249285844079,0.00748927400908045,-0.0120364841993569,0.0173214699162385,0.724215586751059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36992,0.00214650517504082,0.00608360561943671,-0.00977736183905513,0.0140703721891368,0.724218543171086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36880,0.000926275835122417,0.00263167510629246,-0.00423180737321081,0.00608435904345564,0.72486526181371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37221,0.00115158634170521,0.0032937116915459,-0.00530408857372475,0.00760726125713517,0.726620809695015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39477,-0.00910372010246177,0.0262220129240429,-0.0604988654335859,0.0422914252286623,0.728462056240939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36847,0.00107326292590495,0.00312843491342021,-0.00505846950439866,0.00720499535620856,0.731553839443892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36823,-0.00196527488424524,0.00573325788352628,-0.0132024603359567,0.00927191056746627,0.731766024774985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36955,0.00345947523857986,0.010130640113863,-0.0163965793845916,0.0233155298617513,0.732743223547623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39636,0.00124226226526957,0.003648822233606,-0.00590942931259819,0.00839395384313733,0.733518101325025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39477,0.00283130326485157,0.00832765724365296,-0.0134909049327082,0.0191535114624114,0.733870341489007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,37243,0.000744064116313769,0.00219636462302985,-0.00356081054482474,0.00504893877745228,0.734787989795945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36741,-0.00106457974317393,0.00315183991273174,-0.00724218597212815,0.00511302648578028,0.735546406820632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39541,0.000617898682351319,0.0018307937587941,-0.00297045708488512,0.00420625444958775,0.73574232369564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36880,0.00204824696398049,0.00607893971517777,-0.00986647487776795,0.0139629688057289,0.736166702349301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36880,0.000633461937207901,0.00188981471948628,-0.0030705749129852,0.00433749878740101,0.737481458785466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,39187,0.00182953209226358,0.00546274761596442,-0.00887745323502668,0.0125365174195538,0.737697291569025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36823,-0.00138240738037093,0.00413807358671921,-0.00949303161034057,0.00672821684959871,0.73833219270802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37221,0.00283495029480931,0.00852353694894394,-0.0138711821251208,0.0195410827147394,0.739439763099464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,37255,-0.00169708142627535,0.00510886625894655,-0.0117104592938106,0.00831629644125988,0.739756088206455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36763,0.00235655330456933,0.00710377637760959,-0.0115668483955455,0.0162799550046841,0.740096925011516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36861,0.00255461267461125,0.00770758582291366,-0.0125522555382995,0.017661480887522,0.740316730095004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39545,0.000622085705367707,0.00188127551963781,-0.0030652143131224,0.00430938572385782,0.740896616855474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39393,-0.0011878696719289,0.00359699552959117,-0.00823798090992759,0.00586224156606979,0.741223702930271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36880,0.00103265627968963,0.00314043480772487,-0.00512259594345113,0.00718790850283038,0.742292831244244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36847,-0.00156023654908625,0.00475481453638604,-0.0108796730404029,0.00775919994223038,0.742812672528486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36861,0.00159721065773918,0.00490974281427587,-0.00802588525824153,0.0112203065737199,0.744948522564681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36847,0.00192732804402356,0.00595319046608952,-0.0097409252695119,0.013595581357559,0.746134984462453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36861,-0.00118803195726325,0.00368487822307725,-0.00841039327449467,0.00603432935996816,0.74714952067123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36992,-0.00176749250927092,0.00549161091169981,-0.0125310498962025,0.00899606487766071,0.74756927876961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36992,-0.00126461082264214,0.00395246094296661,-0.0090114342708567,0.00648221262557242,0.749007547380668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37164,0.00133159439739925,0.00416437319269014,-0.00683057706027342,0.00949376585507192,0.749156541902495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36823,-0.00155525554081117,0.00487740472003205,-0.011114968792074,0.00800445771045165,0.749830866733088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36847,-0.00211377631128869,0.00664580749369679,-0.0151395589989344,0.010912006376357,0.750443552545587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36823,0.00184497947063048,0.00580580246474862,-0.00953439336027681,0.0132243523015378,0.75065567527196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39485,0.0011183534891298,0.00354336699362874,-0.00582664581838254,0.00806335279664214,0.752296193838731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36847,0.00237088188448265,0.00751625954389846,-0.0123609868215583,0.0171027505905236,0.752437660366448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39428,0.00234384986173296,0.00749147232275354,-0.012339435890864,0.0170271356143299,0.754384505677531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39123,-0.00123412251202009,0.0039616513388098,-0.00899895913608729,0.00653071411204711,0.755411899535468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39462,-0.00232394376936795,0.00746098278694774,-0.0169474700317855,0.0122995824930496,0.755440391576477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,39194,0.00251043150131695,0.00808422077625185,-0.0133346412201367,0.0183555042227706,0.756158725843492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36852,0.00162413961098298,0.00525804885747532,-0.00868163614966863,0.0119299153716346,0.757413156666069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39455,0.00128321027940129,0.00419010284754592,-0.00692939130178871,0.0094958118605913,0.759420139004554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36992,0.00228195737846038,0.00745314324280833,-0.012326203377444,0.0168901181343647,0.759477383115383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39123,0.000886209488845822,0.00290760096923106,-0.00481268841084706,0.0065851073885387,0.760529952867028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39455,-0.00241379331621723,0.00795907986325164,-0.0180135898481905,0.013186003215756,0.761684179057087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39104,0.00197192654730753,0.00652879408265202,-0.0108245098546904,0.0147683629493055,0.762629408924083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36852,-0.00115034498036372,0.00380887413565942,-0.00861573828625619,0.00631504832552874,0.76264412056434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37243,0.00387919262490568,0.0128591487166862,-0.0213247388597993,0.0290831241096106,0.762910131165828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,39104,0.000850723048542452,0.0028231186378045,-0.00468258948155437,0.00638403557863928,0.763158308815841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,39194,0.00136702222914885,0.00454785984713094,-0.00754678307122779,0.0102808275295255,0.763734576408124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,37203,0.00184201021708384,0.00613217188644786,-0.010177046680354,0.0138610671145217,0.763888678995911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36929,-0.003696781974268,0.0124191177784893,-0.0280382528201071,0.0206446888715711,0.765961031981293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,39104,0.00163754078854833,0.00550632564079077,-0.00915485746740158,0.0124299390444982,0.766170968528832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36992,-0.000608559460511443,0.00205152161491927,-0.00462954182575322,0.00341242290473033,0.766747737536221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39104,0.00376425368017055,0.0127557046452293,-0.0212369274244789,0.0287654347848199,0.76791896177786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39526,-0.0015222267263814,0.00516744449962101,-0.0116504179456386,0.00860596449287579,0.768318661847238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36992,-0.00277242686045989,0.009443063880493,-0.0212808320662262,0.0157359783453064,0.769073022749125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36823,-0.00114000074912756,0.00389935738672188,-0.00878274122710244,0.00650273972884732,0.770019305653863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39428,0.000396736512380689,0.00135757846353161,-0.00226411727614126,0.00305759030090264,0.770108427423583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39247,-0.000542604840107017,0.00185879298409632,-0.00418583908893581,0.00310062940872177,0.770357646273092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36916,0.000457535914139825,0.00159247923379974,-0.00266372338410766,0.00357879521238731,0.773879403534992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37221,0.00183043880117792,0.00637671795858133,-0.0106679283976415,0.0143288059999973,0.774078464144195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39104,-0.000954585308742216,0.00333686423199794,-0.00749483920345817,0.00558566858597374,0.774826588399567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37247,-0.00224398084798867,0.00787386068124365,-0.0176767477832262,0.0131887860872489,0.775655511653531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36741,0.00208571423267452,0.00734285196375143,-0.0123062756162783,0.0164777040816273,0.776379235609864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,37093,-0.000741815374348206,0.0026116581634434,-0.00586066537469726,0.00437703462600085,0.776384382082164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37255,0.000652183389277624,0.00229697211908358,-0.00384988196412618,0.00515424874268143,0.776467250472559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39495,0.00268889852489948,0.00950517429418612,-0.0159412430917053,0.0213190401415043,0.777266684455682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39601,0.000635778342402737,0.00226567544357455,-0.00380494552700337,0.00507650221180885,0.779010954313209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39455,-0.000836366618606375,0.00299239769896978,-0.00670146610858714,0.00502873287137439,0.779867180245966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39187,0.00121923362241412,0.00436233015779833,-0.00733093348687061,0.00976940073169886,0.779871684526237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,39187,0.00136095338567771,0.00487266711461786,-0.00818947415897329,0.0109113809303287,0.780015776542201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36992,-0.00206608139741201,0.00740358630155368,-0.0165771105484572,0.0124449477536332,0.78019958730195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39428,0.00223459253915365,0.00802078270608559,-0.0134861415647741,0.0179553266430814,0.780555422216231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36715,0.000862719673163037,0.00313624127537214,-0.00528431322656635,0.00700975257289242,0.783258817503622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36763,0.00102506932019282,0.00375663068976646,-0.00633792683174944,0.00838806547213508,0.784958235755319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39545,-0.00112243863915051,0.00412031469781734,-0.00919825544687249,0.00695337816857146,0.785306086465162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36880,-0.000711679833314206,0.00261680531250136,-0.00584061824581687,0.00441725857918846,0.785653338328043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39578,0.000630691720477425,0.00233942984049313,-0.0039545907668891,0.00521597420784395,0.787477783434222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36595,-0.000553008570266444,0.00206041465246215,-0.00459142128909227,0.00348540414855938,0.788398509902418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39462,0.0013422286661354,0.00502751233005142,-0.00851169550076538,0.0111961528330362,0.789490766259463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39187,-0.000816406540182013,0.00307026147992031,-0.00683411904082581,0.00520130596046179,0.790313921820677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39428,-0.000712942142142959,0.00268794591061212,-0.00598131612694272,0.0045554318426568,0.790830706604901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36955,0.000897735120646068,0.00340151870807758,-0.005769241547186,0.00756471178847813,0.791844485839925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37162,0.00193843269273565,0.00734610618993996,-0.0124599354395467,0.016336800825018,0.791882729180965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36847,-0.00235493428233269,0.00895803439874151,-0.019912681703866,0.0152028131392007,0.792643466076481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37162,-0.00252072196774149,0.00959368423050053,-0.0213243430595225,0.0162828991240395,0.792749026074162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37221,0.00275441461293518,0.0104876478054137,-0.0178013750856756,0.023310204311546,0.792836802173904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,39194,-0.00149915437432119,0.00573878692654995,-0.0127471767503591,0.0097488680017167,0.793917306768878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39187,0.000759791110727156,0.00294516929914557,-0.00501274071559816,0.00653232293705247,0.796426905813568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36992,0.00173396143577859,0.00672992276993238,-0.0114566871932889,0.014924610064846,0.796681628461516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36955,0.000944489760845656,0.00370093375714182,-0.00630934040315231,0.00819831992484362,0.798570435963541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36847,-0.0015447202478881,0.00605750507947788,-0.0134174302036647,0.0103279897078885,0.798720132095144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,37241,-0.000816644695740033,0.00320882728975747,-0.00710594618366467,0.00547265679218461,0.799113841145786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39428,-0.000699750620061673,0.00275020444613298,-0.00609015133448232,0.00469065009435897,0.799162347127062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39608,-0.00060957822432769,0.00239698725665501,-0.0053076732473715,0.00408851679871612,0.799259397574372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39428,0.00048003412490686,0.00190630541653744,-0.00325632449150652,0.00421639274132024,0.801188399233541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36847,-0.00156101815278355,0.00622405388963209,-0.0137601637764624,0.0106381274708953,0.801969738812023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36847,-0.00148904124598731,0.00598482174550739,-0.0132192918671818,0.0102412093752072,0.803517338957952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,37162,-0.0010876145288648,0.00438180989778621,-0.00967596192852577,0.00750073287079618,0.803974969389184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39187,0.00138707891761254,0.00560423639704176,-0.00959722442058932,0.0123713822558144,0.804520541161398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36955,0.000668419044331962,0.00274855176749851,-0.00471874241996513,0.00605558050862905,0.807862557818095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39531,0.00133839734233771,0.00550510321997013,-0.00945160496880375,0.0121283996534792,0.807916216895069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39601,-0.000671673034133373,0.00278902081614435,-0.00613815383377629,0.00479480776550954,0.809692039583131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36861,0.000750722001450941,0.00314044785325081,-0.00540455579092065,0.00690599979382253,0.811071267906328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39123,0.000976003403086372,0.00408538351417295,-0.00703134828469261,0.00898335509086535,0.811185460008806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,39123,-0.00156915848122151,0.00659376570169904,-0.0144929392565516,0.0113546222941086,0.811902973921622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39104,-0.000745843295563652,0.0031474348027954,-0.00691481550904263,0.00542312891791533,0.812684444041122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36847,0.00125458379924175,0.00529999675583391,-0.00913340984219273,0.0116425774406762,0.812882531102564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36742,-0.000535895707727994,0.00227022446422462,-0.00498553565760825,0.00391374424215226,0.813394652972263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39541,0.00220003047760523,0.00934693627634837,-0.0161199646240376,0.020520025579248,0.813921268333267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36763,0.00119504288625181,0.00516739296374236,-0.00893304732268321,0.0113231330951868,0.817111914186461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39541,0.000560079696790605,0.00245047322892355,-0.00424284783189956,0.00536300722548077,0.819214161615941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,39355,0.00113795567086764,0.00499953206126658,-0.00866112716921487,0.0109370385109501,0.819950673620081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36847,0.000974848791446391,0.00429013194428062,-0.00743380981934363,0.00938350740223641,0.820248266313955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39428,0.00148469441235228,0.00655114273756019,-0.0113555453532657,0.0143249341779702,0.820713495212462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36880,0.000897917500194501,0.0039630205224568,-0.00686960272382083,0.00866543772420983,0.820758720496854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39497,0.000806859300293109,0.00356376489205174,-0.00617811988812831,0.00779183848871452,0.820888400111674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39496,-0.000948421632559633,0.00419258117597091,-0.00916588073746261,0.00726903747234335,0.821037856317881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36880,0.00130028166390371,0.00575541429026875,-0.00998033034502304,0.0125808936728305,0.821264861622919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39485,-0.000786403421258806,0.00348246818327483,-0.00761204106047748,0.00603923421795986,0.821346175829352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,39194,0.0016739538487173,0.00746363143083651,-0.0129547637557223,0.0163026714531569,0.822541441557152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39309,0.000820220705949869,0.0036578017150244,-0.00634907065549796,0.0079895120673977,0.822574654388372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39123,-0.0010551565817128,0.00473110418710105,-0.0103281207884309,0.00821780762500527,0.823518813646692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36955,0.000567103081199269,0.00254889640241893,-0.00442873386754183,0.00556294002994037,0.823936359757482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36847,0.00104138906582077,0.00469146931404889,-0.00815389078971504,0.0102366689213566,0.824336974593979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36861,0.00126783032135545,0.00573255661661124,-0.00996798064720258,0.0125036412899135,0.824969033964462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36861,-0.00181665669369738,0.00830508946787378,-0.01809463205073,0.0144613186633352,0.82685605170126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39455,-0.00085582176540674,0.00392173323336609,-0.00854241890280427,0.00683077537199079,0.82725647122173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36880,-0.0017182799116006,0.00788243764656652,-0.017167857698871,0.0137312978756698,0.827441734312883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39654,0.000609094932806215,0.00279930740259263,-0.00487754757627535,0.00609573744188778,0.82775326865432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,39194,-0.00220181083871786,0.0101498772605685,-0.0220955702694321,0.0176919485919964,0.828266055777628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,39194,0.00104509862667963,0.00482305107472763,-0.00840808147978652,0.0104982787331458,0.828454283033434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39396,0.00074729075406494,0.00346298449658016,-0.00604015885923217,0.00753474036736205,0.829151388159711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39462,-0.00214641262280804,0.00996800267221374,-0.021683697860347,0.0173908726147309,0.829512763247661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39432,0.00132056055225747,0.00614619444117366,-0.0107259805524429,0.0133671016569578,0.829880764847696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36763,0.000945685172914746,0.00440162357259285,-0.00768149702936724,0.00957286737519673,0.829888474212429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36880,-0.00152314808547728,0.00710701303393515,-0.0154528936319902,0.0124065974610356,0.830303995391092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37221,-0.000836496458390293,0.00390541800024954,-0.00849111573887939,0.00681812282209881,0.830403316992712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39428,-0.000391195227119065,0.00182997942797317,-0.00397795490594648,0.00319556445170835,0.83072910716674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37164,-0.000504371691449758,0.00236186584169414,-0.00513362874117026,0.00412488535827075,0.830902990195553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39104,-0.000889358866336947,0.00417615723247191,-0.00907462704198189,0.00729590930930799,0.831360299174396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39499,0.000560310853852364,0.00264113797524073,-0.00461631957761947,0.00573694128532419,0.831994826421333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36880,-0.000613760677261848,0.00293880824693225,-0.00637382484124906,0.00514630348672537,0.834571263977535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36763,0.000472719356182673,0.00226841670918683,-0.00397337739382351,0.00491881610618886,0.83492653512099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37162,-0.00086495797379656,0.00415415222880634,-0.00900709634225698,0.00727718039466386,0.835064213778395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37162,0.000974469343910859,0.004690232630989,-0.00821838661282758,0.0101673253006493,0.835415264662872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,39187,-0.000901879277508007,0.00436779418120656,-0.00946275587267287,0.00765899731765686,0.836415774628787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36916,-0.0015135798889039,0.00733073398345069,-0.0158818184964673,0.0128546587186595,0.836426823314073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37255,0.000599924379886643,0.00290577446670627,-0.00509539357485764,0.00629524233463093,0.83643537825336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,37200,0.000429842598926676,0.00208357635163175,-0.00365396705027154,0.0045136522481249,0.836559574062665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39462,-0.00163935001055223,0.00798018991977976,-0.0172805222533206,0.0140018222322161,0.83724096672695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36880,0.000525502680915563,0.00257205201110757,-0.00451571926085527,0.00556672462268639,0.838112555470977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36929,-0.000980613009892269,0.00479969426159945,-0.0103880137626272,0.00842678774284264,0.838116627288848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36763,0.000632948794510471,0.00310880315550108,-0.00546030539027164,0.00672620297929259,0.838670345111456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36928,-0.000576361628850025,0.00284041208011188,-0.00614356930586932,0.00499084604816927,0.839204940779947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37247,0.000536596888501811,0.00264924145796193,-0.00465591636910358,0.0057291101461072,0.839492050658795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36861,0.00126166212550949,0.0062665275623106,-0.0110207318966193,0.0135440561476383,0.84044108482025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39636,-0.00112929519245575,0.00563103267284454,-0.0121661192312311,0.00990752884631955,0.841054311741918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39415,0.000616577201249888,0.00307657837243922,-0.00541351640873099,0.00664667081123076,0.841162630007182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39477,-0.000533486237427058,0.00266298036070219,-0.00575292774440335,0.00468595526954923,0.841221870385086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36992,0.00080626393910654,0.00404020135746003,-0.00711253072151512,0.0087250585997282,0.841827686942421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,39104,0.000933501573387139,0.00468611482138841,-0.00825128347653414,0.0101182866233084,0.842104473113332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39395,-0.000967318544714463,0.00486734067817187,-0.0105073062739313,0.0085726691845024,0.842471527081721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36763,0.0010209580038233,0.00518956195216619,-0.00915058342242244,0.011192499430069,0.844039745169672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39462,-0.00104009197554067,0.00529648535989823,-0.0114212032809412,0.00934101932985986,0.84432010954552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39194,-0.000650774280446686,0.00335496047454524,-0.00722649681055536,0.00592494824966199,0.846199104816252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39401,-0.000470002243630317,0.00242434694267214,-0.00522172225126771,0.00428171776400707,0.84628221364737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36916,0.000621838597013533,0.00321033439834646,-0.00567041682374554,0.0069140940177726,0.846414722929516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37243,-0.000807387588579162,0.00417442184366434,-0.00898925440216127,0.00737447922500294,0.84663858054392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36861,-0.00120318732258384,0.0062405024548635,-0.0134345721341163,0.0110281974889486,0.847116443311491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36763,-0.00154016741767215,0.00801311727108493,-0.0172458772689986,0.0141655424336543,0.84758419237349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36861,-0.00100107991741083,0.0052139227977924,-0.0112203686010839,0.00921820876626226,0.847744334472704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39654,-0.000556263546675204,0.00295233019735236,-0.00634283073348582,0.00523030364013541,0.850553789895455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36847,-0.00117606844973262,0.0062578481952426,-0.0134414509124081,0.0110893140129429,0.850930713338201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39455,0.000449610620962493,0.00239495537479473,-0.00424450191363518,0.00514372315556017,0.851089001630548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,37140,-0.00095287706429379,0.00508217546726982,-0.0109139409801426,0.00900818685155506,0.851276378522572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36992,0.00101138416785979,0.00540086199820734,-0.00957430534862659,0.0115970736843462,0.851457091292402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39187,0.000507141084635347,0.00271303292066354,-0.0048104034398652,0.00582468560913589,0.851719870706916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37162,0.000702049660061286,0.00379876334651196,-0.00674352649910215,0.00814762581922472,0.853380970233001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36763,-0.000558797748772927,0.00305096543538063,-0.00653869000211895,0.0054210945045731,0.854679887389465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36880,-0.000565557039988119,0.00310151017706626,-0.00664451698703799,0.00551340290706175,0.855311881490017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37162,-0.00072143915612959,0.00396446010801019,-0.00849178096782956,0.00704890265557038,0.855603955217329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36916,-0.0011717184948627,0.00647001647454983,-0.0138529507849804,0.011509513795255,0.856292209815685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,39306,-0.000936685405268228,0.00518581917842095,-0.0111008909949733,0.00922752018443683,0.856664877562484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36880,0.00122926683640237,0.00684285704300897,-0.0121827329678952,0.0146412666406999,0.857436293244797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,37203,0.000350264807032973,0.00195236104113247,-0.00347636283358667,0.00417689244765262,0.857621963300467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36847,0.000887599012013547,0.0049660183423558,-0.00884579693900383,0.0106209949630309,0.858149066786022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37162,0.000869981178682469,0.00487586443400279,-0.00868671311196301,0.0104266754693279,0.858391244784323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36823,0.00146632421742858,0.00822251734464379,-0.0146498097780732,0.0175824582129304,0.858466482034342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,39342,-0.000704072868468032,0.0040254786144761,-0.00859401095284119,0.00718586521590513,0.861157336551013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39589,0.000541756024506386,0.00309920928244996,-0.00553269416909554,0.00661620621810832,0.861235515275248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37203,-0.000574827240004974,0.0033178737124432,-0.00707785971639364,0.00592820523638369,0.862456342301801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36880,0.000445158388296093,0.00259211464170927,-0.00463538630945408,0.00552570308604626,0.8636481853505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36763,-0.000464044238395291,0.00278516525037137,-0.00592296812912319,0.0049948796523326,0.867677441516789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37162,-0.000818657678587535,0.00492642334803266,-0.0104744474407316,0.00883713208355648,0.868020394051964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39462,-0.000554098235603527,0.00333824415344166,-0.00709705677634919,0.00598886030514213,0.868171042153072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37221,0.000848232074512745,0.005123431858192,-0.00919369436754358,0.0108901585165691,0.868506356661291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36916,-0.000628322217282393,0.0037992620013763,-0.00807487573997993,0.00681823130541515,0.868647521323086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36916,-0.000987681272367381,0.00604232392508142,-0.012830636165527,0.0108552736207922,0.870158523745692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36763,-0.00169044307796798,0.0104665454782277,-0.0222048722152943,0.0188239860593584,0.871695039502069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39104,0.000716941406138084,0.00444277611850915,-0.00799089978613984,0.00942478259841601,0.87180233517795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39531,-0.00137097863255117,0.00853760914140653,-0.018104692549708,0.0153627352846056,0.872425495994043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39589,0.00039219663792842,0.00244558087318904,-0.0044011418735221,0.00518553514937894,0.872592135985487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36847,-0.000633996002739901,0.00401963388135196,-0.00851247841018974,0.00724448640470994,0.874676216390655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,37193,-0.000896677476903427,0.00569808800342481,-0.0120649299636161,0.0102715750098092,0.874959985502159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36916,-0.00129554423741352,0.00825721986709949,-0.0174796951769285,0.0148886067021015,0.875327495370144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39531,-0.00111249772501784,0.00711185243174929,-0.0150517284912464,0.0128267330412108,0.875697222132098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38700,0.000533700533892131,0.00341488478957635,-0.0061594736536775,0.00722687472146177,0.875809378410825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36880,0.00108068646733641,0.00698630926317602,-0.0126124796884886,0.0147738526231614,0.877071127454198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,37247,0.000640579416247805,0.00414432604610297,-0.00748229963411403,0.00876345846660963,0.877164483853815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,39093,-0.00122245367583842,0.00795643028572958,-0.0168170570358684,0.0143721496841916,0.877892965586181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36861,-0.000430079312002557,0.00279975752239682,-0.00591760405590033,0.00505744543189522,0.877917338990272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39541,-0.000433613711445974,0.00283920593281066,-0.00599845733975487,0.00513122991686292,0.878618302093396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39187,0.000800013182875345,0.00524423405681889,-0.00947868556848968,0.0110787119342404,0.8787544526231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39319,0.00103612198242811,0.00682251086490103,-0.0123359993127779,0.0144082432776341,0.879293004165624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36861,-0.00108037435002899,0.00714275329664766,-0.0150801708114584,0.0129194221114004,0.879777333479882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37221,0.000363283258108898,0.00240808533821663,-0.00435656400479569,0.00508313052101349,0.880088700140722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39123,0.000759885313080754,0.00505422825811294,-0.0091464020728206,0.0106661726989821,0.880493348715609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36880,0.0012316118343723,0.00823000654759103,-0.0148992009989061,0.0173624246676507,0.881044015172436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39194,0.00080115147599842,0.00536557600332075,-0.00971537749051025,0.0113176804425071,0.881308519881194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39194,-0.00057949059435122,0.00392516072299173,-0.00827280561141501,0.00711382442271257,0.88263295311622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36916,0.000547380671245456,0.00371027387657403,-0.00672475612683964,0.00781951746933055,0.882715244830688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39481,-0.000816384248323722,0.00559229857430453,-0.0117772894539606,0.0101445209573131,0.883936240629399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37269,-0.000324641244205081,0.00223498945218788,-0.00470522057049333,0.00405593808208317,0.884512585687989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36916,0.000877668022835449,0.00605045462638852,-0.0109812230448861,0.0127365590905569,0.88466727070565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39401,-0.00135008464147346,0.00933156135037726,-0.0196399448882129,0.016939775605266,0.884965959541253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36992,-0.000460458147124887,0.00322944366090013,-0.00679016772248914,0.00586925142823937,0.886623189083721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36955,-0.000765716682040076,0.00542877842719587,-0.011406122399344,0.00987468903526383,0.887834536321604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39428,0.000704365493805684,0.00502936842359806,-0.00915319661644651,0.0105619276040579,0.888621984477827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36847,-0.000508439775038642,0.00364724713140717,-0.0076570441525967,0.00664016460251942,0.889133407075581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,39104,-0.000603327010796146,0.0043332125764386,-0.00909642366061581,0.00788976963902352,0.889267795550009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39462,-0.00109375313164191,0.00791027201192382,-0.0165978862750126,0.0144103800117288,0.890028906998663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36955,-0.00106757686222154,0.00774518032376374,-0.0162481302967985,0.0141129765723554,0.890371008016037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36880,-0.000522714309638261,0.00380644451377944,-0.00798334555664597,0.00693791693736945,0.890777315118629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36916,-0.000936379758352083,0.00684971648162548,-0.014361824062338,0.0124890645456339,0.891267423748585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36880,-0.000612867229299753,0.00459469126355681,-0.0096184621058711,0.00839272764727159,0.893890321162851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36880,-0.000494576656610769,0.0037305439944996,-0.00780644288582998,0.00681728957260845,0.894531696507566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,37076,-0.000358681534754661,0.0027214204806439,-0.0056926656768167,0.00497530260730738,0.895145076569289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39589,-0.000347242296479979,0.00265089543759788,-0.00554299735417182,0.00484851276121186,0.895784510296788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37247,-0.000320232291630235,0.00244498883178498,-0.00511241040192879,0.00447194581866832,0.895797182289948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39194,-0.000683464420981347,0.00532800728291085,-0.0111263586954866,0.00975942985352391,0.897930976588152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39104,0.000704087739224788,0.0055176732202143,-0.0101105517723952,0.0115187272508448,0.898462601187567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39455,-0.000610320062287311,0.00478810876561017,-0.00999501324288324,0.00877437311830862,0.898573456888003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,39104,0.00051145747921823,0.00403140520682862,-0.00739009672616587,0.00841301168460233,0.899046386717149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,37203,-0.000791186285802218,0.00624770766773939,-0.0130366933145714,0.011454320742967,0.899230299284106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36880,0.00101773109028925,0.0081654820098635,-0.0149866136490432,0.0170220758296217,0.900811990050244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39123,-0.00082300305196082,0.00660379188304009,-0.0137664351427194,0.0121204290387978,0.900821484989107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36880,0.000970766107705912,0.00779075504174529,-0.0142991137741149,0.0162406459895267,0.900838379002131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36880,0.000242075583665885,0.0019448438530975,-0.00356981836840521,0.00405396953573698,0.900944811339633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,39104,-0.000585660736510998,0.00475504617668909,-0.00990555124282162,0.00873422976979962,0.901977218181964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36847,-0.000721521498156667,0.00587047886392817,-0.0122276600714559,0.0107846170751425,0.902182930398442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39531,-0.000464432517133626,0.00381000238576341,-0.00793203719322991,0.00700317215896266,0.902981248016557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39571,0.000323451147034631,0.0026744324857283,-0.00491843652499284,0.0055653388190621,0.903738602030857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39636,0.000582184790864092,0.00483903295939924,-0.00890231980955843,0.0100666893912866,0.904239054205062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36992,-0.000491370894784487,0.00410267103361208,-0.00853260612066416,0.00754986433109519,0.904668427415874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36847,0.000353586993047282,0.00298801333893238,-0.00550291915126018,0.00621009313735474,0.905804028516165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36880,0.000460009876693113,0.00388887194251532,-0.00716217913063692,0.00808219888402315,0.905840767267917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,37243,-0.000253695258659037,0.00215313429343455,-0.00447383847379075,0.00396644795647267,0.906207356956242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,39160,-0.000498472108280726,0.00433514307622665,-0.00899535253768495,0.0079984083211235,0.90845937061523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37224,-0.00108124532150954,0.00941155558448875,-0.0195278942671075,0.0173654036240884,0.908538185177102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36992,0.000661575418873549,0.00576986376261515,-0.0106473575558521,0.0119705083935992,0.908716065730324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,37164,-0.00265076705778709,0.0231641264640695,-0.0480524549273633,0.0427509208117891,0.908895453496046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39123,0.000307357016288492,0.00270095027772816,-0.00498650552805869,0.00560121956063568,0.909401161008456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36823,-0.000331803770107535,0.00291932382847961,-0.00605367847392758,0.00539007093371251,0.909510952466767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38979,-0.000865966544705069,0.00775653815520618,-0.0160687813289092,0.014336848239499,0.911107675474558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36823,0.000546729120696681,0.00491496035148983,-0.00908659316822338,0.0101800514096167,0.911429623424207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37203,-0.0010591130609697,0.00952955822648017,-0.0197370471848708,0.0176188210629314,0.911507248816477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39123,0.000758677381354535,0.00684949445581809,-0.0126663317520489,0.014183686514758,0.911805011208026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37164,-0.000255259129172925,0.00233080828225811,-0.00482364336239882,0.00431312510405297,0.912795529080301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36763,-0.000328669805839725,0.00302976159444181,-0.00626700253094566,0.00560966291926622,0.913616380489879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37162,0.000596748424980074,0.00550496646342342,-0.0101929858433298,0.01138648269329,0.913678662694196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39330,0.00032545204656089,0.00301042905518993,-0.00557498890161138,0.00622589299473316,0.913911326647037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36880,-0.000543981473493157,0.00503748636951364,-0.0104174547577399,0.00932949181075358,0.914007994369699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39462,-0.000348947179881003,0.00323518863811512,-0.00668991691058663,0.00599202255082463,0.914108254330189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36847,-0.00046254010052859,0.00435641485664754,-0.00900111321955777,0.00807603301850059,0.915445633308936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39455,0.000231185543353141,0.00222421793069415,-0.0041282816008074,0.00459065268751368,0.917218234589394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39541,-0.000243516438147234,0.00235062198675951,-0.00485073553219588,0.00436370265590141,0.917490865296038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36763,-0.000501336946605344,0.0048538462024788,-0.0100148755034638,0.00901220161025311,0.917737245814222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36880,-0.000272386500377614,0.00269895927733271,-0.00556234668394972,0.00501757368319449,0.919613379659553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37164,0.00019293868081661,0.00191236840091586,-0.00355530338497847,0.00394118074661169,0.91963944193234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,39194,0.000430765978524634,0.00437080650349284,-0.00813601476832134,0.0089975467253706,0.921492733001337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36823,0.000569262125827574,0.00582468469485136,-0.0108471198760811,0.0119856441277362,0.922146137221704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39589,-0.000839977226794861,0.00859591677725811,-0.0176879741102207,0.016008019656631,0.922157383616645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37162,0.000352593693036731,0.00363505521941336,-0.00677211453701345,0.00747730192308691,0.922729379538344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36955,0.000709517643812532,0.00747557575965917,-0.0139426108451194,0.0153616461327445,0.924386692438075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36763,-0.000679502782675173,0.00723995868380282,-0.0148698218029287,0.0135108162375784,0.925226256478969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,39355,-0.000806848984853005,0.00861536880678436,-0.0176929718461504,0.0160792738764443,0.925386632696811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37162,0.000235706688225476,0.00251889646277829,-0.00470133037881998,0.00517274375527093,0.925447944364075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37221,-0.000649755296970406,0.00699038950629257,-0.0143509187293038,0.013051408135363,0.925944901603967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39516,-0.000701973615146045,0.00760466931109114,-0.0156071254648847,0.0142031782345926,0.926454371806572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39541,0.000222264659203797,0.00249104678334028,-0.00466018703614314,0.00510471635455074,0.928903959464602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39440,-0.000297603947175882,0.00361634351757875,-0.00738563724163022,0.00679042934727846,0.93441389829765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39187,-0.000321930926611607,0.00391224223031393,-0.0079899256980269,0.00734606384480369,0.934418745673059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36880,0.000230126210467715,0.00280114087242965,-0.00526010989949439,0.00572036232042982,0.934525211134065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36880,-0.000279180343704111,0.00342939792286692,-0.00700080027252328,0.00644243958511506,0.9351188171621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,37203,0.000973624712349192,0.0120838907487844,-0.0227108011552683,0.0246580505799667,0.935783502498608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,39194,0.000214938935958167,0.00267367008938759,-0.0050254544392415,0.00545533231115784,0.935927398606915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36861,-0.000330651136250294,0.00417906859452166,-0.00852162558151275,0.00786032330901217,0.936937836896648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36847,0.000288034051062663,0.00364110554960685,-0.00684853282616677,0.0074246009282921,0.936949423131764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39499,0.000232929052154397,0.00294562645375447,-0.00554049879720437,0.00600635690151316,0.936973036894081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36880,-0.000205663675155411,0.00266434413810065,-0.00542777818583269,0.00501645083552186,0.93847275820598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,39194,-0.000329918786876528,0.00438274648250686,-0.00892010189258997,0.00826026431883691,0.939995563801243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39455,-0.000320816151171587,0.00433364225186618,-0.00881475496482931,0.00817312266248613,0.940988122599395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37164,-0.000178531405153535,0.00241670909411728,-0.00491528122962339,0.00455821841931632,0.94111199182713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36763,0.000229964653639928,0.00320932652777954,-0.00606031534080798,0.00652024464808784,0.942877543224158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37164,0.000885193051587974,0.0123901625411963,-0.0233995255291568,0.0251699116323328,0.943046140417403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39411,-0.000226460157050445,0.00322422089797658,-0.00654593311708454,0.00609301280298365,0.944005827443506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39187,0.000211373829992801,0.00301352909879905,-0.00569514320365335,0.00611789086363895,0.944081887618863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,37203,-0.000585685908727445,0.0085239319595323,-0.0172925925494108,0.0161212207319559,0.945220924480143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,39104,0.000197831016179812,0.00294438532932619,-0.00557316422929952,0.00596882626165914,0.946431966780161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,37203,0.000228567676818267,0.00344660849309795,-0.00652678496965372,0.00698392032329025,0.947126733198987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39194,-0.000222498076901429,0.00344575323686103,-0.00697617442114904,0.00653117826734618,0.948515908884756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,39274,-0.000264195065022062,0.00416197771868652,-0.00842167139364764,0.00789328126360351,0.949386533723888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36763,0.0002935991065831,0.00465840180062167,-0.00883686842263537,0.00942406663580157,0.949747050211262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37209,0.000378903862647316,0.00608257588246441,-0.0115429448669829,0.0123007525922776,0.950330221725012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37221,-0.000256277867904759,0.00421873522287191,-0.00852499890473371,0.00801244316892419,0.951561205496058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39455,0.000204133113487304,0.00339231766110439,-0.00644480950227731,0.00685307572925191,0.952016964729137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36861,-0.000192133827947893,0.00324646163605551,-0.00655519863461668,0.0061709309787209,0.952807673659181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37203,-0.000242098996195924,0.00410703081728994,-0.0082918793980842,0.00780768140569235,0.952994887361413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39123,-0.000189878181502201,0.00336450326062454,-0.0067843045723263,0.0064045482093219,0.954995466216782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,39104,-0.000248669250248571,0.00443123470454892,-0.00893388927116445,0.00843655077066731,0.955249069357951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,39123,-0.000339642760652542,0.00614749007370853,-0.0123887233051213,0.0117094377838162,0.955940833913324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36880,0.000139006574698966,0.00251991040339133,-0.00480001781594804,0.00507803096534597,0.956009253104178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,39194,0.000254047225130644,0.0046085505963281,-0.00877871194367244,0.00928680639393373,0.956039475313449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39412,0.00016376991340191,0.00311425642192673,-0.00594017267357447,0.00626771250037829,0.958061546551026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39194,0.000288310737702918,0.00548322148616037,-0.0104588033751714,0.0110354248505773,0.958066836086334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36992,0.000306677731599926,0.00597903333659557,-0.0114122276081274,0.0120255830713272,0.959093505992039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36955,0.000194212659710352,0.00385080158150931,-0.0073533584400479,0.0077417837594686,0.959777072611052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37269,-7.76566180822112e-05,0.00155971302719355,-0.00313469415138157,0.00297938091521715,0.960291274550753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39618,0.000233627238133067,0.0047104261730221,-0.00899880806099025,0.00946606253725639,0.960443474643834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,39342,-0.000560641559162833,0.0114411600432944,-0.0229853152440199,0.0218640321256942,0.960918231519858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37235,0.000208457359144196,0.00428734385374298,-0.00819473659419204,0.00861165131248043,0.961221645122498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39462,0.000151899362278369,0.00312596597030759,-0.00597499393952451,0.00627879266408125,0.961244474082768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36880,-0.000400655584669401,0.00838431325264528,-0.0168339095598541,0.0160325983905153,0.961887296680763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39531,-0.000158781903928265,0.00332908101860067,-0.00668378070038559,0.00636621689252906,0.961959619130916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36861,-0.000256013995229411,0.00553672600366028,-0.0111079969624036,0.0105959689719447,0.963120312024893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,37162,0.000145140404247767,0.00315488978511456,-0.00603844357457677,0.00632872438307231,0.963307063336296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36861,0.000238576312344094,0.00538593932066347,-0.0103178647561563,0.0107950173808445,0.964669062683951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39355,0.000362785419993119,0.00846860559349948,-0.0162356815432659,0.0169612523832521,0.96583055951573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36763,0.000260848034115876,0.00612633020235191,-0.0117467591624939,0.0122684552307256,0.966038474320736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39194,0.000147471522337402,0.00359038914163221,-0.00688969119526172,0.00718463423993652,0.96723748525406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39428,7.88627421435246e-05,0.00195041347265157,-0.00374394766425356,0.00390167314854061,0.967747776214119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39552,-0.000243859684793752,0.00616849372348122,-0.0123341073828169,0.0118463880132294,0.968465886067023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37243,-7.78260792196392e-05,0.00197587015817115,-0.0039505315892351,0.00379487943079582,0.968581457873624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,37221,-0.000189513312320071,0.00488065169542393,-0.00975559063535097,0.00937656401071083,0.969026924263184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37221,8.88858116475582e-05,0.00237421278166366,-0.00456457124041322,0.00474234286370834,0.970136348260569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39531,7.91845172577345e-05,0.00213525763370786,-0.00410592044480968,0.00426428947932514,0.970418287602417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36880,0.000127625779718393,0.00361088694310794,-0.00694971262877317,0.00720496418820996,0.971805433641932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39104,0.000180555701603236,0.00529511680731047,-0.0101978732407253,0.0105589846439318,0.972799044829528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39601,-6.16706419662508e-05,0.00182550423597235,-0.00363965894447206,0.00351631766053956,0.973050797913997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36992,0.000209386895420193,0.00620475895570575,-0.0119519406577631,0.0123707144486035,0.97308009290873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36955,9.66666466441199e-05,0.0030220331555906,-0.00582651833831346,0.0060198516316017,0.974482698532063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,39123,-0.000231548197710008,0.00752561212804291,-0.0149817479686741,0.0145186515732541,0.975454961803844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36763,0.000225827189759871,0.00816925130747746,-0.0157859053728959,0.0162375597524157,0.977946887031259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,39194,-9.14559452774141e-05,0.00345811459253124,-0.00686936054663865,0.00668644865608382,0.978901351770057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39654,3.86030148555879e-05,0.0015246285762349,-0.00294966899456483,0.003026875024276,0.979800357481117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,39187,-6.18355721200116e-05,0.0024795309940478,-0.0049217163204537,0.00479804517621368,0.98010442397621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36847,7.47693561020112e-05,0.00322619045376283,-0.00624856393327313,0.00639810264547715,0.981510461920167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36823,0.000153172269850596,0.00678005666214277,-0.0131357387879492,0.0134420833276504,0.981976415558009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39485,0.000240145110009395,0.0107922020518697,-0.0209125709116551,0.0213928611316739,0.982247452693235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36763,9.20298731419684e-05,0.00413838698749523,-0.00801920862234869,0.00820326836863263,0.98225838426845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,39194,-6.37730685017116e-05,0.00290227914547545,-0.00575224019363359,0.00562469405663016,0.982469436365686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39654,-0.000130873450938023,0.00602862238687187,-0.0119469733292069,0.0116852264273308,0.982680622469437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36955,-0.000196835673873198,0.0092132894118016,-0.0182548829210043,0.0178612115732579,0.982955375578202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36916,-6.4415141256287e-05,0.00362241877415824,-0.00716435593860644,0.00703552565609387,0.985812764807496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38957,4.16496220675442e-05,0.00235937981514261,-0.00458273481561197,0.00466603405974706,0.985916090537529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36861,0.000120656849228448,0.00704097324133588,-0.0136796507037899,0.0139209644022468,0.986328085258379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,39068,5.12182196511153e-05,0.00306196316139057,-0.00595022957667439,0.00605266601597662,0.986654437106696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39636,-4.83399306505927e-05,0.00305088627887444,-0.00602807703724449,0.00593139717594331,0.987358612566972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37709,-4.34533651996096e-05,0.00280992420195907,-0.00555090480103938,0.00546399807064017,0.987662039615662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37162,-5.16436839101037e-05,0.00335249795514428,-0.00662253967599289,0.00651925230817269,0.987709684422081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36823,-8.45162234385615e-05,0.00575195540530731,-0.0113583488178409,0.0111893163709638,0.988276960480725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36861,0.00017008017697363,0.0116800167019087,-0.0227227525587675,0.0230629129127147,0.988382138412319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37162,5.80488461022869e-05,0.00579344670998721,-0.0112971067054726,0.0114132043976772,0.992005692921442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36763,4.867273155576e-05,0.00510664862648363,-0.00996035857635216,0.0100577040394637,0.992395434415588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37255,-1.81401889862457e-05,0.00197729070049332,-0.00389362996195315,0.00385734958398066,0.992680241174848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,37162,3.21199111835897e-05,0.0040533630556941,-0.00791247167797684,0.00797671150034402,0.993677544162027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,37164,-2.60126143491396e-05,0.00518676688591624,-0.010192075710745,0.0101400504820467,0.995998553887842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36763,3.13218622019555e-05,0.00694603136334938,-0.0135828996099628,0.0136455433343667,0.996402170280195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39187,-9.07979316457076e-06,0.00544794154259262,-0.0106870452166461,0.010668885630317,0.998670231599158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,37164,-6.66569732678495e-06,0.00599130415377061,-0.0117496218387172,0.0117362904440636,0.999112321598755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39462,-3.30383241337963e-06,0.00593077834632462,-0.0116276293912096,0.0116210217263829,0.999555533409131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36880,-1.88637279854357e-06,0.00466451258187826,-0.00914433103327993,0.00914055828768284,0.999677334472105
